_unit_id,_created_at,_id,_started_at,_tainted,_channel,_trust,_worker_id,_country,_region,_city,_ip,b1,b2,confirmids1,confirmids2,e1,e2,factor1,factor2,firstfactor,saveselectionids1,saveselectionids2,secondfactor,sentence,wordid1,wordid2,orig_b1,orig_b2,baseline-decision,orig_e1,orig_e2,relation,sent_id,orig_sentence,term1,term2
724533665,5/21/2015 16:04:14,1640403534,5/21/2015 16:03:47,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,83,TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:08:20,1640406019,5/21/2015 16:07:55,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,71-83,Combination TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:12:58,1640408589,5/21/2015 16:12:22,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,83,TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:14:00,1640409429,5/21/2015 16:13:43,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,OSTEOPOROSIS:,138,83,TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:14:22,1640409628,5/21/2015 16:13:55,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,71-83-96-100-111,Combination TERIPARATIDE and raloxifene therapy,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:17:40,1640411624,5/21/2015 16:17:23,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,71-83-96-100-111,Combination TERIPARATIDE and raloxifene therapy,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:18:36,1640412260,5/21/2015 16:18:26,false,instagc,1,31184650,USA,IA,West Des Moines,63.153.203.116,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,OSTEOPOROSIS:,138,83,TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:20:38,1640413583,5/21/2015 16:19:56,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,83,TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:24:31,1640416266,5/21/2015 16:22:58,false,clixsense,1,22947672,GBR,,,88.144.127.68,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,71-83-96-100-111,Combination TERIPARATIDE and raloxifene therapy,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533665,5/21/2015 16:25:14,1640416646,5/21/2015 16:24:47,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,138,83,,,150,95,OSTEOPOROSIS,TERIPARATIDE,postmenopausal OSTEOPOROSIS:,123-138,83,TERIPARATIDE,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial.",138,83,138,83,-1,150,95,TWrex-cause,800713,"1]  Deal C, Omizo M, Schwartz EN, Eriksen EF, Cantor P, Wang J, et al. Combination teriparatide and raloxifene therapy for postmenopausal osteoporosis: results from a 6-month double-blind placebo-controlled trial",osteoporosis,teriparatide
724533666,5/21/2015 16:11:10,1640407649,5/21/2015 16:10:55,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:15:02,1640410022,5/21/2015 16:14:34,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:21:12,1640413992,5/21/2015 16:20:51,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:23:36,1640415631,5/21/2015 16:23:13,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:32:58,1640422042,5/21/2015 16:32:37,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:34:03,1640422717,5/21/2015 16:33:49,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,72,40,,,77,51,TINEA,TERBINAFINE,TINEA,72,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:42:05,1640427909,5/21/2015 16:39:55,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40-78,TERBINAFINE capitis,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 16:59:44,1640439350,5/21/2015 16:59:31,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 17:01:35,1640440614,5/21/2015 17:01:18,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,72,40,,,77,51,TINEA,TERBINAFINE,TINEA,72,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533666,5/21/2015 17:10:36,1640446150,5/21/2015 17:08:52,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,72,40,,,77,51,TINEA,TERBINAFINE,TINEA capitis,72-78,40,TERBINAFINE,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children.",72,40,72,40,-1,77,51,TWrex-cause,804079,"Rademaker M, Havill S. Griseofulvin and terbinafine in the treatment of tinea capitis in children",tinea,terbinafine
724533667,5/21/2015 19:51:04,1640568985,5/21/2015 19:50:35,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,197,177,,,204,185,OBESITY,ORLISTAT,is used in OBESITY treatment.,186-189-194-197-205,131-141-165-177,nutrition therapy[185][186][187] Medication: ORLISTAT,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 19:55:58,1640571745,5/21/2015 19:55:37,false,clixsense,1,31482589,NLD,,,31.201.11.16,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY treatment.,197-205,177,ORLISTAT,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 19:59:06,1640573430,5/21/2015 19:58:47,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY treatment.,197-205,177,ORLISTAT,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:00:14,1640574147,5/21/2015 19:59:53,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY,197,165-177,Medication: ORLISTAT,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:32:01,1640591816,5/21/2015 20:31:42,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY treatment.,197-205,177,ORLISTAT,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:34:46,1640593703,5/21/2015 20:34:12,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY,197,177-186-189-194-197-205,ORLISTAT is used in obesity treatment.,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:36:44,1640594982,5/21/2015 20:36:18,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY treatment.,197-205,177-186-189-194-197-205,ORLISTAT is used in obesity treatment.,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:53:19,1640606947,5/21/2015 20:53:06,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,197,177,,,204,185,OBESITY,ORLISTAT,is used in OBESITY treatment.,186-189-194-197-205,131-141-165-177-186-189-194,nutrition therapy[185][186][187] Medication: ORLISTAT is used in,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:53:44,1640607241,5/21/2015 20:53:25,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,197,177,,,204,185,OBESITY,ORLISTAT,OBESITY treatment.,197-205,177,ORLISTAT,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533667,5/21/2015 20:55:52,1640608752,5/21/2015 20:54:16,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,197,177,,,204,185,OBESITY,ORLISTAT,Interpersonal psychotherapy Music Therapy Recreation Therapy Art therapy[183] Nutrition counseling[184] Medical nutrition therapy[185][186][187] Medication: Orlistat is used in OBESITY treatment.,0-14-40-46-55-66-75-79-93-103-123-131-141-177-186-189-194-197-205-165,131-141-165-177-186-189-194-197-205,nutrition therapy[185][186][187] Medication: ORLISTAT is used in obesity treatment.,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment.,197,177,197,177,-1,204,185,TWrex-cause,800271,Interpersonal psychotherapy (IPT)[182]  Music Therapy  Recreation Therapy  Art therapy[183]  Nutrition counseling[184] and Medical nutrition therapy[185][186][187]  Medication: Orlistat is used in obesity treatment,obesity,orlistat
724533668,5/21/2015 17:27:17,1640457072,5/21/2015 17:26:58,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,CAMPYLOBACTER INFECTIONS,3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 17:32:57,1640460415,5/21/2015 17:32:00,false,points4rewards,1,28703583,USA,,,97.73.83.199,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,CAMPYLOBACTER INFECTIONS,3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 17:54:15,1640474109,5/21/2015 17:53:58,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,i CAMPYLOBACTER INFECTIONS,0-3-17,53-60-64-42,infections caused by CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:07:07,1640482742,5/21/2015 18:06:41,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,i CAMPYLOBACTER INFECTIONS,0-3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:09:26,1640484214,5/21/2015 18:09:17,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,i CAMPYLOBACTER INFECTIONS Treatment of infections Campylobacter.,0-3-17-29-39-42-64,3-17-42-53-60-64-29,Campylobacter Infections Treatment infections caused by CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:10:27,1640485029,5/21/2015 18:10:06,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,CAMPYLOBACTER INFECTIONS,3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:16:20,1640489529,5/21/2015 18:16:00,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,CAMPYLOBACTER INFECTIONS,3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:16:33,1640489701,5/21/2015 18:15:57,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,CAMPYLOBACTER INFECTIONS,3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:38:35,1640499491,5/21/2015 18:38:17,false,clixsense,1,6574449,USA,,,216.216.68.85,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,i CAMPYLOBACTER INFECTIONS,0-3-17,64,CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533668,5/21/2015 18:39:10,1640499940,5/21/2015 18:38:55,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,3,64,,,27,77,CAMPYLOBACTER INFECTION,CAMPYLOBACTER,i CAMPYLOBACTER INFECTIONS Treatment of infections caused by Campylobacter.,0-3-17-29-39-42-53-60-64,0-3-17-29-42-53-60-64-39,i Campylobacter Infections Treatment of infections caused by CAMPYLOBACTER.,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter.,3 17,64,3,64,1,27,77,TWrex-cause,810772,i  Campylobacter Infections  Treatment of infections caused by  Campylobacter,campylobacter infection,campylobacter
724533669,5/21/2015 19:21:21,1640536109,5/21/2015 19:20:58,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,36,95,,,45,99,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,67-77-88-91-95,"intrinsic properties of the DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 19:49:09,1640567720,5/21/2015 19:48:24,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,36,95,,,45,99,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,77-88-91-95,"properties of the DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 19:51:11,1640569048,5/21/2015 19:51:01,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,36,95,,,45,99,REACTION,DRUG,REACTIONS,36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 19:54:42,1640571040,5/21/2015 19:54:24,false,clixsense,1,31482589,NLD,,,31.201.11.16,36,95,,,45,99,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 19:57:15,1640572357,5/21/2015 19:56:44,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,36,95,,,45,99,REACTION,DRUG,drug REACTIONS,31-36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 19:57:22,1640572403,5/21/2015 19:56:56,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,36,95,,,45,99,REACTION,DRUG,drug REACTIONS,31-36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 19:59:19,1640573522,5/21/2015 19:58:59,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,36,95,,,45,99,REACTION,DRUG,REACTIONS,36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 20:30:41,1640590959,5/21/2015 20:30:13,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,36,95,,,45,99,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 20:32:16,1640591908,5/21/2015 20:31:45,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,36,95,,,45,99,REACTION,DRUG,Pathogenesis Hypersensitivity REACTIONS,0-14-36,77-88-91-95-101-105-121-125-129,"properties of the DRUG, its administration, and the host.","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533669,5/21/2015 20:34:00,1640593111,5/21/2015 20:33:27,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,36,95,,,45,99,REACTION,DRUG,Pathogenesis Hypersensitivity drug REACTIONS,0-14-31-36,95,"DRUG,","Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host.",36,95,36,95,1,45,99,TWrex-cause,812333,"Pathogenesis  Hypersensitivity drug reactions can be influenced by intrinsic properties of the drug, its administration, and the host",reaction,drug
724533670,5/21/2015 16:09:00,1640406333,5/21/2015 16:08:48,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:12:54,1640408556,5/21/2015 16:12:33,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23-41-46-33,MYOTONIA CONGENITA present with myotonia,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:18:51,1640412408,5/21/2015 16:18:35,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:20:54,1640413784,5/21/2015 16:20:38,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:30:08,1640420103,5/21/2015 16:29:51,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:31:42,1640421251,5/21/2015 16:31:29,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:32:23,1640421794,5/21/2015 16:32:09,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:51:59,1640434000,5/21/2015 16:51:50,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:57:57,1640438145,5/21/2015 16:57:47,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533670,5/21/2015 16:58:18,1640438423,5/21/2015 16:58:09,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,70,14,,,88,32,MUSCLE HYPERTROPHY,MYOTONIA CONGENITA,MUSCLE HYPERTROPHY.,70-77,14-23,MYOTONIA CONGENITA,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy.,70 77,14 23,70,14,1,88,32,TWrex-cause,813670,Patients with myotonia congenita present with myotonia and often with muscle hypertrophy,muscle hypertrophy,myotonia congenita
724533671,5/21/2015 19:53:22,1640570195,5/21/2015 19:52:55,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,87,41,,,95,52,DISORDER,FLUVOXAMINE,obsessive compulsive DISORDER.,66-76-87,41-53-63-66-76-87,FLUVOXAMINE treatment of obsessive compulsive disorder.,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 19:56:42,1640572071,5/21/2015 19:56:30,false,clixsense,1,31482589,NLD,,,31.201.11.16,87,41,,,95,52,DISORDER,FLUVOXAMINE,obsessive compulsive DISORDER.,66-76-87,41-53,FLUVOXAMINE treatment,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:00:33,1640574293,5/21/2015 20:00:12,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,87,41,,,95,52,DISORDER,FLUVOXAMINE,obsessive compulsive DISORDER.,66-76-87,41,FLUVOXAMINE,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:01:10,1640574602,5/21/2015 20:00:52,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,87,41,,,95,52,DISORDER,FLUVOXAMINE,of obsessive compulsive DISORDER.,63-66-76-87,41,FLUVOXAMINE,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:33:49,1640593011,5/21/2015 20:33:27,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,87,41,,,95,52,DISORDER,FLUVOXAMINE,obsessive compulsive DISORDER.,66-76-87,41-53,FLUVOXAMINE treatment,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:36:56,1640595131,5/21/2015 20:36:22,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,87,41,,,95,52,DISORDER,FLUVOXAMINE,DISORDER.,87,41,FLUVOXAMINE,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:38:45,1640596304,5/21/2015 20:38:24,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,87,41,,,95,52,DISORDER,FLUVOXAMINE,obsessive compulsive DISORDER.,66-76-87,41-53-63-66-76-87,FLUVOXAMINE treatment of obsessive compulsive disorder.,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:53:58,1640607412,5/21/2015 20:53:51,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,87,41,,,95,52,DISORDER,FLUVOXAMINE,Fluvoxamine of obsessive compulsive DISORDER.,63-66-76-87-41,31-34-37-41-53-63-66,JW et al. FLUVOXAMINE treatment of obsessive,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:55:24,1640608410,5/21/2015 20:54:57,false,clixsense,1,25038425,AUS,2,Sydney,49.182.141.110,87,41,,,95,52,DISORDER,FLUVOXAMINE,Fluvoxamine treatment of obsessive compulsive DISORDER.,41-63-66-76-87-53,31-34-37-41-53-63-66-75-76-87,JW et al. FLUVOXAMINE treatment of obsessive - compulsive disorder.,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533671,5/21/2015 20:55:52,1640608762,5/21/2015 20:55:26,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,87,41,,,95,52,DISORDER,FLUVOXAMINE,obsessive compulsive DISORDER.,66-76-87,41-53,FLUVOXAMINE treatment,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder.",87,41,87,41,-1,95,52,TWrex-cause,803999,"Perse TL, Greist JH, Jefferson JW et al. Fluvoxamine treatment of obsessive-compulsive disorder",disorder,fluvoxamine
724533672,5/21/2015 17:26:14,1640456332,5/21/2015 17:25:59,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 17:29:31,1640458445,5/21/2015 17:29:08,false,points4rewards,1,28703583,USA,,,97.73.83.199,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70-116,MILRINONE CHF.,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 17:53:03,1640473347,5/21/2015 17:52:42,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,116,70,,,119,79,CHF,MILRINONE,mortality associated with CHF.,90-100-111-116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:01:39,1640479122,5/21/2015 17:59:26,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:08:34,1640483615,5/21/2015 18:08:22,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,116,70,,,119,79,CHF,MILRINONE,milrinone decreases mortality associated with CHF.,70-90-100-111-116-80,57-60-65-70-80-90-100-111-116,to date that MILRINONE decreases mortality associated with CHF.,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:08:34,1640483618,5/21/2015 18:07:08,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:09:52,1640484485,5/21/2015 18:09:31,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:15:10,1640488495,5/21/2015 18:14:55,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:37:17,1640498467,5/21/2015 18:36:54,false,clixsense,1,6574449,USA,,,216.216.68.85,116,70,,,119,79,CHF,MILRINONE,CHF.,116,70,MILRINONE,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533672,5/21/2015 18:38:16,1640499297,5/21/2015 18:38:01,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,116,70,,,119,79,CHF,MILRINONE,milrinone decreases mortality associated with CHF.,70-90-100-111-116-80,70-80-90-100-111-116,MILRINONE decreases mortality associated with CHF.,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF.",116,70,116,70,-1,119,79,TWrex-cause,800593,"1 ,   3 ,   13 ,   15 ,   16 ,   22 ,   23   No evidence to date that milrinone decreases mortality associated with CHF",CHF,milrinone
724533673,5/21/2015 17:29:30,1640458441,5/21/2015 17:29:14,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,12,57,,,22,67,INFECTION,SALMONELLA,INFECTIONS,12,57,SALMONELLA,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 17:57:25,1640476372,5/21/2015 17:56:50,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS EPIDEMIOLOGY,0-12-24,57,SALMONELLA,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:29:33,1640491720,5/21/2015 18:28:38,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS,0-12,57,SALMONELLA,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:38:43,1640499611,5/21/2015 18:38:00,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS EPIDEMIOLOGY,0-12-24,57-69,SALMONELLA organisms,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:42:58,1640503023,5/21/2015 18:42:39,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS EPIDEMIOLOGY Disease caused by Salmonella organisms,0-12-24-38-46-53-57-69,38-46-53-57-69-79-83-86-94-99-103-24,EPIDEMIOLOGY Disease caused by SALMONELLA organisms can be divided into two categories:,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:44:08,1640503749,5/21/2015 18:43:44,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS EPIDEMIOLOGY Disease caused by Salmonella organisms can be divided into two categories: typhoidal and nontyphoidal.,0-12-24-38-46-53-57-69-79-83-86-94-99-103-115-125-129,0-12-24-38-46-53-57-69-79-83-86-94-99-103-115-125-129,Salmonella Infections EPIDEMIOLOGY Disease caused by SALMONELLA organisms can be divided into two categories: typhoidal and nontyphoidal.,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:45:18,1640504929,5/21/2015 18:44:53,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS EPIDEMIOLOGY,0-12-24,57,SALMONELLA,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:51:06,1640509531,5/21/2015 18:50:47,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS,0-12,57,SALMONELLA,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:51:32,1640509879,5/21/2015 18:51:19,false,elite,1,26544151,GBR,,,213.205.252.83,12,57,,,22,67,INFECTION,SALMONELLA,INFECTIONS,12,57,SALMONELLA,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533673,5/21/2015 18:51:43,1640510044,5/21/2015 18:51:27,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,12,57,,,22,67,INFECTION,SALMONELLA,Salmonella INFECTIONS EPIDEMIOLOGY,0-12-24,38-46-53-57-69,Disease caused by SALMONELLA organisms,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal.,12,57,12,57,1,22,67,TWrex-cause,810394,Salmonella  Infections  EPIDEMIOLOGY  Disease caused by  Salmonella  organisms can be divided into two categories: typhoidal and nontyphoidal,infection,salmonella
724533674,5/21/2015 19:00:53,1640517629,5/21/2015 19:00:33,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:01:17,1640517906,5/21/2015 19:01:04,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:19:24,1640532793,5/21/2015 19:19:08,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,25-51,OMEPRAZOLE reflux,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:46:23,1640565828,5/21/2015 19:45:48,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,for refractory reflux ESOPHAGITIS: efficacy and safety.,36-40-51-58-71-80-84,10-20-25-36-40-51,treatment with OMEPRAZOLE for refractory reflux,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:47:01,1640566250,5/21/2015 19:45:19,false,clixsense,1,22947672,GBR,,,88.144.127.68,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,10-20-25,treatment with OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:50:23,1640568405,5/21/2015 19:50:14,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:52:52,1640569942,5/21/2015 19:52:30,false,clixsense,1,31482589,NLD,,,31.201.11.16,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:53:59,1640570590,5/21/2015 19:53:31,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,reflux ESOPHAGITIS:,51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:54:31,1640570895,5/21/2015 19:54:00,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,refractory reflux ESOPHAGITIS:,40-51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533674,5/21/2015 19:58:09,1640572886,5/21/2015 19:57:43,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,58,25,,,69,35,ESOPHAGITIS,OMEPRAZOLE,for refractory reflux ESOPHAGITIS:,36-40-51-58,25,OMEPRAZOLE,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.,58,25,58,25,-1,69,35,TWrex-cause,800893,Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety,esophagitis,omeprazole
724533675,5/21/2015 18:57:24,1640514978,5/21/2015 18:56:59,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,Effects of oral propafenone administration before electrical cardioversion of chronic ATRIAL FIBRILLATION:,38-46-49-54-66-81-88-99-113-116-124-131,38-46-49-54-66-81-88-99-113-116-124-131,Effects of oral PROPAFENONE administration before electrical cardioversion of chronic atrial fibrillation:,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 18:58:05,1640515468,5/21/2015 18:57:45,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,chronic ATRIAL FIBRILLATION:,116-124-131,49-54,oral PROPAFENONE,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 18:58:06,1640515492,5/21/2015 18:57:44,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,ATRIAL FIBRILLATION:,124-131,54,PROPAFENONE,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 18:58:57,1640516024,5/21/2015 18:58:40,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,chronic ATRIAL FIBRILLATION:,116-124-131,49-54-66,oral PROPAFENONE administration,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 19:00:13,1640517073,5/21/2015 18:59:33,false,elite,1,26544151,GBR,,,213.205.252.83,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,ATRIAL FIBRILLATION:,124-131,54,PROPAFENONE,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 19:01:20,1640517933,5/21/2015 19:01:06,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,chronic ATRIAL FIBRILLATION:,116-124-131,54,PROPAFENONE,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 19:16:13,1640528280,5/21/2015 19:15:06,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,ATRIAL FIBRILLATION:,124-131,49-54-66,oral PROPAFENONE administration,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 19:39:53,1640560131,5/21/2015 19:39:30,false,clixsense,1,22947672,GBR,,,88.144.127.68,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,chronic ATRIAL FIBRILLATION:,116-124-131,49-54-66,oral PROPAFENONE administration,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 19:40:28,1640560613,5/21/2015 19:40:04,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,chronic ATRIAL FIBRILLATION:,116-124-131,49-54,oral PROPAFENONE,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533675,5/21/2015 19:41:27,1640561440,5/21/2015 19:40:25,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,124,54,,,143,65,ATRIAL FIBRILLATION,PROPAFENONE,cardioversion of chronic ATRIAL FIBRILLATION:,99-113-116-124-131,38-46-49-54-66,Effects of oral PROPAFENONE administration,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study.",124 131,54,124,54,-1,143,65,TWrex-cause,800857,"Bianconi L, Mennuni M, Lukic V et al. Effects of oral propafenone administration before electrical cardioversion of chronic atrial fibrillation: a placebo-controlled study",atrial fibrillation,propafenone
724533676,5/21/2015 19:52:04,1640569564,5/21/2015 19:51:06,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,62,120,,,71,129,INFECTION,VARICELLA,primary varicella INFECTION,44-52-62,96-102-109-120-130,weeks causes congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 19:56:16,1640571886,5/21/2015 19:56:00,false,clixsense,1,31482589,NLD,,,31.201.11.16,62,120,,,71,129,INFECTION,VARICELLA,primary varicella INFECTION,44-52-62,109-120-130,congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 19:59:38,1640573681,5/21/2015 19:59:08,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,62,120,,,71,129,INFECTION,VARICELLA,varicella INFECTION,52-62,109-120-130,congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:00:35,1640574303,5/21/2015 20:00:16,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,62,120,,,71,129,INFECTION,VARICELLA,varicella INFECTION,52-62,109-120-130,congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:32:16,1640591905,5/21/2015 20:32:03,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,62,120,,,71,129,INFECTION,VARICELLA,primary varicella INFECTION,44-52-62,109-120-130,congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:35:32,1640594336,5/21/2015 20:34:48,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,62,120,,,71,129,INFECTION,VARICELLA,INFECTION,62,120,VARICELLA,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:37:25,1640595374,5/21/2015 20:36:51,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,62,120,,,71,129,INFECTION,VARICELLA,primary varicella INFECTION,44-52-62,109-120-130,congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:53:37,1640607144,5/21/2015 20:53:26,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,62,120,,,71,129,INFECTION,VARICELLA,that primary varicella INFECTION of the mother varicella,39-44-52-62-72-75-79-120,96-102-109-120-130-139-142,weeks causes congenital VARICELLA syndrome in up,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:54:42,1640607963,5/21/2015 20:53:45,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,62,120,,,71,129,INFECTION,VARICELLA,primary varicella INFECTION,44-52-62,109-120-130,congenital VARICELLA syndrome,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533676,5/21/2015 20:54:54,1640608154,5/21/2015 20:54:24,false,clixsense,1,25038425,AUS,2,Sydney,49.182.141.110,62,120,,,71,129,INFECTION,VARICELLA,that primary varicella INFECTION of the mother congenital varicella syndrome,39-44-52-62-72-75-79-109-120-130,52-96-102-109-120-130-139-142-62,varicella infection weeks causes congenital VARICELLA syndrome in up,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases.,62,120,62,120,1,71,129,TWrex-cause,810788,Evidence: • A review article indicates that primary varicella infection of the mother before 23 weeks causes congenital varicella syndrome in up to 2% of cases,infection,varicella
724533677,5/21/2015 17:26:36,1640456630,5/21/2015 17:26:15,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA,76-87,39-42,L. MICDADEI,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 17:31:11,1640459499,5/21/2015 17:29:36,false,points4rewards,1,28703583,USA,,,97.73.83.199,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,L. micdadei PITTSBURGH PNEUMONIA acute suppurative pneumonia,42-76-87-115-121-133-39,39-42-115-121-133,L. MICDADEI acute suppurative pneumonia,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 17:53:32,1640473648,5/21/2015 17:53:05,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA agent,76-87-97,39-42,L. MICDADEI,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:04:34,1640480959,5/21/2015 18:01:41,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA agent,76-87-97,39-42,L. MICDADEI,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:09:02,1640483996,5/21/2015 18:08:35,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia in eight immunosuppressed patients,72-76-87-97-103-108-115-121-133-143-146-152-169,20-28-32-39-42-52-56-69-76-87-97,"TATLOCK and HEBA, L. MICDADEI was rediscovered as Pittsburgh pneumonia agent","Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:09:24,1640484194,5/21/2015 18:08:37,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA,76-87,39-42,L. MICDADEI,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:14:13,1640487704,5/21/2015 18:13:25,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA agent,76-87-97,20-28-32-39-42,"TATLOCK and HEBA, L. MICDADEI","Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:15:36,1640488968,5/21/2015 18:15:11,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA,76-87,39-42,L. MICDADEI,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:37:49,1640498889,5/21/2015 18:37:18,false,clixsense,1,6574449,USA,,,216.216.68.85,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,PITTSBURGH PNEUMONIA agent,76-87-97,39-42-32,"HEBA, L. MICDADEI","Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533677,5/21/2015 18:38:53,1640499714,5/21/2015 18:38:17,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,76,39,,,96,50,PITTSBURGH PNEUMONIA,L. MICDADEI,micdadei was rediscovered as the PITTSBURGH PNEUMONIA agent that caused acute suppurative pneumonia,42-52-56-69-72-76-87-97-103-108-115-121-133,20-28-32-39-42-52-56-69-72-76-87-108-115-121-133,"TATLOCK and HEBA, L. MICDADEI was rediscovered as the Pittsburgh pneumonia caused acute suppurative pneumonia","Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979.",76 87,39 42,76,39,1,96,50,TWrex-cause,812582,"Previously known as TATLOCK and HEBA,  L. micdadei  was rediscovered as the Pittsburgh pneumonia agent that caused acute suppurative pneumonia in eight immunosuppressed patients from two centers in 1979",pittsburgh pneumonia,L. micdadei
724533678,5/21/2015 18:59:39,1640516656,5/21/2015 18:59:12,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,140-150-157-146,"Avian and Animal SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 18:59:44,1640516749,5/21/2015 18:59:19,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,157,"SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:00:16,1640517142,5/21/2015 19:00:00,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,150-157,"Animal SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:01:36,1640518141,5/21/2015 19:01:18,false,elite,1,26544151,GBR,,,213.205.252.83,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,157,"SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:02:06,1640518525,5/21/2015 19:01:55,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,157,"SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:17:59,1640530627,5/21/2015 19:17:33,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,140-146-150-157,"Avian and Animal SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:42:49,1640562859,5/21/2015 19:42:20,false,clixsense,1,22947672,GBR,,,88.144.127.68,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,140-146-150-157,"Avian and Animal SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:43:54,1640563771,5/21/2015 19:43:13,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,Symptoms and Signs SCHISTOSOME DERMATITIS,0-9-13-20-32,140-146-150-157,"Avian and Animal SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:49:35,1640567980,5/21/2015 19:49:15,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,157,"SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533678,5/21/2015 19:50:24,1640568411,5/21/2015 19:49:57,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,20,157,,,42,169,SCHISTOSOME DERMATITIS,SCHISTOSOME,SCHISTOSOME DERMATITIS,20-32,140-146-157-150,"Avian and Animal SCHISTOSOMES,","Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people.",20 32,157,20,157,1,42,169,TWrex-cause,810852,"Symptoms and Signs  Schistosome dermatitis is a pruritic papular rash where the cercariae penetrate the skin (see also Dermatitis Caused by Avian and Animal Schistosomes, below) in previously sensitized people",schistosome dermatitis,schistosome
724533679,5/21/2015 16:14:19,1640409579,5/21/2015 16:14:05,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 16:18:05,1640411899,5/21/2015 16:17:49,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 16:25:12,1640416612,5/21/2015 16:24:50,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 16:27:47,1640418623,5/21/2015 16:27:25,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78-87-98-103,"ESTROGEN containing oral contraceptives,","WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 16:37:16,1640424738,5/21/2015 16:36:48,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78-87-98-103,"ESTROGEN containing oral contraceptives,","WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 16:37:38,1640424948,5/21/2015 16:37:05,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 16:56:19,1640437189,5/21/2015 16:55:45,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 17:03:24,1640441701,5/21/2015 17:03:08,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 17:04:59,1640442525,5/21/2015 17:04:37,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533679,5/21/2015 17:13:13,1640447637,5/21/2015 17:12:56,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,119,78,,,128,86,PREGNANCY,ESTROGEN,"PREGNANCY,",119,78,ESTROGEN,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy.",119,78,119,78,-1,128,86,TWrex-cause,803204,"WOMEN'S HEALTH  VTE is a women's health problem because it is associated with estrogen-containing oral contraceptives, pregnancy, and postmenopausal hormone replacement therapy",pregnancy,estrogen
724533680,5/21/2015 16:06:07,1640404651,5/21/2015 16:05:38,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,10-14-15-20-25,Long - term LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:09:46,1640406943,5/21/2015 16:09:21,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,138,20,,,142,24,GOUT,LEAD,"hypertension, and saturnine GOUT from reduced renal excretion",110-124-128-138-143-148-156-162,5-10-15-20-25-34-38-45-48-56-75-89-95-110,"93 Long term LEAD exposure can result in chronic tubulointerstitial nephritis renal insufficiency, hypertension,","91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:15:09,1640410110,5/21/2015 16:14:53,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,138,20,,,142,24,GOUT,LEAD,GOUT,138,20,LEAD,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:15:24,1640410206,5/21/2015 16:14:50,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,20-25,LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:16:35,1640411069,5/21/2015 16:16:08,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,20-25,LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:23:12,1640415339,5/21/2015 16:22:23,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,138-128,10-15-20-25,Long term LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:26:50,1640417718,5/21/2015 16:26:29,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,20,LEAD,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:28:42,1640419149,5/21/2015 16:28:19,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,20-25,LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:47:55,1640431829,5/21/2015 16:47:10,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,20-25,LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533680,5/21/2015 16:52:03,1640434040,5/21/2015 16:51:34,false,clixsense,1,22947672,GBR,,,88.144.127.68,138,20,,,142,24,GOUT,LEAD,saturnine GOUT,128-138,10-15-20-25,Long term LEAD exposure,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid.",138,20,138,20,1,142,24,TWrex-cause,811170,"91 - 93   Long-term lead exposure can result in chronic tubulointerstitial nephritis and renal insufficiency, hypertension, and saturnine gout from reduced renal excretion of uric acid",gout,lead
724533681,5/21/2015 17:28:55,1640458029,5/21/2015 17:28:40,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,223,171,,,232,175,PREGNANCY,ACID,PREGNANCY.,223,171,ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 17:56:24,1640475743,5/21/2015 17:56:02,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,223,171,,,232,175,PREGNANCY,ACID,PREGNANCY.,223,162-171,valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:15:45,1640489064,5/21/2015 18:14:12,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,223,171,,,232,175,PREGNANCY,ACID,PREGNANCY.,223,162-171,valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:37:18,1640498486,5/21/2015 18:36:46,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,223,171,,,232,175,PREGNANCY,ACID,PREGNANCY.,223,162-171,valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:42:12,1640502557,5/21/2015 18:41:27,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,223,171,,,232,175,PREGNANCY,ACID,valproic acid compared with other antiepileptic drugs during PREGNANCY.,162-171-176-185-196-210-216-223-190,98-109-123-126-140-150-155-159-162-171,congenital malformations is substantially increased with use of valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:42:52,1640502948,5/21/2015 18:42:19,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,223,171,,,232,175,PREGNANCY,ACID,Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during PREGNANCY.,84-89-92-98-109-123-126-140-150-155-159-162-171-176-185-196-210-216-223-190,84-89-92-98-109-123-126-140-150-155-159-162-171-176-185-190-196-210-216-223,Risk of major congenital malformations is substantially increased with use of valproic ACID compared with other antiepileptic drugs during pregnancy.,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:44:00,1640503688,5/21/2015 18:41:48,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,223,171,,,232,175,PREGNANCY,ACID,PREGNANCY.,223,162-171,valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:50:29,1640509037,5/21/2015 18:50:13,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,223,171,,,232,175,PREGNANCY,ACID,PREGNANCY.,223,162-171,valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:50:59,1640509451,5/21/2015 18:50:14,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,223,171,,,232,175,PREGNANCY,ACID,Risk of major congenital malformations is increased antiepileptic drugs during PREGNANCY.,84-89-92-98-109-123-196-210-216-223-140,98-109-123-126-150-155-159-162-171-176-185-190-140,congenital malformations is substantially increased with use of valproic ACID compared with other,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533681,5/21/2015 18:51:26,1640509799,5/21/2015 18:50:56,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,223,171,,,232,175,PREGNANCY,ACID,antiepileptic drugs during PREGNANCY.,196-210-216-223,155-159-162-171,use of valproic ACID,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy.",223,171,223,171,-1,232,175,TWrex-cause,803157,"182 ,   183 ,   184 ,   185 ,   188 ,   189 ,   190 ,   191 ,   192 ,   194 ,   b   Risk of major congenital malformations is substantially increased with use of valproic acid compared with other antiepileptic drugs during pregnancy",pregnancy,acid
724533682,5/21/2015 18:54:08,1640511967,5/21/2015 18:52:58,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,144,101,,,146,113,MI,EPTIFIBATIDE,eptifibatide will prevent 1 'PURSUIT like' MI in aggressively managed patients with high risk acute coronary syndrome.,102-115-128-130-140-147-150-153-166-174-183-188-193-198-204-213-120,102-115-120-128-130-140-147-150-153-166-174-183-188-193-198-204-213,EPTIFIBATIDe will prevent 1 'PURSUIT like' MI in aggressively managed patients with high risk acute coronary syndrome.,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 18:56:19,1640514149,5/21/2015 18:55:44,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,144,101,,,146,113,MI,EPTIFIBATIDE,MI,147,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 18:56:33,1640514448,5/21/2015 18:56:11,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,144,101,,,146,113,MI,EPTIFIBATIDE,MI,147,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 18:57:32,1640515069,5/21/2015 18:56:38,false,elite,1,26544151,GBR,,,213.205.252.83,144,101,,,146,113,MI,EPTIFIBATIDE,MI,147,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 18:57:33,1640515080,5/21/2015 18:57:16,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,144,101,,,146,113,MI,EPTIFIBATIDE,'PURSUIT like' MI,130-140-147,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 19:00:13,1640517068,5/21/2015 18:59:46,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,144,101,,,146,113,MI,EPTIFIBATIDE,high risk acute coronary syndrome.,188-193-198-204-213,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 19:11:38,1640525229,5/21/2015 19:10:14,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,144,101,,,146,113,MI,EPTIFIBATIDE,MI acute coronary syndrome.,147-198-204-213,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 19:12:24,1640525689,5/21/2015 19:12:04,false,cointasker,1,21783324,NLD,,,31.151.239.133,144,101,,,146,113,MI,EPTIFIBATIDE,- MI,139-147,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 19:35:41,1640556654,5/21/2015 19:35:17,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,144,101,,,146,113,MI,EPTIFIBATIDE,1 'PURSUIT,128-130,102,EPTIFIBATIDe,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533682,5/21/2015 19:37:54,1640558382,5/21/2015 19:37:36,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,144,101,,,146,113,MI,EPTIFIBATIDE,'PURSUIT like' MI in aggressively managed patients,130-140-147-150-153-166-174,89-93-99-102-115-120,000 worth of EPTIFIBATIDe will prevent,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,,,144,101,-1,146,113,TWrex-cause,804663,The findings of this study can be summarized in a more pragmatic way: Approximately $38 000 worth of eptifibatide will prevent 1 'PURSUIT-like' MI in aggressively managed patients with high-risk acute coronary syndrome,mi,eptifibatide
724533683,5/21/2015 16:14:04,1640409435,5/21/2015 16:13:50,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,acute HYPERCALCEMIA.,158-164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 16:17:48,1640411739,5/21/2015 16:17:35,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,HYPERCALCEMIA.,164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 16:24:49,1640416414,5/21/2015 16:24:33,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,acute HYPERCALCEMIA.,158-164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 16:27:24,1640418397,5/21/2015 16:27:04,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,acute HYPERCALCEMIA.,158-164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 16:36:47,1640424321,5/21/2015 16:36:23,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,acute HYPERCALCEMIA.,164-158,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 16:37:00,1640424476,5/21/2015 16:36:31,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,acute HYPERCALCEMIA.,158-164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 16:55:33,1640436469,5/21/2015 16:54:45,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,HYPERCALCEMIA.,164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 17:03:07,1640441564,5/21/2015 17:02:55,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,acute HYPERCALCEMIA.,158-164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 17:04:36,1640442299,5/21/2015 17:04:18,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,HYPERCALCEMIA.,164,81,PLICAMYCIN,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533683,5/21/2015 17:13:00,1640447490,5/21/2015 17:12:27,false,points4rewards,1,28703583,USA,,,97.73.83.199,164,81,,,177,91,HYPERCALCEMIA,PLICAMYCIN,of acute HYPERCALCEMIA.,155-158-164,81-158-164,PLICAMYCIN acute hypercalcemia.,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia.",164,81,164,81,-1,177,91,TWrex-cause,804817,"Comments: • Despite the fact that it provides marked reduction in serum calcium, plicamycin is not approved by the FDA and is no longer used for treatment of acute hypercalcemia",hypercalcemia,plicamycin
724533684,5/21/2015 19:53:55,1640570538,5/21/2015 19:53:23,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,the treatment of DEPRESSION:,93-97-107-110,77-90-93-97-107-110,CLOMIPRAMINE in the treatment of depression:,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 19:57:17,1640572352,5/21/2015 19:56:44,false,clixsense,1,31482589,NLD,,,31.201.11.16,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,treatment of DEPRESSION:,97-107-110,77,CLOMIPRAMINE,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:01:08,1640574590,5/21/2015 20:00:35,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,DEPRESSION:,110,77,CLOMIPRAMINE,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:01:33,1640574933,5/21/2015 20:01:14,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,DEPRESSION:,110,77-97,CLOMIPRAMINE treatment,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:34:21,1640593335,5/21/2015 20:33:52,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,DEPRESSION:,110,77,CLOMIPRAMINE,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:37:35,1640595502,5/21/2015 20:37:06,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,DEPRESSION:,110,77,CLOMIPRAMINE,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:39:11,1640596579,5/21/2015 20:38:46,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,DEPRESSION:,110,77-90-93-97-107-110,CLOMIPRAMINE in the treatment of depression:,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:55:55,1640608783,5/21/2015 20:55:32,false,clixsense,1,25038425,AUS,2,Sydney,49.182.141.110,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,clomipramine in the treatment of DEPRESSION: a double blind,77-93-97-107-110-122-124-131-90,63-67-73-77-90-93-97-107-110,11 1163) vs. CLOMIPRAMINE in the treatment of depression:,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 20:57:17,1640609480,5/21/2015 20:55:57,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,Moclobemide vs. clomipramine in the treatment of DEPRESSION:,47-73-77-90-93-97-107-110,77-90-93-97-107-110,CLOMIPRAMINE in the treatment of depression:,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533684,5/21/2015 21:02:10,1640612434,5/21/2015 21:01:51,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,110,77,,,120,89,DEPRESSION,CLOMIPRAMINE,DEPRESSION:,110,77,CLOMIPRAMINE,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium.",110,77,110,77,-1,120,89,TWrex-cause,803967,"Cattiez PH, Dierick M, Troisfontaines B et al. Moclobemide (Ro 11- 1163) vs. clomipramine in the treatment of depression: a double-blind multicenter study in Belgium",depression,clomipramine
724533685,5/21/2015 18:56:57,1640514725,5/21/2015 18:56:24,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,Intermittent trimethoprim sulfamethoxazole compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and TOXOPLASMOSIS in patients infected with HIV.,42-55-68-85-94-99-107-121-125-129-142-150-162-165-178-188-192-206-209-218-227-232,42-55-68-85-94-99-107-121-125-129-142-150-162-165-178-188-192-206-209-218-227-232,Intermittent trimethoprim SULFAMETHOXAZOLE compared with dapsone pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 18:57:43,1640515234,5/21/2015 18:57:22,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,55-68,trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 18:57:44,1640515272,5/21/2015 18:57:28,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,42-55-68,Intermittent trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 18:58:39,1640515860,5/21/2015 18:58:25,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,42-55-68,Intermittent trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 18:59:30,1640516535,5/21/2015 18:59:16,false,elite,1,26544151,GBR,,,213.205.252.83,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,68,SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 19:01:05,1640517785,5/21/2015 19:00:52,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,55-68,trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 19:15:05,1640527448,5/21/2015 19:14:02,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,pneumocystis pneumonia and TOXOPLASMOSIS,165-178-188-192,42-55-68,Intermittent trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 19:39:29,1640559728,5/21/2015 19:38:43,false,clixsense,1,22947672,GBR,,,88.144.127.68,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,42-55-68,Intermittent trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 19:40:01,1640560236,5/21/2015 19:39:40,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,TOXOPLASMOSIS,192,42-55-68,Intermittent trimethoprim SULFAMETHOXAZOLE,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533685,5/21/2015 19:40:24,1640560570,5/21/2015 19:39:59,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,192,68,,,205,84,TOXOPLASMOSIS,SULFAMETHOXAZOLE,pneumonia and TOXOPLASMOSIS,178-188-192,42-55-68-85-94-99-107,Intermittent trimethoprim SULFAMETHOXAZOLE compared with dapsone pyrimethamine,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV.",192,68,192,68,-1,205,84,TWrex-cause,800011,"Podzamczer D, Salazar A, Jimenez J et al. Intermittent trimethoprim-sulfamethoxazole compared with dapsone-pyrimethamine for the simultaneous primary prophylaxis of pneumocystis pneumonia and toxoplasmosis in patients infected with HIV",toxoplasmosis,sulfamethoxazole
724533686,5/21/2015 16:13:19,1640408753,5/21/2015 16:12:52,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,95,164,,,103,172,REACTION,NEOMYCIN,Severe allergic REACTION,79-86-95,149-164,"vaccine NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 16:17:06,1640411289,5/21/2015 16:16:54,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,95,164,,,103,172,REACTION,NEOMYCIN,• Severe allergic REACTION anaphylaxis),76-79-86-95-111,145-149-157-164-174-184,"the vaccine (e.g., NEOMYCIN, polymyxin B)","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 16:23:40,1640415657,5/21/2015 16:23:16,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,95,164,,,103,172,REACTION,NEOMYCIN,• Severe allergic REACTION,76-79-86-95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 16:26:13,1640417416,5/21/2015 16:25:47,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,95,164,,,103,172,REACTION,NEOMYCIN,Severe allergic REACTION,79-86-95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 16:35:11,1640423296,5/21/2015 16:34:48,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,95,164,,,103,172,REACTION,NEOMYCIN,allergic REACTION,86-95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 16:35:39,1640423463,5/21/2015 16:35:14,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,95,164,,,103,172,REACTION,NEOMYCIN,allergic REACTION,95-86,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 16:52:45,1640434581,5/21/2015 16:52:21,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,95,164,,,103,172,REACTION,NEOMYCIN,allergic REACTION,86-95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 17:02:01,1640440928,5/21/2015 17:01:26,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,95,164,,,103,172,REACTION,NEOMYCIN,Severe allergic REACTION,79-86-95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 17:03:27,1640441753,5/21/2015 17:03:07,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,95,164,,,103,172,REACTION,NEOMYCIN,REACTION,95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533686,5/21/2015 17:11:45,1640446781,5/21/2015 17:11:28,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,95,164,,,103,172,REACTION,NEOMYCIN,REACTION,95,164,"NEOMYCIN,","1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens.",95,164,95,164,-1,103,172,TWrex-cause,803086,"1  Fixed-combination Vaccine Containing DTaP and IPV (DTaP-IPV; Kinrix ® ,  •  Severe allergic reaction (e.g., anaphylaxis) to any ingredient in the vaccine (e.g., neomycin, polymyxin B) or after previous dose of any vaccine containing diphtheria, tetanus, pertussis, or poliovirus antigens",reaction,neomycin
724533687,5/21/2015 18:52:42,1640510690,5/21/2015 18:52:08,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop DIARRHEA while being treated with antibiotics, one fewer will develop antibiotic associated diarrhea if also receiving probiotics ( 12.",0-4-10-16-25-29-35-43-52-58-64-72-77-90-94-100-105-113-124-135-144-147-152-162-175-173,0-4-10-16-25-29-35-43-52-58-64-72-77-90-94-100-105-113-124-135-144-147-152-162-175-173,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop ANTIBIOTIC ASSOCIATED DIARRHEA if also receiving probiotics ( 12.","For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 18:55:19,1640513273,5/21/2015 18:54:56,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 18:55:50,1640513767,5/21/2015 18:55:31,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 18:56:15,1640514103,5/21/2015 18:55:56,false,elite,1,26544151,GBR,,,213.205.252.83,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 18:56:49,1640514631,5/21/2015 18:56:33,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 18:59:31,1640516553,5/21/2015 18:58:58,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 19:09:12,1640523647,5/21/2015 19:08:17,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 19:11:48,1640525284,5/21/2015 19:11:34,false,cointasker,1,21783324,NLD,,,31.151.239.133,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 19:31:42,1640553245,5/21/2015 19:29:42,false,clixsense,1,22947672,GBR,,,88.144.127.68,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,DIARRHEA,43,113-124-135,ANTIBIOTIC ASSOCIATED DIARRHEA,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533687,5/21/2015 19:32:04,1640553486,5/21/2015 19:31:47,false,instagc,1,23657877,USA,DE,Dover,98.252.20.214,43,113,,,51,143,DIARRHEA,ANTIBIOTIC ASSOCIATED DIARRHEA,who would develop DIARRHEA while being treated,25-29-35-43-52-58-64,94-100-105-113-124-135-144-147-152,fewer will develop ANTIBIOTIC ASSOCIATED DIARRHEA if also receiving,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12.",43,113 124 135,43,113,1,51,143,TWrex-cause,813692,"For every seven patients who would develop diarrhea while being treated with antibiotics, one fewer will develop antibiotic-associated diarrhea if also receiving probiotics ( 12",diarrhea,antibiotic associated diarrhea
724533688,5/21/2015 19:01:48,1640518335,5/21/2015 19:01:32,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,Diabetes mellitus: no Gas GANGRENE,9-19-23-27-0,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:20:31,1640534724,5/21/2015 19:19:47,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,no Gas GANGRENE,23-27-19,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:47:52,1640566805,5/21/2015 19:46:51,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,mellitus: no Gas GANGRENE associated with trauma,9-19-23-27-36-47-52,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:50:22,1640568378,5/21/2015 19:48:07,false,clixsense,1,22947672,GBR,,,88.144.127.68,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,Gas GANGRENE associated with trauma,23-27-36-47-52,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:50:47,1640568805,5/21/2015 19:50:37,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,GANGRENE,27,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:53:44,1640570419,5/21/2015 19:53:13,false,clixsense,1,31482589,NLD,,,31.201.11.16,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,no Gas GANGRENE,23-27-19,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:55:22,1640571343,5/21/2015 19:54:53,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,Gas GANGRENE,23-27,76-88-101-104,"CLOSTRIDIUM perfringens, C. septicum,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:55:56,1640571731,5/21/2015 19:54:31,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,Gas GANGRENE,23-27,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 19:58:39,1640573195,5/21/2015 19:58:27,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,no Gas GANGRENE,19-23-27,76-88-101-104,"CLOSTRIDIUM perfringens, C. septicum,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533688,5/21/2015 20:29:41,1640590357,5/21/2015 20:28:32,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,27,76,,,35,87,GANGRENE,CLOSTRIDIUM,Gas GANGRENE,27-23,76-88,"CLOSTRIDIUM perfringens,","Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry.",27,76,27,76,1,35,87,TWrex-cause,810201,"Diabetes mellitus: no  Gas gangrene associated with trauma may be caused by Clostridium perfringens, C. septicum, or C. histolyticum, and there is always a portal of entry",gangrene,clostridium
724533689,5/21/2015 18:33:59,1640495381,5/21/2015 18:33:21,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,89,73,,,95,77,ANEMIA,IRON,iron deficiency ANEMIA,73-78-89,73-78-89,IRON deficiency anemia,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:46:49,1640506108,5/21/2015 18:46:24,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,89,73,,,95,77,ANEMIA,IRON,Avoid the use of erythropoietin in patients with proved or suspected iron deficiency ANEMIA until the iron deficiency is corrected.,4-10-14-18-21-36-39-48-53-60-63-73-78-89-96-102-106-111-122-125,4-10-14-18-21-36-39-48-53-60-63-73-78-89-96-102-106-111-122-125,Avoid the use of erythropoietin in patients with proved or suspected IRON deficiency anemia until the iron deficiency is corrected.,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:52:45,1640510728,5/21/2015 18:52:29,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,89,73,,,95,77,ANEMIA,IRON,iron deficiency ANEMIA,73-78-89,73-78-89,IRON deficiency anemia,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:53:09,1640510995,5/21/2015 18:52:51,false,elite,1,26544151,GBR,,,213.205.252.83,89,73,,,95,77,ANEMIA,IRON,ANEMIA,89,73,IRON,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:53:18,1640511152,5/21/2015 18:53:02,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,89,73,,,95,77,ANEMIA,IRON,iron deficiency ANEMIA,73-78-89,73-78-89,IRON deficiency anemia,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:53:58,1640511821,5/21/2015 18:53:41,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,89,73,,,95,77,ANEMIA,IRON,Avoid use of erythropoietin suspected iron deficiency ANEMIA until the iron,4-14-18-63-73-78-89-96-102-106-21,4-10-14-18-21-36-53-60-63-73-78-89-96-39,Avoid the use of erythropoietin in patients proved or suspected IRON deficiency anemia until,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:54:27,1640512289,5/21/2015 18:54:17,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,89,73,,,95,77,ANEMIA,IRON,iron deficiency ANEMIA,73-78-89,73-78-89,IRON deficiency anemia,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:56:32,1640514409,5/21/2015 18:56:20,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,89,73,,,95,77,ANEMIA,IRON,iron deficiency ANEMIA,73-78-89,73-78-89,IRON deficiency anemia,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 18:59:57,1640516857,5/21/2015 18:59:09,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,89,73,,,95,77,ANEMIA,IRON,iron deficiency ANEMIA,73-78-89,73-78-89,IRON deficiency anemia,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533689,5/21/2015 19:06:37,1640521737,5/21/2015 19:06:30,false,clixsense,1,30681680,NLD,11,Rotterdam,87.211.12.50,89,73,,,95,77,ANEMIA,IRON,suspected iron deficiency ANEMIA until the iron,63-73-78-89-96-102-106,53-60-63-73-78-89-96,proved or suspected IRON deficiency anemia until,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected.,89,73,89,73,-1,95,77,TWrex-cause,805214,7.5 Avoid the use of erythropoietin in patients with proved or suspected iron deficiency anemia until the iron deficiency is corrected,anemia,iron
724533690,5/21/2015 16:12:28,1640408257,5/21/2015 16:11:55,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,"methicillin resistant STAPHYLOCOCCUS AUREUS [MRSA]),",114-126-137-152-160,82,AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 16:16:29,1640411025,5/21/2015 16:16:08,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,"STAPHYLOCOCCUS AUREUS [MRSA]),",137-152-160,79-82,S. AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 16:22:52,1640415118,5/21/2015 16:22:22,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,methicillin resistant STAPHYLOCOCCUS AUREUS,114-126-137-152,79-82,S. AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 16:25:19,1640416736,5/21/2015 16:24:56,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,methicillin resistant STAPHYLOCOCCUS AUREUS,114-126-137-152,79-82,S. AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 16:34:19,1640422854,5/21/2015 16:34:02,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,"methicillin resistant STAPHYLOCOCCUS AUREUS [MRSA]),",114-126-137-152-160,79-82,S. AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 16:35:02,1640423181,5/21/2015 16:34:48,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,"STAPHYLOCOCCUS AUREUS [MRSA]),",137-152-160,82,AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 16:44:35,1640429713,5/21/2015 16:43:58,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,STAPHYLOCOCCUS AUREUS,137-152,82,AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 17:01:00,1640440156,5/21/2015 17:00:43,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,STAPHYLOCOCCUS AUREUS,137-152,82,AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 17:02:51,1640441438,5/21/2015 17:02:34,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,STAPHYLOCOCCUS AUREUS,137-152,82,AUREUS,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533690,5/21/2015 17:12:21,1640447109,5/21/2015 17:11:15,false,points4rewards,1,28703583,USA,,,97.73.83.199,137,82,,,158,88,STAPHYLOCOCCUS AUREUS,AUREUS,STAPHYLOCOCCUS AUREUS,137-152,82-137-152,AUREUS Staphylococcus aureus,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens.",137 152,82,137,82,1,158,88,TWrex-cause,812526,"The range of organisms causing these contiguous infections is wide, including  S. aureus  (increasingly including methicillin-resistant  Staphylococcus aureus  [MRSA]), coagulase-negative staphylococci, aerobic gram-negative bacilli, occasional anaerobes, and other less common pathogens",staphylococcus aureus,aureus
724533691,5/21/2015 18:54:30,1640512310,5/21/2015 18:54:09,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,47,72,,,55,80,SEIZURE,EPILEPSY,"For SEIZURES associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",43-47-56-67-72-82-102-105-121-130-132,43-47-56-67-72-82-102-105-121-130-132,"For seizures associated with EPILEPSY, glomerulonephritis, or hypothyroidism: Usually, 1 g.",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 18:56:38,1640514477,5/21/2015 18:56:20,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,47,72,,,55,80,SEIZURE,EPILEPSY,SEIZURES,47,72,"EPILEPSY,",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 18:56:48,1640514618,5/21/2015 18:56:34,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,47,72,,,55,80,SEIZURE,EPILEPSY,SEIZURES,47,72,"EPILEPSY,",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 18:57:52,1640515344,5/21/2015 18:57:35,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,47,72,,,55,80,SEIZURE,EPILEPSY,"SEIZURES epilepsy,",47-72,72,"EPILEPSY,",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 18:57:58,1640515397,5/21/2015 18:57:35,false,elite,1,26544151,GBR,,,213.205.252.83,47,72,,,55,80,SEIZURE,EPILEPSY,SEIZURES,47,72,"EPILEPSY,",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 19:00:25,1640517231,5/21/2015 19:00:14,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,47,72,,,55,80,SEIZURE,EPILEPSY,SEIZURES,47,72,"EPILEPSY,",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 19:12:23,1640525663,5/21/2015 19:11:39,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,47,72,,,55,80,SEIZURE,EPILEPSY,"SEIZURES associated with epilepsy, glomerulonephritis, or hypothyroidism:",47-56-67-72-82-102-105,47-56-67-72-82-102-105,"seizures associated with EPILEPSY, glomerulonephritis, or hypothyroidism:",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 19:12:38,1640525751,5/21/2015 19:12:26,false,cointasker,1,21783324,NLD,,,31.151.239.133,47,72,,,55,80,SEIZURE,EPILEPSY,SEIZURES,47,72-82,"EPILEPSY, glomerulonephritis,",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 19:36:28,1640557248,5/21/2015 19:35:48,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,47,72,,,55,80,SEIZURE,EPILEPSY,SEIZURES,47,72-82-102-105,"EPILEPSY, glomerulonephritis, or hypothyroidism:",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533691,5/21/2015 19:38:15,1640558644,5/21/2015 19:37:55,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,47,72,,,55,80,SEIZURE,EPILEPSY,"SEIZURES associated with epilepsy,",47-56-67-72,47-56-67-72-102-105-82,"seizures associated with EPILEPSY, glomerulonephritis, or hypothyroidism:",">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g.",47,72,47,72,1,55,80,TWrex-cause,813403,">     Other Seizure Etiologies  IM or IV:  For seizures associated with epilepsy, glomerulonephritis, or hypothyroidism: Usually, 1 g",seizure,epilepsy
724533692,5/21/2015 16:07:50,1640405733,5/21/2015 16:07:30,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69-79-81-84-86,INFLUENZA A or B virus.,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:11:31,1640407807,5/21/2015 16:11:17,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION with either influenza A or B virus.,47-57-62-69-79-81-84-86,47-57-62-69-79-81-84-86,infection with either INFLUENZA A or B virus.,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:17:30,1640411511,5/21/2015 16:17:10,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69-79-81-84,INFLUENZA A or B,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:19:12,1640412643,5/21/2015 16:18:54,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69-79-81-84,INFLUENZA A or B,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:25:26,1640416876,5/21/2015 16:25:14,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69,INFLUENZA,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:28:38,1640419082,5/21/2015 16:28:18,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69-79,INFLUENZA A,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:29:36,1640419739,5/21/2015 16:28:26,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION influenza,47-69,69-79-81-84-86,INFLUENZA A or B virus.,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:30:26,1640420384,5/21/2015 16:30:13,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69-79-81-84,INFLUENZA A or B,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:50:51,1640433431,5/21/2015 16:50:29,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION,47,69,INFLUENZA,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533692,5/21/2015 16:57:54,1640438104,5/21/2015 16:55:04,false,clixsense,1,22947672,GBR,,,88.144.127.68,47,69,,,56,78,INFECTION,INFLUENZA,INFECTION with influenza,47-57-69,47-62-69-79-81-84-86,infection either INFLUENZA A or B vir<span id=transmark></span>us.,These agents have an impact on the duration of infection with either influenza A or B virus.,47,69,47,69,1,56,78,TWrex-cause,812070,These agents have an impact on the duration of infection with either influenza A or B virus,infection,influenza
724533693,5/21/2015 19:22:21,1640537749,5/21/2015 19:21:23,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,50,2,,,54,10,BONE,FRACTURE,fracture BONE,50-2,2-50,FRACTURE bone,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 19:49:30,1640567962,5/21/2015 19:49:10,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,50,2,,,54,10,BONE,FRACTURE,"side of the BONE is compressed,",38-43-46-50-55-58,0-2-11-17-21,A FRACTURE where the structure,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 19:55:04,1640571180,5/21/2015 19:54:43,false,clixsense,1,31482589,NLD,,,31.201.11.16,50,2,,,54,10,BONE,FRACTURE,BONE,50,2,FRACTURE,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 19:58:29,1640573098,5/21/2015 19:57:30,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,50,2,,,54,10,BONE,FRACTURE,BONE,50,2,FRACTURE,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 19:58:50,1640573262,5/21/2015 19:57:25,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,50,2,,,54,10,BONE,FRACTURE,BONE,50,2,FRACTURE,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 19:59:34,1640573664,5/21/2015 19:59:20,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,50,2,,,54,10,BONE,FRACTURE,BONE,50,2,FRACTURE,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 20:31:05,1640591188,5/21/2015 20:30:41,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,50,2,,,54,10,BONE,FRACTURE,"BONE is compressed,",50-55-58,2,FRACTURE,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 20:33:26,1640592717,5/21/2015 20:32:18,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,50,2,,,54,10,BONE,FRACTURE,BONE,50,0-2-11-17-21-31-34-38-43-46-50-55-58-70-76-80-89-94-103-108-112-119-126-134-138-145,"A FRACTURE where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.","A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 20:34:46,1640593694,5/21/2015 20:34:02,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,50,2,,,54,10,BONE,FRACTURE,"BONE compressed,",50-58,2,FRACTURE,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533693,5/21/2015 20:52:24,1640606302,5/21/2015 20:49:30,false,clixsense,1,25038425,AUS,2,Sydney,49.182.141.110,50,2,,,54,10,BONE,FRACTURE,"side of the BONE is compressed,",38-43-46-50-55-58,0-2-11-17-21,A FRACTURE where the structure,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact.",50,2,50,2,-1,54,10,TWrex-cause,802729,"A fracture where the structure of one side of the bone is compressed, while the opposite side deflects from the growth plate, leaving the cortex intact",bone,fracture
724533694,5/21/2015 17:29:12,1640458233,5/21/2015 17:28:57,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 17:56:49,1640476081,5/21/2015 17:56:25,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:16:22,1640489556,5/21/2015 18:15:49,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:37:58,1640499022,5/21/2015 18:37:19,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:42:37,1640502769,5/21/2015 18:42:14,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,many prescription drugs may cause BLEEDING DIATHESES.,157-175-181-185-191-200-162,52-60-67-83-91-94-107-112-125-132-145-181-185-191-200,"illicit drugs Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, may cause bleeding diatheses.","History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:43:42,1640503501,5/21/2015 18:42:53,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,"History Use of prescription, over the counter, and illicit drugs Anticoagulants, aspirin or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause BLEEDING DIATHESES.",0-9-13-16-30-35-39-48-52-60-67-83-91-94-107-112-125-132-145-153-157-175-181-185-191-200-162,0-9-13-16-30-35-39-48-52-60-67-83-91-94-107-112-125-132-145-153-157-162-175-181-185-191-200,"History Use of prescription, over the counter, and illicit drugs Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.","History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:44:50,1640504310,5/21/2015 18:44:03,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:50:46,1640509285,5/21/2015 18:50:31,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:51:18,1640509638,5/21/2015 18:50:58,false,elite,1,26544151,GBR,,,213.205.252.83,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,BLEEDING DIATHESES.,191-200,83,ASPIRIN,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533694,5/21/2015 18:51:35,1640509917,5/21/2015 18:51:00,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,191,83,,,209,90,BLEEDING DIATHESIS,ASPIRIN,"aspirin or nonsteroidal anti inflammatory drugs, drugs may cause BLEEDING DIATHESES.",83-91-94-107-112-175-181-185-191-200-125,30-35-39-48-52-60-67-83-91-94-107-112-125-181-185-191-200,"over the counter, and illicit drugs Anticoagulants, ASPIRIN or nonsteroidal anti inflammatory drugs, may cause bleeding diatheses.","History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses.",191 200,83,191,83,1,209,90,TWrex-cause,811559,"History  Use of prescription, over-the-counter, and illicit drugs  Anticoagulants, aspirin or nonsteroidal anti-inflammatory drugs, antiplatelet agents, and many prescription drugs may cause bleeding diatheses",bleeding diathesis,aspirin
724533695,5/21/2015 16:11:28,1640407770,5/21/2015 16:11:11,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA Herpes zoster ACP,124-134-149-141,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 16:15:26,1640410214,5/21/2015 16:15:03,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA Herpes,124-134,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 16:21:42,1640414362,5/21/2015 16:21:13,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA Herpes,124-134,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 16:24:14,1640416095,5/21/2015 16:23:37,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,124,35,,,133,44,NEURALGIA,CAPSAICIN,postherpetic NEURALGIA,90-124,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 16:33:21,1640422250,5/21/2015 16:32:59,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA,124,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 16:34:20,1640422855,5/21/2015 16:34:04,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA,124,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 16:42:26,1640428185,5/21/2015 16:42:12,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA Herpes,124-134,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 17:00:15,1640439736,5/21/2015 16:59:45,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA Herpes,124-134,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 17:01:52,1640440835,5/21/2015 17:01:36,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,124,35,,,133,44,NEURALGIA,CAPSAICIN,NEURALGIA,124,35,"CAPSAICIN,","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533695,5/21/2015 17:10:32,1640446078,5/21/2015 17:09:56,false,points4rewards,1,28703583,USA,,,97.73.83.199,124,35,,,133,44,NEURALGIA,CAPSAICIN,postherpetic neuralgia NEURALGIA,90-103-124,35-90-103,"CAPSAICIN, postherpetic neuralgia","Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club.",124,35,124,35,-1,133,44,TWrex-cause,804596,"Review: Tricyclic antidepressants, capsaicin, gabapentin, and oxycodone are effective for postherpetic neuralgia  Keywords: Neuralgia Herpes zoster  ACP Journal Club",neuralgia,capsaicin
724533696,5/21/2015 16:05:27,1640404189,5/21/2015 16:04:54,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85-96-99-105,PERMETHRIN 5% cream (Elimite),"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:09:16,1640406479,5/21/2015 16:08:59,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,67-73-81-85-96-99-105,cream (Eurax) and PERMETHRIN 5% cream (Elimite),"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:14:49,1640409855,5/21/2015 16:14:18,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85-96-99,PERMETHRIN 5% cream,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:14:51,1640409876,5/21/2015 16:14:38,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85,PERMETHRIN,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:16:07,1640410814,5/21/2015 16:15:11,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85-96-99,PERMETHRIN 5% cream,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:22:22,1640414770,5/21/2015 16:21:52,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85,PERMETHRIN,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:26:27,1640417514,5/21/2015 16:26:09,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85,PERMETHRIN,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:28:18,1640418900,5/21/2015 16:27:55,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85-96,PERMETHRIN 5%,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:46:53,1640431429,5/21/2015 16:46:06,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES,136,85,PERMETHRIN,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533696,5/21/2015 16:51:29,1640433744,5/21/2015 16:49:25,false,clixsense,1,22947672,GBR,,,88.144.127.68,136,85,,,143,95,SCABIES,PERMETHRIN,SCABIES in children.,136-144-147,85-96-99-105-123,PERMETHRIN 5% cream (Elimite) tre<span id=transmark></span>atment,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children.",136,85,136,85,-1,143,95,TWrex-cause,803495,"Taplin D, Meinking TL, Chen JA et al. Comparison of crotamiton 10% cream (Eurax) and permethrin 5% cream (Elimite) for the treatment of scabies in children",scabies,permethrin
724533697,5/21/2015 18:33:15,1640494842,5/21/2015 18:32:18,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,NOCARDIA INFECTIONS,21-30,77,NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:46:23,1640505734,5/21/2015 18:45:58,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,NOCARDIA INFECTIONS Treatment of infections caused by Nocardia +.,21-30-42-52-55-66-73-77-89,21-30-42-52-55-66-73-77-89,Nocardia Infections Treatment of infections caused by NOCARDIA +.,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:52:28,1640510554,5/21/2015 18:52:14,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,", NOCARDIA INFECTIONS",14-21-30,77,NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:52:49,1640510743,5/21/2015 18:52:37,false,elite,1,26544151,GBR,,,213.205.252.83,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,NOCARDIA INFECTIONS,21-30,77,NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:53:00,1640510886,5/21/2015 18:52:37,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,NOCARDIA INFECTIONS,21-30,55-66-73-77,infections caused by NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:53:40,1640511533,5/21/2015 18:53:26,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,"6 , 9 NOCARDIA INFECTIONS Treatment of infections caused by Nocardia",12-14-18-21-30-42-52-55-66-73-77,42-55-66-73-77-52,Treatment of infections caused by NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:54:16,1640512109,5/21/2015 18:54:01,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,NOCARDIA INFECTIONS,21-30,77,NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:56:19,1640514148,5/21/2015 18:56:07,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,", NOCARDIA INFECTIONS",14-21-30,77,NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:57:17,1640514893,5/21/2015 18:54:28,false,cointasker,1,21783324,NLD,,,31.151.239.133,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,", NOCARDIA INFECTIONS",14-21-30,77,NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533697,5/21/2015 18:59:08,1640516211,5/21/2015 18:57:08,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,21,77,,,40,85,NOCARDIA INFECTION,NOCARDIA,"6 , 9 NOCARDIA INFECTIONS",12-14-18-21-30,30-77-21,Nocardia Infections NOCARDIA,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +.",21 30,77,21,77,1,40,85,TWrex-cause,811473,"4 ,   5 ,   6 ,   9  Nocardia Infections  Treatment of infections caused by  Nocardia    +",nocardia infection,nocardia
724533698,5/21/2015 17:27:54,1640457478,5/21/2015 17:27:35,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,PNEUMOCYSTIS,99,38,CLINDAMYCIN,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 17:34:30,1640461228,5/21/2015 17:33:48,false,points4rewards,1,28703583,USA,,,97.73.83.199,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,PNEUMOCYSTIS carinii pneumonia (PCP) AIDS.,99-112-121-131-140,38-99-112-121-131-140,CLINDAMYCIN Pneumocystis carinii pneumonia (PCP) AIDS.,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 17:55:09,1640474591,5/21/2015 17:54:47,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,trimethoprim sulfamethoxazole for PNEUMOCYSTIS carinii pneumonia,64-77-94-99-112-121,38-50,CLINDAMYCIN primaquine,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:12:33,1640486568,5/21/2015 18:11:28,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,PNEUMOCYSTIS carinii pneumonia (PCP),99-112-121-131,38,CLINDAMYCIN,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:16:45,1640489832,5/21/2015 18:16:16,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,trimethoprim sulfamethoxazole for PNEUMOCYSTIS carinii pneumonia (PCP),64-77-94-99-112-121-131,38-50-61-64-77,CLINDAMYCIN primaquine vs trimethoprim sulfamethoxazole,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:39:30,1640500249,5/21/2015 18:39:03,false,clixsense,1,6574449,USA,,,216.216.68.85,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,PNEUMOCYSTIS carinii pneumonia (PCP),99-112-121-131,38-50,CLINDAMYCIN primaquine,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:40:13,1640500777,5/21/2015 18:39:47,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,trimethoprim sulfamethoxazole for PNEUMOCYSTIS carinii pneumonia in AIDS.,64-77-94-99-112-121-137-140,38-50-61-64-94-99-112-121-137-140,CLINDAMYCIN primaquine vs trimethoprim for Pneumocystis carinii pneumonia in AIDS.,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:40:42,1640501341,5/21/2015 18:40:19,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,PNEUMOCYSTIS carinii pneumonia,99-112-121,38-50,CLINDAMYCIN primaquine,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:40:59,1640501593,5/21/2015 18:40:33,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,Clindamycin primaquine vs trimethoprim sulfamethoxazole for PNEUMOCYSTIS carinii pneumonia (PCP) in AIDS.,38-50-61-64-77-94-99-112-121-131-137-140,38-50-61-64-77-94-99-112-121-131-137-140,CLINDAMYCIN primaquine vs trimethoprim sulfamethoxazole for Pneumocystis carinii pneumonia (PCP) in AIDS.,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533698,5/21/2015 18:49:45,1640508377,5/21/2015 18:49:04,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,99,38,,,111,49,PNEUMOCYSTIS,CLINDAMYCIN,PNEUMOCYSTIS carinii pneumonia,99-112-121,38,CLINDAMYCIN,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS.",99,38,99,38,-1,111,49,TWrex-cause,800509,"Toma E, Fournier S, Morisset R et al. Clindamycin/primaquine vs trimethoprim/sulfamethoxazole for  Pneumocystis carinii  pneumonia (PCP) in AIDS",pneumocystis,clindamycin
724533699,5/21/2015 18:59:59,1640516890,5/21/2015 18:59:40,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,CEREBRAL MALARIA,15-24,39-50-60-71,mefloquine resistant PLASMODIUM falciparum,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:00:31,1640517324,5/21/2015 19:00:18,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,Smear negative CEREBRAL MALARIA,0-6-15-24,39-50-60-71,mefloquine resistant PLASMODIUM falciparum,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:02:07,1640518551,5/21/2015 19:01:38,false,elite,1,26544151,GBR,,,213.205.252.83,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,CEREBRAL MALARIA,15-24,60,PLASMODIUM,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:02:20,1640518744,5/21/2015 19:02:07,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,CEREBRAL MALARIA,15-24,60-71,PLASMODIUM falciparum,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:18:27,1640531282,5/21/2015 19:18:00,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,CEREBRAL MALARIA,15-24,60-71,PLASMODIUM falciparum,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:43:30,1640563399,5/21/2015 19:42:51,false,clixsense,1,22947672,GBR,,,88.144.127.68,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,Smear negative CEREBRAL MALARIA,0-6-15-24,39-50-60-71,mefloquine resistant PLASMODIUM falcipar<span id=transmark></span>um,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:44:25,1640564110,5/21/2015 19:43:56,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,Smear negative CEREBRAL MALARIA,0-6-15-24,36-39-50-60,to mefloquine resistant PLASMODIUM,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:49:45,1640568081,5/21/2015 19:49:35,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,CEREBRAL MALARIA,15-24,60,PLASMODIUM,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:50:44,1640568727,5/21/2015 19:50:26,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,Smear negative CEREBRAL MALARIA,0-6-15-24,39-50-60-71,mefloquine resistant PLASMODIUM falciparum,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533699,5/21/2015 19:51:49,1640569391,5/21/2015 19:51:10,false,clixsense,1,31482589,NLD,,,31.201.11.16,15,60,,,31,70,CEREBRAL MALARIA,PLASMODIUM,CEREBRAL MALARIA,15-24,39-50-60-71,mefloquine resistant PLASMODIUM falciparum,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon.,15 24,60,15,60,1,31,70,TWrex-cause,811457,Smear-negative cerebral malaria due to mefloquine-resistant Plasmodium falciparum acquired in the Amazon,cerebral malaria,plasmodium
724533700,5/21/2015 19:52:54,1640569968,5/21/2015 19:52:08,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,109,225,,,113,228,PAIN,FMS,function and alleviate PAIN,86-95-99-109,204-211-220-225,female patients with FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 19:56:29,1640571973,5/21/2015 19:56:18,false,clixsense,1,31482589,NLD,,,31.201.11.16,109,225,,,113,228,PAIN,FMS,PAIN,109,225,FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:00:11,1640574109,5/21/2015 19:59:39,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,109,225,,,113,228,PAIN,FMS,alleviate PAIN,99-109,225-231,FMS 99.,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:00:51,1640574496,5/21/2015 20:00:36,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,109,225,,,113,228,PAIN,FMS,PAIN,109,225,FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:33:26,1640592747,5/21/2015 20:32:18,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,109,225,,,113,228,PAIN,FMS,PAIN and fatigue,109-114-118,225,FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:36:13,1640594615,5/21/2015 20:35:35,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,109,225,,,113,228,PAIN,FMS,PAIN,109,225,FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:38:14,1640595888,5/21/2015 20:37:38,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,109,225,,,113,228,PAIN,FMS,PAIN and fatigue,109-114-118,211-220-225,patients with FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:53:50,1640607318,5/21/2015 20:53:40,false,clixsense,1,6352682,GBR,H9,London,2.122.19.138,109,225,,,113,228,PAIN,FMS,function and alleviate PAIN and fatigue as,86-95-99-109-114-118-126,204-211-220-225-231,female patients with FMS 99.,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:55:07,1640608268,5/21/2015 20:54:31,false,quickrewards,1,8672587,USA,TX,El Paso,209.194.208.150,109,225,,,113,228,PAIN,FMS,PAIN,109,225,FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533700,5/21/2015 20:55:19,1640608346,5/21/2015 20:54:43,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,109,225,,,113,228,PAIN,FMS,alleviate PAIN and fatigue,99-109-114-118,204-211-220-225,female patients with FMS,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99.",109,225,109,225,1,113,228,TWrex-cause,812802,"◊ Fluoxetine alone, at an average dose of 55 mg/d, was found to significantly benefit function and alleviate pain and fatigue as compared with placebo in a double-blind randomized, controlled study of 60 female patients with FMS ( 99",pain,FMS
724533701,5/21/2015 16:04:53,1640403912,5/21/2015 16:04:31,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:08:58,1640406289,5/21/2015 16:08:40,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER, dengue 2 and dengue 3 viruses",53-60-72-79-86-88-92-99-101,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:14:17,1640409563,5/21/2015 16:13:30,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:14:37,1640409760,5/21/2015 16:14:17,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,72,18,,,77,32,FEVER,DENGUE VIRUS,"FEVER, dengue",72-79,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:15:10,1640410090,5/21/2015 16:14:48,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:21:51,1640414482,5/21/2015 16:21:31,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:26:05,1640417287,5/21/2015 16:25:41,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:27:54,1640418679,5/21/2015 16:27:27,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,72,18,,,77,32,FEVER,DENGUE VIRUS,"hemorrhagic FEVER, dengue 2",60-72-79-86,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:31:14,1640420858,5/21/2015 16:30:45,false,clixsense,1,22947672,GBR,,,88.144.127.68,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533701,5/21/2015 16:45:54,1640430732,5/21/2015 16:44:37,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,72,18,,,77,32,FEVER,DENGUE VIRUS,"dengue hemorrhagic FEVER,",53-60-72,18-25,DENGUE VIRUSES,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21.",72,18 25,72,18,1,77,32,TWrex-cause,811399,"Although all four dengue viruses are able to produce dengue hemorrhagic fever, dengue-2 and dengue-3 viruses are more frequently associated with severe disease ( 9 ;  21",fever,dengue virus
724533702,5/21/2015 16:09:48,1640406921,5/21/2015 16:09:24,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,56-69,trimethoprim SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:13:32,1640408932,5/21/2015 16:13:19,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,69,SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:19:43,1640412921,5/21/2015 16:19:22,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,56-69,trimethoprim SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:22:00,1640414562,5/21/2015 16:21:25,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,community acquired URINARY TRACT INFECTIONS.,119-129-138-146-152,56-69,trimethoprim SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:31:12,1640420833,5/21/2015 16:30:50,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,56-69,trimethoprim SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:32:59,1640422072,5/21/2015 16:32:45,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,56-69,trimethoprim SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:33:52,1640422622,5/21/2015 16:33:27,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,69,SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:58:44,1640438883,5/21/2015 16:58:15,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,69-56,trimethoprim SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 16:59:54,1640439480,5/21/2015 16:59:40,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,URINARY TRACT INFECTIONS.,138-146-152,69,SULFAMETHOXAZOLE,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533702,5/21/2015 17:03:38,1640441784,5/21/2015 17:03:29,false,neodev,1,31789301,USA,CA,Torrance,66.171.228.87,138,69,,,162,85,URINARY TRACT INFECTION,SULFAMETHOXAZOLE,"uncomplicated, community acquired URINARY TRACT INFECTIONS.",104-119-129-138-146-152,37-49-56-69-86-89-93,Norfloxacin versus trimethoprim SULFAMETHOXAZOLE in the therapy,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections.",138 146 152,69,138,69,-1,162,85,TWrex-cause,800384,"Goldstein EJ, Alpert JL, Ginsberg B. Norfloxacin versus trimethoprim-sulfamethoxazole in the therapy of uncomplicated, community-acquired urinary tract infections",urinary tract infection,sulfamethoxazole
724533703,5/21/2015 16:06:26,1640404815,5/21/2015 16:06:08,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:10:07,1640407076,5/21/2015 16:09:47,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,146-158,", STREPTOCOCCI.","Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:15:30,1640410269,5/21/2015 16:15:11,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:15:55,1640410658,5/21/2015 16:15:32,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:17:31,1640411523,5/21/2015 16:17:07,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:24:14,1640416117,5/21/2015 16:23:14,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:27:09,1640418146,5/21/2015 16:26:51,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:29:01,1640419329,5/21/2015 16:28:43,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:48:28,1640432115,5/21/2015 16:48:06,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,158,STREPTOCOCCI.,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533703,5/21/2015 16:53:22,1640434942,5/21/2015 16:52:05,false,clixsense,1,22947672,GBR,,,88.144.127.68,25,158,,,49,170,STREPTOCOCCAL INFECTION,STREPTOCOCCUS,STREPTOCOCCAL INFECTIONS,25-39,121-135-146-148-158-152,"Streptococcus pneumoniae , and ot<span id=transmark></span>her STREPTOCOCCI.","Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci.",25 39,158,25,158,1,49,170,TWrex-cause,810339,"Uses  Staphylococcal and Streptococcal Infections  Treatment of serious infections caused by susceptible staphylococci,  Streptococcus pneumoniae , and other streptococci",streptococcal infection,streptococcus
724533704,5/21/2015 17:28:38,1640457890,5/21/2015 17:28:14,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,SKIN,40,63-73-75-80,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 17:56:00,1640475326,5/21/2015 17:55:33,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,premalignant SKIN conditions,27-40-45,63-73-75-80,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:14:09,1640487656,5/21/2015 18:13:32,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,premalignant SKIN,27-40,63-73-75-80-89,"CUTANEOUS T CELL LYMPHOMA [CTCL]),","Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:36:43,1640497997,5/21/2015 18:36:08,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,premalignant SKIN conditions,27-40-45,63-73-75-80,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:41:26,1640501962,5/21/2015 18:40:45,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,premalignant SKIN conditions cutaneous which may appear clinically similar to dermatitis.,27-40-45-63-98-104-108-115-126-134-137,40-45-56-63-73-75-80-98-104-108-115-126-134-137-14,"malignant skin conditions (e.g., CUTANEOUS T CELL LYMPHOMA which may appear clinically similar to dermatitis.","Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:41:42,1640502147,5/21/2015 18:41:03,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,premalignant SKIN,27-40,63-73-75-80,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:42:18,1640502639,5/21/2015 18:41:50,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant SKIN conditions (e.g., cutaneous T cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",0-6-10-14-24-27-40-45-56-63-73-75-80-89-98-104-108-115-126-134-137,0-6-10-14-24-27-40-45-56-63-73-75-80-89-98-104-108-115-126-134-137,"Avoid use for malignant or premalignant skin conditions (e.g., CUTANEOUS T CELL LYMPHOMA [CTCL]), which may appear clinically similar to dermatitis.","Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:50:12,1640508807,5/21/2015 18:49:46,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,SKIN,40,63-73-75-80,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:50:57,1640509411,5/21/2015 18:50:12,false,elite,1,26544151,GBR,,,213.205.252.83,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,SKIN,40,63-73-75-80-89,"CUTANEOUS T CELL LYMPHOMA [CTCL]),","Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533704,5/21/2015 18:52:34,1640510610,5/21/2015 18:49:57,false,cointasker,1,21783324,NLD,,,31.151.239.133,40,63,,,44,88,SKIN,CUTANEOUS T CELL LYMPHOMA,premalignant SKIN conditions,27-40-45,63-73-75-80,CUTANEOUS T CELL LYMPHOMA,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis.",40,63 73 75 80,40,63,-1,44,88,TWrex-cause,802748,"Avoid use for malignant or premalignant skin conditions (e.g., cutaneous T-cell lymphoma [CTCL]), which may appear clinically similar to dermatitis",skin,cutaneous t cell lymphoma
724533705,5/21/2015 19:00:14,1640517112,5/21/2015 19:00:01,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,90,49,,,100,58,INFARCTION,VERAPAMIL,myocardial INFARCTION.,79-90,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:00:46,1640517554,5/21/2015 19:00:32,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,90,49,,,100,58,INFARCTION,VERAPAMIL,imminent myocardial INFARCTION.,79-90-70,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:02:24,1640518812,5/21/2015 19:02:10,false,elite,1,26544151,GBR,,,213.205.252.83,90,49,,,100,58,INFARCTION,VERAPAMIL,INFARCTION.,90,49,VERAPAMIL,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:02:30,1640518845,5/21/2015 19:02:21,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,90,49,,,100,58,INFARCTION,VERAPAMIL,myocardial INFARCTION.,79-90,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:18:43,1640531612,5/21/2015 19:18:28,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,90,49,,,100,58,INFARCTION,VERAPAMIL,myocardial INFARCTION.,79-90,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:44:03,1640563819,5/21/2015 19:43:32,false,clixsense,1,22947672,GBR,,,88.144.127.68,90,49,,,100,58,INFARCTION,VERAPAMIL,imminent myocardial INFARCTION.,70-79-90,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:45:21,1640564918,5/21/2015 19:44:27,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,90,49,,,100,58,INFARCTION,VERAPAMIL,in imminent myocardial INFARCTION.,67-70-79-90,37-49-59-67-70,Intravenous VERAPAMIL therapy in imminent,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:49:57,1640568166,5/21/2015 19:49:47,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,90,49,,,100,58,INFARCTION,VERAPAMIL,imminent myocardial INFARCTION.,70-79-90,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:51:05,1640568974,5/21/2015 19:50:46,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,90,49,,,100,58,INFARCTION,VERAPAMIL,imminent myocardial INFARCTION.,70-79-90,37-49,Intravenous VERAPAMIL,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533705,5/21/2015 19:52:06,1640569573,5/21/2015 19:51:50,false,clixsense,1,31482589,NLD,,,31.201.11.16,90,49,,,100,58,INFARCTION,VERAPAMIL,myocardial INFARCTION.,79-90,37-49-59,Intravenous VERAPAMIL therapy,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction.",90,49,90,49,-1,100,58,TWrex-cause,803527,"Hasin Y, Freiman I, Schwarz T et al. Intravenous verapamil therapy in imminent myocardial infarction",infarction,verapamil
724533706,5/21/2015 18:52:57,1640510847,5/21/2015 18:52:43,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in PNEUMOCYSTIS therapy, prophylaxis.",0-8-20-32-42-46-60-69-5,0-5-8-20-32-42-46-60-69,"Merz B. Aerosolized PENTAMIDINE promising in Pneumocystis therapy, prophylaxis.","Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 18:55:42,1640513670,5/21/2015 18:55:20,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,46,20,PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 18:56:10,1640514008,5/21/2015 18:55:51,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,"PNEUMOCYSTIS therapy,",46-60,8-20,Aerosolized PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 18:56:36,1640514457,5/21/2015 18:56:17,false,elite,1,26544151,GBR,,,213.205.252.83,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,46,20,PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 18:57:15,1640514884,5/21/2015 18:56:50,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,46,20-8,Aerosolized PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 18:59:46,1640516795,5/21/2015 18:59:32,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,"PNEUMOCYSTIS therapy,",46-60,20,PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 19:10:07,1640524230,5/21/2015 19:09:21,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,"PNEUMOCYSTIS therapy, prophylaxis.",46-60-69,8-20,Aerosolized PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 19:12:03,1640525425,5/21/2015 19:11:49,false,cointasker,1,21783324,NLD,,,31.151.239.133,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,PNEUMOCYSTIS,46,5-8-20-0,Merz B. Aerosolized PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 19:32:16,1640553644,5/21/2015 19:32:09,false,instagc,1,23657877,USA,DE,Dover,98.252.20.214,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,"pentamidine promising in PNEUMOCYSTIS therapy, prophylaxis.",20-32-42-46-60-69,0-5-8-20-32-42-46,Merz B. Aerosolized PENTAMIDINE promising in Pneumocystis,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533706,5/21/2015 19:33:46,1640554895,5/21/2015 19:31:46,false,clixsense,1,22947672,GBR,,,88.144.127.68,46,20,,,58,31,PNEUMOCYSTIS,PENTAMIDINE,"PNEUMOCYSTIS therapy,",46-60,20,PENTAMIDINE,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis.",46,20,46,20,-1,58,31,TWrex-cause,803646,"Merz B. Aerosolized pentamidine promising in  Pneumocystis  therapy, prophylaxis",pneumocystis,pentamidine
724533707,5/21/2015 17:05:46,1640442929,5/21/2015 17:05:25,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:06:41,1640443700,5/21/2015 17:06:28,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE,48,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:14:26,1640448436,5/21/2015 17:14:12,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE,48,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:18:18,1640450943,5/21/2015 17:17:38,false,points4rewards,1,28703583,USA,,,97.73.83.199,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31-48-53,AZELAIC ACID acne vulgaris.,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:21:36,1640453342,5/21/2015 17:21:19,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE,48,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:29:18,1640458300,5/21/2015 17:28:17,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:38:41,1640464138,5/21/2015 17:38:30,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:38:47,1640464174,5/21/2015 17:38:33,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31,AZELAIC ACID,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:44:53,1640468293,5/21/2015 17:44:15,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31-36,AZELAIC ACID therapy,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533707,5/21/2015 17:46:47,1640469599,5/21/2015 17:46:18,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,48,23,,,52,35,ACNE,AZELAIC ACID,ACNE vulgaris.,48-53,23-31-36-44-48,AZELAIC ACID therapy for acne,Webster G: Combination azelaic acid therapy for acne vulgaris.,48,23 31,48,23,-1,52,35,TWrex-cause,804226,Webster G: Combination azelaic acid therapy for acne vulgaris,acne,azelaic acid
724533708,5/21/2015 16:13:37,1640408999,5/21/2015 16:13:20,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 16:17:19,1640411460,5/21/2015 16:17:09,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,233,190,,,242,201,PREGNANCY,MEPROBAMATE,first trimester of PREGNANCY.,214-220-230-233,149-161-180-190,"anxiolytics (chlordiazepoxide, diazepam, MEPROBAMATE)","a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 16:24:10,1640416003,5/21/2015 16:23:40,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,233,190,,,242,201,PREGNANCY,MEPROBAMATE,first trimester of PREGNANCY.,214-230-233-220,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 16:26:39,1640417613,5/21/2015 16:26:15,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,233,190,,,242,201,PREGNANCY,MEPROBAMATE,first trimester of PREGNANCY.,214-220-230-233,190-214,MEPROBAMATE) first,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 16:35:44,1640423495,5/21/2015 16:35:13,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 16:36:12,1640424011,5/21/2015 16:35:50,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 16:53:58,1640435347,5/21/2015 16:52:51,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190-233,MEPROBAMATE) pregnancy.,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 17:02:23,1640441156,5/21/2015 17:02:02,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 17:03:45,1640441824,5/21/2015 17:03:29,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533708,5/21/2015 17:12:09,1640446923,5/21/2015 17:11:48,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,233,190,,,242,201,PREGNANCY,MEPROBAMATE,PREGNANCY.,233,190,MEPROBAMATE),"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy.",233,190,233,190,-1,242,201,TWrex-cause,803077,"a ,   b ,   c  Fetal/Neonatal Morbidity  Retrospective studies suggest increased risk of congenital malformations in infants of mothers who received anxiolytics (chlordiazepoxide, diazepam, meprobamate) during the first trimester of pregnancy",pregnancy,meprobamate
724533709,5/21/2015 17:59:03,1640477463,5/21/2015 17:58:43,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,rapid onset VIRILIZATION;,38-44-50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:32:15,1640493886,5/21/2015 18:31:42,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,rapid onset VIRILIZATION;,38-44-50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:45:58,1640505414,5/21/2015 18:45:30,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid onset VIRILIZATION; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",0-8-18-24-33-38-44-50-64-67-70-76-87-92-101-110-115-118-127-137-141-148,0-8-18-24-33-38-44-50-64-67-70-76-87-92-101-110-115-118-127-137-141-148,"ADRENAL CARCINOMA often presents with rapid onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.","Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:51:34,1640509912,5/21/2015 18:51:00,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,VIRILIZATION;,50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:52:13,1640510368,5/21/2015 18:52:00,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,VIRILIZATION;,50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:52:35,1640510645,5/21/2015 18:52:23,false,elite,1,26544151,GBR,,,213.205.252.83,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,VIRILIZATION;,50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:52:36,1640510649,5/21/2015 18:52:22,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,rapid onset VIRILIZATION;,38-44-50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:53:25,1640511260,5/21/2015 18:53:05,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,"Adrenal carcinoma often with rapid onset VIRILIZATION; it is often associated symptoms fatigue, weakness, weight loss.",0-8-18-33-38-44-50-64-67-70-76-101-118-127-141-148,0-8-18-24-33-118-127-137-148-141,"ADRENAL CARCINOMA often presents with fatigue, weakness, and weight loss.","Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:53:59,1640511803,5/21/2015 18:53:47,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,rapid onset VIRILIZATION;,38-44-50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533709,5/21/2015 18:54:27,1640512277,5/21/2015 18:54:11,false,cointasker,1,21783324,NLD,,,31.151.239.133,50,0,,,62,17,VIRILIZATION,ADRENAL CARCINOMA,rapid onset VIRILIZATION;,38-44-50,0-8,ADRENAL CARCINOMA,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss.",50,0 8,50,0,1,62,17,TWrex-cause,812622,"Adrenal carcinoma often presents with rapid-onset virilization; it is often associated with systemic symptoms such as fatigue, weakness, and weight loss",virilization,adrenal carcinoma
724533710,5/21/2015 18:55:04,1640512970,5/21/2015 18:54:32,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,96,9,,,103,17,DYSPNEA,MORPHINE,"Low dose morphine may blunt the medullary response to CO 2 retention or O 2 decline, reducing DYSPNEA and decreasing anxiety without causing significant respiratory depression.",0-4-9-18-22-28-32-42-51-54-57-60-70-73-75-78-87-96-104-108-119-127-135-143-155-167,0-4-9-18-22-28-32-42-51-54-57-60-70-73-75-78-87-96-104-108-119-127-135-143-155-167,"Low dose MORPHINE may blunt the medullary response to CO 2 retention or O 2 decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.","Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 18:56:59,1640514754,5/21/2015 18:56:39,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,9,MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 18:57:09,1640514815,5/21/2015 18:56:50,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,9,MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 18:58:08,1640515513,5/21/2015 18:57:53,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,0-4-9,Low dose MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 18:58:49,1640515909,5/21/2015 18:58:00,false,elite,1,26544151,GBR,,,213.205.252.83,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,9,MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 19:00:37,1640517438,5/21/2015 19:00:26,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,9,MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 19:12:54,1640525964,5/21/2015 19:12:40,false,cointasker,1,21783324,NLD,,,31.151.239.133,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,9,MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 19:13:16,1640526249,5/21/2015 19:12:24,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,96,9,,,103,17,DYSPNEA,MORPHINE,"O 2 decline, reducing DYSPNEA and decreasing anxiety",75-78-87-96-104-108-119-73,0-4-9,Low dose MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 19:37:12,1640557750,5/21/2015 19:36:30,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,96,9,,,103,17,DYSPNEA,MORPHINE,DYSPNEA,96,9,MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533710,5/21/2015 19:39:16,1640559580,5/21/2015 19:38:16,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,96,9,,,103,17,DYSPNEA,MORPHINE,reducing DYSPNEA and decreasing anxiety,87-96-104-108-119,0-4-9,Low dose MORPHINE,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression.",96,9,96,9,-1,103,17,TWrex-cause,800687,"Low-dose morphine may blunt the medullary response to CO 2  retention or O 2  decline, reducing dyspnea and decreasing anxiety without causing significant respiratory depression",dyspnea,morphine
724533711,5/21/2015 17:05:18,1640442617,5/21/2015 17:04:46,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,granulocytic EHRLICHIOSIS,83-96,37-47,ANAPLASMA phagocytophila,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:06:27,1640443579,5/21/2015 17:06:07,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,EHRLICHIOSIS,96,37,ANAPLASMA,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:14:10,1640448332,5/21/2015 17:13:57,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,EHRLICHIOSIS,96,37,ANAPLASMA,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:17:32,1640450446,5/21/2015 17:16:09,false,points4rewards,1,28703583,USA,,,97.73.83.199,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,human granulocytic EHRLICHIOSIS babesiosis,77-83-96-219,37-47-77-83-96-219,ANAPLASMA phagocytophila human granulocytic ehrlichiosis babesiosis,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:21:18,1640453190,5/21/2015 17:20:58,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,EHRLICHIOSIS,96,37,ANAPLASMA,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:28:16,1640457660,5/21/2015 17:28:00,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,granulocytic EHRLICHIOSIS,83-96,37-47,ANAPLASMA phagocytophila,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:38:29,1640464017,5/21/2015 17:38:14,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,granulocytic EHRLICHIOSIS,83-96,37,ANAPLASMA,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:38:33,1640464059,5/21/2015 17:38:16,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,granulocytic EHRLICHIOSIS,83-96,25-32-37-47,vector for ANAPLASMA phagocytophila,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:44:14,1640467852,5/21/2015 17:43:01,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,human granulocytic EHRLICHIOSIS,77-83-96,37-47,ANAPLASMA phagocytophila,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533711,5/21/2015 17:46:16,1640469276,5/21/2015 17:45:41,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,96,37,,,108,46,EHRLICHIOSIS,ANAPLASMA,human granulocytic EHRLICHIOSIS,77-83-96,37-47,ANAPLASMA phagocytophila,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections.",96,37,96,37,1,108,46,TWrex-cause,810278,"I. scapularis  is also a vector for  Anaplasma phagocytophila , which causes human granulocytic ehrlichiosis [  see 7:XVII Infections Due to   Rickettsia, Ehrlichia,  and  Coxiella], and  Babesia microti , which causes babesiosis [  see 7:XXXIV Protozoan Infections",ehrlichiosis,anaplasma
724533712,5/21/2015 19:20:56,1640535323,5/21/2015 19:20:33,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87-95,LINDANE 1%,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:48:23,1640567224,5/21/2015 19:47:53,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,151,87,,,158,94,SCABIES,LINDANE,effective treatments for SCABIES,126-136-147-151,64-72-82-87,scabies concluded that LINDANE,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:51:00,1640568925,5/21/2015 19:50:48,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87-95,LINDANE 1%,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:53:04,1640570059,5/21/2015 19:50:23,false,clixsense,1,22947672,GBR,,,88.144.127.68,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87-95,LINDANE 1%,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:54:23,1640570775,5/21/2015 19:53:45,false,clixsense,1,31482589,NLD,,,31.201.11.16,151,87,,,158,94,SCABIES,LINDANE,treatments for SCABIES,136-147-151,87-95,LINDANE 1%,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:56:42,1640572072,5/21/2015 19:55:28,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87,LINDANE,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:56:54,1640572192,5/21/2015 19:55:58,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87,LINDANE,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 19:58:58,1640573344,5/21/2015 19:58:41,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87-95,LINDANE 1%,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 20:30:12,1640590726,5/21/2015 20:29:42,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87-95-98-102-113,LINDANE 1% and permethrin 5%,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533712,5/21/2015 20:31:44,1640591534,5/21/2015 20:30:27,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,151,87,,,158,94,SCABIES,LINDANE,SCABIES,151,87,LINDANE,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46.",151,87,151,87,-1,158,94,TWrex-cause,800373,"• An extensive review of medical literature on the treatment of scabies concluded that lindane 1% and permethrin 5% were both effective treatments for scabies but that lindane should be used with extreme caution, especially in infants, young children, pregnant females, and lactating women because of possible neurotoxicity ( 46",scabies,lindane
724533713,5/21/2015 17:04:39,1640442344,5/21/2015 17:04:15,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:06:06,1640443245,5/21/2015 17:05:48,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:13:56,1640448209,5/21/2015 17:13:43,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:15:58,1640449446,5/21/2015 17:15:19,false,points4rewards,1,28703583,USA,,,97.73.83.199,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA AIDS,62-116,18-62-116,DRONABINOL anorexia AIDS,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:20:57,1640452945,5/21/2015 17:20:30,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA AIDS,62-116,18-116,DRONABINOL AIDS,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:27:59,1640457498,5/21/2015 17:27:40,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:38:13,1640463801,5/21/2015 17:37:56,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:38:14,1640463811,5/21/2015 17:37:41,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:43:00,1640467028,5/21/2015 17:42:01,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,62,18,,,70,28,ANOREXIA,DRONABINOL,ANOREXIA,62,18,DRONABINOL,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533713,5/21/2015 17:45:24,1640468552,5/21/2015 17:45:19,false,neodev,1,31977841,USA,IL,Chicago,69.175.85.2,62,18,,,70,28,ANOREXIA,DRONABINOL,the treatment of ANOREXIA associated with weight,45-49-59-62-71-82-87,0-5-8-18-29-32-41,"59 In addition, DRONABINOL is approved for","59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability.",62,18,62,18,-1,70,28,TWrex-cause,803827,"59   In addition, dronabinol is approved for the treatment of anorexia associated with weight loss in patients with AIDS (starting with 2.5 mg twice daily, before lunch and supper, and titrating to effect and tolerability",anorexia,dronabinol
724533714,5/21/2015 19:00:32,1640517338,5/21/2015 19:00:16,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:01:03,1640517772,5/21/2015 19:00:48,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION artery,106-113-141,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:19:06,1640532217,5/21/2015 19:18:44,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:45:16,1640564882,5/21/2015 19:44:04,false,clixsense,1,22947672,GBR,,,88.144.127.68,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:45:47,1640565353,5/21/2015 19:45:22,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,the incidence of ATRIAL FIBRILLATION,89-93-103-106-113,56-65-68-73-81-89-93,Radegran K. Oral SOTALOL reduces the incidence,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:50:12,1640568297,5/21/2015 19:49:59,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,73,SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:52:29,1640569780,5/21/2015 19:52:09,false,clixsense,1,31482589,NLD,,,31.201.11.16,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:53:29,1640570308,5/21/2015 19:53:05,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:53:58,1640570581,5/21/2015 19:51:07,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,68-73,Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533714,5/21/2015 19:57:40,1640572656,5/21/2015 19:57:12,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,106,73,,,125,80,ATRIAL FIBRILLATION,SOTALOL,ATRIAL FIBRILLATION,106-113,65-68-73,K. Oral SOTALOL,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery.",106 113,73,106,73,-1,125,80,TWrex-cause,800939,"1]  Nystrom U, Edvardsson N, Berggren H, Pizzarelli GP, Radegran K. Oral sotalol reduces the incidence of atrial fibrillation after coronary artery bypass surgery",atrial fibrillation,sotalol
724533715,5/21/2015 17:29:48,1640458663,5/21/2015 17:29:31,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,37,0,,,45,9,SEIZURE,ECLAMPSIA,SEIZURES,37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 17:57:51,1640476621,5/21/2015 17:57:27,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,37,0,,,45,9,SEIZURE,ECLAMPSIA,SEIZURES,37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:30:04,1640492014,5/21/2015 18:29:36,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,37,0,,,45,9,SEIZURE,ECLAMPSIA,unexplained generalized SEIZURES,13-25-37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:39:37,1640500363,5/21/2015 18:38:46,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,37,0,,,45,9,SEIZURE,ECLAMPSIA,generalized SEIZURES,25-37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:43:09,1640503173,5/21/2015 18:43:00,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,37,0,,,45,9,SEIZURE,ECLAMPSIA,Eclampsia is unexplained generalized SEIZURES in patients with preeclampsia.,0-10-13-25-37-46-49-58-63,0-10-13-25-37-46-49-58-63,ECLAMPSIA is unexplained generalized seizures in patients with preeclampsia.,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:44:19,1640503923,5/21/2015 18:44:09,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,37,0,,,45,9,SEIZURE,ECLAMPSIA,Eclampsia is unexplained generalized SEIZURES in patients with preeclampsia.,0-10-13-25-37-46-49-58-63,0-10-13-25-37-46-49-58-63,ECLAMPSIA is unexplained generalized seizures in patients with preeclampsia.,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:46:22,1640505722,5/21/2015 18:45:23,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,37,0,,,45,9,SEIZURE,ECLAMPSIA,SEIZURES,37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:51:23,1640509730,5/21/2015 18:51:07,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,37,0,,,45,9,SEIZURE,ECLAMPSIA,SEIZURES,37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:51:47,1640510129,5/21/2015 18:51:35,false,elite,1,26544151,GBR,,,213.205.252.83,37,0,,,45,9,SEIZURE,ECLAMPSIA,SEIZURES,37,0,ECLAMPSIA,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533715,5/21/2015 18:52:06,1640510325,5/21/2015 18:51:36,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,37,0,,,45,9,SEIZURE,ECLAMPSIA,Eclampsia is unexplained generalized SEIZURES in patients with preeclampsia.,0-10-13-25-37-46-49-58-63,0-10-13-25-37-46-49-58-63,ECLAMPSIA is unexplained generalized seizures in patients with preeclampsia.,Eclampsia is unexplained generalized seizures in patients with preeclampsia.,37,0,37,0,1,45,9,TWrex-cause,814695,Eclampsia is unexplained generalized seizures in patients with preeclampsia,seizure,eclampsia
724533716,5/21/2015 17:09:04,1640445078,5/21/2015 17:08:47,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,10,55,,,20,63,INFECTION,YERSINIA,INFECTIONS,10,55,YERSINIA,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 17:22:52,1640454202,5/21/2015 17:22:09,false,points4rewards,1,28703583,USA,,,97.73.83.199,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS EPIDEMIOLOGY,0-10-22,0-10-22-55,Yersinia Infections EPIDEMIOLOGY YERSINIA,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 17:23:39,1640454638,5/21/2015 17:23:22,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,10,55,,,20,63,INFECTION,YERSINIA,INFECTIONS,10,55,YERSINIA,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 17:49:37,1640471034,5/21/2015 17:49:03,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS EPIDEMIOLOGY,0-10-22,44-55-65,the YERSINIA species—,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 17:53:50,1640473857,5/21/2015 17:52:13,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS EPIDEMIOLOGY,0-10-22,55-65-74,YERSINIA species— Y.,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 17:56:59,1640476186,5/21/2015 17:54:33,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS,0-10,55,YERSINIA,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 18:06:03,1640482098,5/21/2015 18:05:44,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS EPIDEMIOLOGY Each of pathogenic for humans.,0-10-22-36-41-136-147-151,41-44-48-55-65-74-77,"of the three YERSINIA species— Y. enterocolitica,","Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 18:06:45,1640482550,5/21/2015 18:06:06,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS,0-10,55-65,YERSINIA species—,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 18:11:47,1640486069,5/21/2015 18:10:52,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS,0-10,55-65,YERSINIA species—,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533716,5/21/2015 18:14:24,1640487812,5/21/2015 18:14:17,false,clixsense,1,24329110,USA,FL,Tampa,66.192.17.130,10,55,,,20,63,INFECTION,YERSINIA,Yersinia INFECTIONS EPIDEMIOLOGY Each of,0-10-22-36-41,41-44-48-55-65-74-77,"of the three YERSINIA species— Y. enterocolitica,","Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans.",10,55,10,55,1,20,63,TWrex-cause,811664,"Yersinia  Infections  EPIDEMIOLOGY  Each of the three  Yersinia  species— Y. enterocolitica, Y. pseudotuberculosis , and  Y. pestis —is pathogenic for humans",infection,yersinia
724533717,5/21/2015 17:07:42,1640444220,5/21/2015 17:07:00,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45,BUDESONIDE,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:08:30,1640444801,5/21/2015 17:08:04,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45,BUDESONIDE,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:15:50,1640449387,5/21/2015 17:15:36,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45,BUDESONIDE,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:21:38,1640453360,5/21/2015 17:21:02,false,points4rewards,1,28703583,USA,,,97.73.83.199,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45-119-129-138,"BUDESONIDE perennial allergic rhinitis,","Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:23:06,1640454300,5/21/2015 17:22:44,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45,BUDESONIDE,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:30:32,1640459099,5/21/2015 17:30:17,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45,BUDESONIDE,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:48:38,1640470672,5/21/2015 17:48:10,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45-56-64-70,BUDESONIDE aqueous nasal spray,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:50:48,1640471673,5/21/2015 17:48:12,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45-56-64-70,BUDESONIDE aqueous nasal spray,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 17:53:19,1640473536,5/21/2015 17:52:14,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45,BUDESONIDE,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533717,5/21/2015 18:04:33,1640480914,5/21/2015 18:04:07,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,119,45,,,146,55,PERENNIAL ALLERGIC RHINITIS,BUDESONIDE,"PERENNIAL ALLERGIC RHINITIS,",119-129-138,45-56-64-70,BUDESONIDE aqueous nasal spray,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours.",119 129 138,45,119,45,-1,146,55,TWrex-cause,803746,"Fokkens WJ, Cserhati E, dos Santos JM et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours",perennial allergic rhinitis,budesonide
724533718,5/21/2015 18:58:36,1640515802,5/21/2015 18:57:59,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,"Enterotoxigenic E. coli which produces heat labile toxin and / or heat stable toxin, is the most common known cause of TRAVELER'S DIARRHEA.",2-19-22-29-35-44-49-56-62-65-66-69-74-81-88-91-95-107-113-119-122-133-100,0-2-18-19-22-29-35-44-49-56-62-66-69-74-81-88-91-95-100-107-113-119-122-133,"• ENTEROTOXIGENIC  E. COLI which produces heat labile toxin and or heat stable toxin, is the most common known cause of traveler's diarrhea.","• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 18:58:50,1640515944,5/21/2015 18:58:35,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18-19-22,ENTEROTOXIGENIC  E. COLI,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 18:58:55,1640516023,5/21/2015 18:58:27,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18-22-19,ENTEROTOXIGENIC  E. COLI,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 18:59:43,1640516748,5/21/2015 18:59:13,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18-19-22,ENTEROTOXIGENIC  E. COLI,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 19:00:53,1640517636,5/21/2015 19:00:40,false,elite,1,26544151,GBR,,,213.205.252.83,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18,ENTEROTOXIGENIC,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 19:01:42,1640518252,5/21/2015 19:01:32,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18-19-22,ENTEROTOXIGENIC  E. COLI,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 19:17:03,1640529475,5/21/2015 19:16:46,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,0-2-18-22-19,• ENTEROTOXIGENIC  E. COLI,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 19:41:14,1640561232,5/21/2015 19:40:59,false,clixsense,1,22947672,GBR,,,88.144.127.68,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18-19-22,ENTEROTOXIGENIC  E. COLI,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 19:42:36,1640562575,5/21/2015 19:42:03,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,TRAVELER'S DIARRHEA.,122-133,2-18-22-29-35-44-56-49,ENTEROTOXIGENIC  COLI which produces heat labile toxin,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533718,5/21/2015 19:48:53,1640567545,5/21/2015 19:48:28,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,122,2,,,141,26,TRAVELER'S DIARRHEA,ENTEROTOXIGENIC E. COLI,Enterotoxigenic coli most common known cause of TRAVELER'S DIARRHEA.,2-22-95-107-113-119-122-133-100,0-2-18-22-107-113-119-122-133,• ENTEROTOXIGENIC  COLI known cause of traveler's diarrhea.,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea.",122 133,2 18,122,2,1,141,26,TWrex-cause,810204,"• Enterotoxigenic  E. coli , which produces heat labile toxin and/or heat stable toxin, is the most common known cause of traveler's diarrhea",traveler's diarrhea,enterotoxigenic e. coli
724533719,5/21/2015 16:08:03,1640405862,5/21/2015 16:07:52,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:11:43,1640407923,5/21/2015 16:11:32,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,76,98,,,81,105,COLD,VIRUS,COLDS caused by other viruses.,76-82-89-92-98,82-89-92-98,caused by other VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:17:46,1640411723,5/21/2015 16:17:31,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:19:31,1640412775,5/21/2015 16:19:14,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:25:35,1640416968,5/21/2015 16:25:27,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:29:00,1640419327,5/21/2015 16:28:39,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:29:50,1640419900,5/21/2015 16:29:38,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:30:51,1640420554,5/21/2015 16:30:27,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:51:13,1640433587,5/21/2015 16:50:55,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533719,5/21/2015 16:57:16,1640437725,5/21/2015 16:56:21,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,76,98,,,81,105,COLD,VIRUS,COLDS,76,98,VIRUSES.,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses.,76,98,76,98,1,81,105,TWrex-cause,810572,Infections produce a typical coryzal illness that is indistinguishable from colds caused by other viruses,cold,virus
724533720,5/21/2015 17:06:32,1640443627,5/21/2015 17:06:22,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:07:32,1640444027,5/21/2015 17:06:59,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:14:58,1640448667,5/21/2015 17:14:47,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:20:18,1640452525,5/21/2015 17:19:44,false,points4rewards,1,28703583,USA,,,97.73.83.199,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING Skin damage,0-14-19,0-14-19-53-65,photoaging Skin damage ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:22:29,1640453946,5/21/2015 17:22:18,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:30:05,1640458777,5/21/2015 17:29:51,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:39:04,1640464395,5/21/2015 17:38:54,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:39:13,1640464534,5/21/2015 17:39:06,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING,0,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:46:47,1640469633,5/21/2015 17:46:14,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING Skin damage,0-14-19,53-65,ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533720,5/21/2015 17:47:47,1640470139,5/21/2015 17:47:22,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,0,53,,,10,69,PHOTOAGING,ULTRAVIOLET RAY,PHOTOAGING Skin damage,0-14-19,41-53-65-50,exposure to ULTRAVIOLET RAYS.,photoaging    Skin damage as a result of exposure to ultraviolet rays.,0,53 65,0,53,1,10,69,TWrex-cause,811572,photoaging    Skin damage as a result of exposure to ultraviolet rays,photoaging,ultraviolet ray
724533721,5/21/2015 18:35:32,1640496717,5/21/2015 18:34:56,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:47:36,1640506726,5/21/2015 18:47:21,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,66,15,,,75,28,INFECTION,HERPES ZOSTER,Herpes Zoster Herpes zoster results from the reactivation of VZV INFECTION.,0-7-15-22-29-37-46-59-62-66-42,0-7-15-22-29-37-42-46-59-62-66,Herpes Zoster HERPES ZOSTER results from the reactivation of VZV infection.,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:53:25,1640511283,5/21/2015 18:53:02,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:53:50,1640511702,5/21/2015 18:53:36,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:54:05,1640511920,5/21/2015 18:53:24,false,elite,1,26544151,GBR,,,213.205.252.83,66,15,,,75,28,INFECTION,HERPES ZOSTER,INFECTION.,66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:54:38,1640512460,5/21/2015 18:54:24,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,66,15,,,75,28,INFECTION,HERPES ZOSTER,Herpes zoster results from the reactivation of VZV INFECTION.,15-22-29-42-46-59-62-66-37,0-7-15-22-29-37-42-46-59-62-66,Herpes Zoster HERPES ZOSTER results from the reactivation of VZV infection.,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:55:02,1640512930,5/21/2015 18:54:46,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 18:56:54,1640514695,5/21/2015 18:56:45,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 19:01:00,1640517731,5/21/2015 19:00:51,false,clixsense,1,6574449,USA,,,216.216.68.85,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533721,5/21/2015 19:02:02,1640518511,5/21/2015 19:00:54,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,66,15,,,75,28,INFECTION,HERPES ZOSTER,VZV INFECTION.,62-66,15-22,HERPES ZOSTER,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection.,66,15 22,66,15,1,75,28,TWrex-cause,810761,Herpes Zoster  Herpes zoster results from the reactivation of VZV infection,infection,herpes zoster
724533722,5/21/2015 16:38:21,1640425353,5/21/2015 16:38:03,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,61,113,,,71,118,INFECTION,STAPH,staphylococcal INFECTIONS,46-61,100-113-119,"nonmenstrual STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:04:06,1640442014,5/21/2015 17:03:45,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,61,113,,,71,118,INFECTION,STAPH,staphylococcal INFECTIONS,46-61,100-113-119,"nonmenstrual STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:05:45,1640442913,5/21/2015 17:05:29,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,61,113,,,71,118,INFECTION,STAPH,INFECTIONS,61,113,STAPH,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:13:42,1640448053,5/21/2015 17:13:26,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,61,113,,,71,118,INFECTION,STAPH,INFECTIONS,61,113,STAPH,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:15:04,1640448733,5/21/2015 17:14:16,false,points4rewards,1,28703583,USA,,,97.73.83.199,61,113,,,71,118,INFECTION,STAPH,"staphylococcal INFECTIONS nonmenstrual staph TSS,",46-61-100-113-119,46-61-113-119,"staphylococcal infections STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:20:28,1640452630,5/21/2015 17:19:10,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,61,113,,,71,118,INFECTION,STAPH,INFECTIONS,61,113,STAPH,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:27:40,1640457275,5/21/2015 17:27:17,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,61,113,,,71,118,INFECTION,STAPH,staphylococcal INFECTIONS,46-61,113-119,"STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:37:39,1640463512,5/21/2015 17:37:14,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,61,113,,,71,118,INFECTION,STAPH,staphylococcal INFECTIONS,46-61,84-95-100-113-119,"associated with nonmenstrual STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:37:56,1640463656,5/21/2015 17:37:25,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,61,113,,,71,118,INFECTION,STAPH,staphylococcal INFECTIONS,46-61,113-119,"STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533722,5/21/2015 17:41:59,1640466374,5/21/2015 17:41:33,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,61,113,,,71,118,INFECTION,STAPH,staphylococcal INFECTIONS,46-61,100-113-119,"nonmenstrual STAPH TSS,","Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best.",61,113,61,113,1,71,118,TWrex-cause,810145,"Comments: • There are many different types of staphylococcal infections that may be associated with nonmenstrual staph TSS, and thus strategies to prevent cases are difficult at best",infection,staph
724533723,5/21/2015 16:10:54,1640407451,5/21/2015 16:10:26,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192-205-208,PANTOPRAZOLE 40 mg,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:14:33,1640409738,5/21/2015 16:14:10,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,pylori infection and GASTRO OESOPHAGEAL REFLUX DISEASE,125-132-142-146-153-165-172,192,PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:20:50,1640413752,5/21/2015 16:20:26,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192-205-208,PANTOPRAZOLE 40 mg,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:23:08,1640415313,5/21/2015 16:22:41,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192-205-208,PANTOPRAZOLE 40 mg,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:32:35,1640421870,5/21/2015 16:32:14,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192,PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:33:48,1640422594,5/21/2015 16:33:30,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192,PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:39:52,1640426309,5/21/2015 16:39:13,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192,PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 16:59:29,1640439213,5/21/2015 16:59:16,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192,PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 17:01:08,1640440303,5/21/2015 17:00:30,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,GASTRO OESOPHAGEAL REFLUX DISEASE,146-153-165-172,192,PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533723,5/21/2015 17:09:52,1640445528,5/21/2015 17:08:31,false,points4rewards,1,28703583,USA,,,97.73.83.199,146,192,,,179,204,GASTRO OESOPHAGEAL REFLUX DISEASE,PANTOPRAZOLE,Helicobacter pylori infection GASTRO OESOPHAGEAL REFLUX DISEASE,112-125-132-146-153-165-172,112-125-132-192,Helicobacter pylori infection PANTOPRAZOLE,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs.",146 153 165 172,192,146,192,-1,179,204,TWrex-cause,804373,"upper gastrointestinal symptoms: a randomized placebo-controlled trial  Meta-analysis: the relationship between Helicobacter pylori infection and gastro-oesophageal reflux disease  Once-daily pantoprazole 40 mg and esomeprazole 40 mg have equivalent overall efficacy in relieving GERD-related symptoms  Is there any association between myocardial infarction, gastro-oesophageal reflux disease and acid-suppressing drugs",gastro oesophageal reflux disease,pantoprazole
724533724,5/21/2015 17:09:28,1640445235,5/21/2015 17:09:12,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125,MEDROXYPROGESTERONE,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 17:23:31,1640454603,5/21/2015 17:22:58,false,points4rewards,1,28703583,USA,,,97.73.83.199,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,Ectopic Pregnancy PREGNANCY,0-8-68,0-8-125,Ectopic Pregnancy MEDROXYPROGESTERONE,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 17:23:58,1640454900,5/21/2015 17:23:41,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125,MEDROXYPROGESTERONE,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 17:50:09,1640471320,5/21/2015 17:49:38,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125-145,MEDROXYPROGESTERONE contraception.,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 17:55:32,1640474903,5/21/2015 17:53:51,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125-145,MEDROXYPROGESTERONE contraception.,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 17:57:47,1640476594,5/21/2015 17:57:03,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125,MEDROXYPROGESTERONE,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 18:06:30,1640482415,5/21/2015 18:06:07,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,ectopic pregnancy if PREGNANCY or severe abdominal pain women using medroxyprogesterone,47-55-65-68-78-81-88-98-113-119-125,81-88-110-113-119-125-145-98,severe abdominal pain in women using MEDROXYPROGESTERONE contraception.,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 18:07:13,1640482806,5/21/2015 18:06:46,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125-145,MEDROXYPROGESTERONE contraception.,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 18:12:11,1640486330,5/21/2015 18:11:49,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125-145,MEDROXYPROGESTERONE contraception.,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533724,5/21/2015 18:35:00,1640496230,5/21/2015 18:34:17,false,clixsense,1,6574449,USA,,,216.216.68.85,68,125,,,77,144,PREGNANCY,MEDROXYPROGESTERONE,PREGNANCY,68,125-145,MEDROXYPROGESTERONE contraception.,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception.,68,125,68,125,-1,77,144,TWrex-cause,803315,Ectopic Pregnancy  Consider the possibility of ectopic pregnancy if pregnancy or severe abdominal pain occurs in women using medroxyprogesterone contraception,pregnancy,medroxyprogesterone
724533725,5/21/2015 17:08:05,1640444529,5/21/2015 17:07:49,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13,RALOXIFENE,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:08:46,1640444920,5/21/2015 17:08:31,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13,RALOXIFENE,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:16:00,1640449492,5/21/2015 17:15:51,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13,RALOXIFENE,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:22:03,1640453611,5/21/2015 17:21:44,false,points4rewards,1,28703583,USA,,,97.73.83.199,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,0-13-66-81,7.3 RALOXIFENE postmenopausal osteoporosis.,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:23:21,1640454488,5/21/2015 17:23:08,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13,RALOXIFENE,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:30:42,1640459184,5/21/2015 17:30:33,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13,RALOXIFENE,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:49:02,1640470804,5/21/2015 17:48:39,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13-24-32-36,RALOXIFENE therapy for treatment,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:52:10,1640472655,5/21/2015 17:50:50,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13-24,RALOXIFENE therapy,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 17:54:29,1640474196,5/21/2015 17:53:24,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13-24,RALOXIFENE therapy,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533725,5/21/2015 18:06:00,1640482080,5/21/2015 18:04:35,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,66,13,,,93,23,POSTMENOPAUSAL OSTEOPOROSIS,RALOXIFENE,POSTMENOPAUSAL OSTEOPOROSIS.,66-81,13-24,RALOXIFENE therapy,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis.,66 81,13,66,13,-1,93,23,TWrex-cause,804306,7.3 Consider raloxifene therapy for treatment (and prevention) of postmenopausal osteoporosis,postmenopausal osteoporosis,raloxifene
724533726,5/21/2015 16:11:43,1640407926,5/21/2015 16:11:30,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 16:15:53,1640410640,5/21/2015 16:15:34,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 16:22:02,1640414586,5/21/2015 16:21:43,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 16:24:38,1640416317,5/21/2015 16:24:16,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,46-53-61,single dose FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 16:33:41,1640422502,5/21/2015 16:33:23,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 16:34:34,1640422950,5/21/2015 16:34:22,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 16:42:52,1640428564,5/21/2015 16:42:32,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 17:00:30,1640439892,5/21/2015 17:00:17,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 17:02:06,1640440993,5/21/2015 17:01:54,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,61,FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533726,5/21/2015 17:11:09,1640446418,5/21/2015 17:10:37,false,points4rewards,1,28703583,USA,,,97.73.83.199,11,61,,,27,72,ORAL CANDIDIASIS,FLUCONAZOLE,ORAL CANDIDIASIS,11-16,11-16-61,Oral candidiasis FLUCONAZOLE,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days.,11 16,61,11,61,-1,27,72,TWrex-cause,800089,TREATMENT: Oral candidiasis is treated with a single dose of fluconazole or with clotrimazole lozenges or nystatin oral solution (which must be held in the mouth for several minutes before swallowing) for 14 days,oral candidiasis,fluconazole
724533727,5/21/2015 17:10:07,1640445675,5/21/2015 17:09:51,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,ENCEPHALITIS,112,135,CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 17:24:36,1640455433,5/21/2015 17:24:19,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,ENCEPHALITIS,112,135,CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 17:24:41,1640455464,5/21/2015 17:24:06,false,points4rewards,1,28703583,USA,,,97.73.83.199,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,100-135-112,toxoplasmic encephalitis CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 17:50:59,1640471778,5/21/2015 17:50:40,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,112-125-130-135-147-151,encephalitis with oral CLINDAMYCIN and pyrimethamine.,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 17:57:14,1640476302,5/21/2015 17:56:06,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,112-125-130-135-147-151-100,toxoplasmic encephalitis with oral CLINDAMYCIN and pyrimethamine.,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 18:00:42,1640478426,5/21/2015 17:59:55,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,135,CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 18:07:06,1640482726,5/21/2015 18:06:50,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS with oral clindamycin pyrimethamine.,100-112-125-130-135-151,112-125-130-135-147-151-100,toxoplasmic encephalitis with oral CLINDAMYCIN and pyrimethamine.,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 18:08:04,1640483270,5/21/2015 18:07:36,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,130-135,oral CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 18:13:02,1640486854,5/21/2015 18:12:34,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,130-135,oral CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533727,5/21/2015 18:35:24,1640496597,5/21/2015 18:35:02,false,clixsense,1,6574449,USA,,,216.216.68.85,112,135,,,124,146,ENCEPHALITIS,CLINDAMYCIN,toxoplasmic ENCEPHALITIS,100-112,130-135,oral CLINDAMYCIN,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine.",112,135,112,135,-1,124,146,TWrex-cause,800387,"Uberti Foppa C, Bini T, Gregis G et al. A retrospective study of primary and maintenance therapy of toxoplasmic encephalitis with oral clindamycin and pyrimethamine",encephalitis,clindamycin
724533728,5/21/2015 17:28:11,1640457608,5/21/2015 17:27:55,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,DISEASE,52,4,CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 17:55:32,1640474905,5/21/2015 17:55:11,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,cytomegalic inclusion DISEASE of infants,30-42-52-60-63,4,CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:13:28,1640487185,5/21/2015 18:12:39,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,cytomegalic inclusion DISEASE,30-42-52,4,CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:17:33,1640490271,5/21/2015 18:16:46,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,cytomegalic inclusion DISEASE,30-42-52,4,CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:40:02,1640500645,5/21/2015 18:39:32,false,clixsense,1,6574449,USA,,,216.216.68.85,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,cytomegalic inclusion DISEASE,30-42-52,4,CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:40:44,1640501359,5/21/2015 18:40:14,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,"Although cytomegalic inclusion DISEASE of infants was recognized as a clinical entity at the turn of the 20th century,",21-30-42-52-60-63-71-75-86-89-91-100-107-110-114-119-122-126-131,0-4-21-30-42-52-60-63-71-75-86-89-91-100,28 CYTOMEGALOVIRUS Although cytomegalic inclusion disease of infants was recognized as a clinical entity,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:41:01,1640501622,5/21/2015 18:40:45,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,DISEASE,52,0-4,28 CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:41:49,1640502235,5/21/2015 18:41:01,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,"Cytomegalovirus Although cytomegalic inclusion DISEASE of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid 1950s.",4-21-30-42-52-60-63-71-75-86-89-91-100-107-110-114-119-122-126-131-140-144-154-161-166-170-174-183-189-193-197,4-21-30-42-52-60-63-71-75-86-89-91-100-107-110-114-119-122-126-131-140-144-154-161-166-170-174-183-189-193-197,"CYTOMEGALOVIRUS Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid 1950s.","28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:49:56,1640508603,5/21/2015 18:49:31,false,cointasker,1,21783324,NLD,,,31.151.239.133,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,cytomegalic inclusion DISEASE,30-52-42,4,CYTOMEGALOVIRUS,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533728,5/21/2015 18:50:12,1640508817,5/21/2015 18:49:33,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,52,4,,,59,19,DISEASE,CYTOMEGALOVIRUS,"cytomegalic inclusion DISEASE of infants was recognized the turn of the 20th century,",30-42-52-60-63-71-75-110-114-119-122-126-131,0-4-21-30-42-52-60-63-71-75-107-110-114-119-122-126-131,"28 CYTOMEGALOVIRUS Although cytomegalic inclusion disease of infants was recognized at the turn of the 20th century,","28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s.",52,4,52,4,1,59,19,TWrex-cause,815007,"28  Cytomegalovirus  Although cytomegalic inclusion disease of infants was recognized as a clinical entity at the turn of the 20th century, the etiologic agent, CMV, was not isolated until the mid-1950s",disease,cytomegalovirus
724533729,5/21/2015 16:09:21,1640406592,5/21/2015 16:09:01,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,205,187,,,209,192,SKIN,SWEAT,"nonintact SKIN,",195-205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:13:18,1640408750,5/21/2015 16:12:55,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,205,187,,,209,192,SKIN,SWEAT,"(except sweat), nonintact SKIN, and mucous membranes",179-187-195-205-211-215-222,179-187,"(except SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:19:22,1640412702,5/21/2015 16:18:52,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,205,187,,,209,192,SKIN,SWEAT,"nonintact SKIN,",195-205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:21:23,1640414119,5/21/2015 16:20:55,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,205,187,,,209,192,SKIN,SWEAT,"nonintact SKIN,",195-205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:30:43,1640420439,5/21/2015 16:30:09,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,205,187,,,209,192,SKIN,SWEAT,"SKIN,",205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:32:44,1640421908,5/21/2015 16:32:25,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,205,187,,,209,192,SKIN,SWEAT,"nonintact SKIN,",205-195,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:33:26,1640422329,5/21/2015 16:31:46,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,205,187,,,209,192,SKIN,SWEAT,"SKIN,",205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:58:13,1640438373,5/21/2015 16:57:58,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,205,187,,,209,192,SKIN,SWEAT,"SKIN,",205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:58:54,1640439002,5/21/2015 16:58:17,false,clixsense,1,22947672,GBR,,,88.144.127.68,205,187,,,209,192,SKIN,SWEAT,"nonintact SKIN,",195-205,168-179-187,"excretions (except SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533729,5/21/2015 16:59:38,1640439299,5/21/2015 16:58:25,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,205,187,,,209,192,SKIN,SWEAT,"SKIN,",205,187,"SWEAT),","These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control.",205,187,205,187,-1,209,192,TWrex-cause,802282,"These precautions (e.g., handwashing and wearing personal protective equipment such as gloves, mask, eye protection, gown) apply to blood, all body fluids, secretions, excretions (except sweat), nonintact skin, and mucous membranes of all patients and are the primary strategy for successful nosocomial infection control",skin,sweat
724533730,5/21/2015 17:25:58,1640456186,5/21/2015 17:25:42,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,86,ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 17:29:03,1640458165,5/21/2015 17:28:34,false,points4rewards,1,28703583,USA,,,97.73.83.199,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,86-131-137,ALPRAZOLAM panic disorder.,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 17:52:41,1640473050,5/21/2015 17:52:18,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,86,ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 17:59:24,1640477659,5/21/2015 17:58:43,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,75-81-86,short term ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 18:07:03,1640482666,5/21/2015 18:06:17,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,86,ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 18:08:20,1640483408,5/21/2015 18:08:03,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,short term alprazolam group treatment of PANIC DISORDER.,75-81-112-118-128-131-137-86,69-75-81-86-97-101-112-118-128-131-137,after short term ALPRAZOLAM and behavioral group treatment of panic disorder.,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 18:09:29,1640484216,5/21/2015 18:09:09,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,75-81-86,short term ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 18:14:54,1640488226,5/21/2015 18:14:37,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,86,ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 18:36:52,1640498103,5/21/2015 18:36:31,false,clixsense,1,6574449,USA,,,216.216.68.85,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,PANIC DISORDER.,131-137,86,ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533730,5/21/2015 18:38:00,1640499059,5/21/2015 18:37:31,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,131,86,,,145,96,PANIC DISORDER,ALPRAZOLAM,alprazolam and behavioral group treatment of PANIC DISORDER.,86-101-112-118-128-131-137-97,37-46-50-61-69-75-81-86,Clinical and medication outcome after short term ALPRAZOLAM,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder.",131 137,86,131,86,-1,145,96,TWrex-cause,800918,"Nagy LM, Krystal JH, Woods SW et al. Clinical and medication outcome after short-term alprazolam and behavioral group treatment of panic disorder",panic disorder,alprazolam
724533731,5/21/2015 19:50:33,1640568565,5/21/2015 19:49:31,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,94,38,,,101,43,SCABIES,MITE,cases of normal SCABIES,78-84-87-94,20-24-35-38,the prevalence of MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 19:55:34,1640571497,5/21/2015 19:55:12,false,clixsense,1,31482589,NLD,,,31.201.11.16,94,38,,,101,43,SCABIES,MITE,normal SCABIES,87-94,38,MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 19:58:46,1640573236,5/21/2015 19:58:30,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,94,38,,,101,43,SCABIES,MITE,normal SCABIES,87-94,38,MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 19:59:52,1640573875,5/21/2015 19:59:35,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,94,38,,,101,43,SCABIES,MITE,SCABIES,94,38,MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 20:31:36,1640591362,5/21/2015 20:31:05,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,94,38,,,101,43,SCABIES,MITE,normal SCABIES,87-94,38,MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 20:34:11,1640593248,5/21/2015 20:33:28,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,94,38,,,101,43,SCABIES,MITE,SCABIES,94,38,MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 20:36:00,1640594587,5/21/2015 20:34:47,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,94,38,,,101,43,SCABIES,MITE,SCABIES,94,38-44-78-84-94,MITES in cases of scabies,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 20:53:19,1640606966,5/21/2015 20:52:51,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,94,38,,,101,43,SCABIES,MITE,normal SCABIES,87-94,24-35-38,prevalence of MITES,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 20:54:15,1640607629,5/21/2015 20:52:36,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,94,38,,,101,43,SCABIES,MITE,cases of normal SCABIES revealed live mites from dust samples,78-84-87-94-102-111-116-122-127-132,20-24-35-38-44-47-51-60,the prevalence of MITES in the personal environment,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533731,5/21/2015 20:54:21,1640607734,5/21/2015 20:53:03,false,clixsense,1,25038425,AUS,2,Sydney,49.182.141.110,94,38,,,101,43,SCABIES,MITE,cases of normal SCABIES revealed live mites,78-84-87-94-102-111-116,20-24-35-38-44-47-51-94-87,the prevalence of MITES in the personal normal scabies,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11.",94,38,94,38,1,101,43,TWrex-cause,811101,"• Investigations of the prevalence of mites in the personal environment of 37 cases of normal scabies revealed live mites from dust samples taken from bedroom floors, overstuffed chairs, and couches in all 37 cases ( 11",scabies,mite
724533732,5/21/2015 17:27:33,1640457216,5/21/2015 17:27:18,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,42,179,,,46,182,PAIN,RSD,PAIN,42,179,RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 17:33:43,1640460822,5/21/2015 17:33:03,false,points4rewards,1,28703583,USA,,,97.73.83.199,42,179,,,46,182,PAIN,RSD,PAIN posttraumatic RSD,42-165-179,165-179,posttraumatic RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 17:54:46,1640474326,5/21/2015 17:54:16,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,42,179,,,46,182,PAIN,RSD,PAIN,42,165-179,posttraumatic RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:11:23,1640485826,5/21/2015 18:10:31,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,42,179,,,46,182,PAIN,RSD,PAIN,42,165-179,posttraumatic RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:16:14,1640489415,5/21/2015 18:13:23,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,42,179,,,46,182,PAIN,RSD,alleviate PAIN,32-42,165-179-185,posttraumatic RSD 50.,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:17:31,1640490228,5/21/2015 18:16:35,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,42,179,,,46,182,PAIN,RSD,PAIN,42,165-179,posttraumatic RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:39:01,1640499795,5/21/2015 18:38:36,false,clixsense,1,6574449,USA,,,216.216.68.85,42,179,,,46,182,PAIN,RSD,PAIN,42,165-179,posttraumatic RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:39:46,1640500416,5/21/2015 18:39:11,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,42,179,,,46,182,PAIN,RSD,Alendronate has been shown to alleviate PAIN and improve joint mobility,2-14-18-23-29-32-42-47-51-59-65,126-133-139-145-148-151-160-165-179,double blind study in 40 patients with posttraumatic RSD,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:40:16,1640500833,5/21/2015 18:39:15,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,42,179,,,46,182,PAIN,RSD,PAIN,42,165-179-185,posttraumatic RSD 50.,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533732,5/21/2015 18:40:32,1640501186,5/21/2015 18:39:53,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,42,179,,,46,182,PAIN,RSD,"Alendronate has been shown to alleviate PAIN and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with posttraumatic RSD 50.",2-14-18-23-29-32-42-47-51-59-65-74-78-87-97-100-102-114-126-133-139-145-148-151-160-165-179-185,2-14-18-23-29-32-42-47-51-59-65-74-78-87-97-100-102-114-126-133-139-145-151-160-165-179-185-148,"Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double blind study in 40 patients with posttraumatic RSD 50.","• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50.",42,179,42,179,1,46,182,TWrex-cause,813736,"• Alendronate has been shown to alleviate pain and improve joint mobility and pressure tolerance in a randomized, controlled, double-blind study in 40 patients with posttraumatic RSD ( 50",pain,RSD
724533733,5/21/2015 16:38:01,1640425154,5/21/2015 16:37:39,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,51-56,mild SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:03:39,1640441797,5/21/2015 17:03:25,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,56,SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:05:25,1640442669,5/21/2015 17:05:02,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,56,SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:13:25,1640447782,5/21/2015 17:13:15,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,56,SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:14:12,1640448338,5/21/2015 17:13:05,false,points4rewards,1,28703583,USA,,,97.73.83.199,157,56,,,162,67,COUGH,SARCOIDOSIS,mild sarcoidosis COUGH.,51-56-157,56-141-157-147,SARCOIDOSIS nasal polyps cough.,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:19:09,1640451550,5/21/2015 17:18:36,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,56,SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:27:16,1640457058,5/21/2015 17:26:56,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,157,56,,,162,67,COUGH,SARCOIDOSIS,nasal polyps or COUGH.,141-147-154-157,56,SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:37:13,1640463151,5/21/2015 17:36:31,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,157,56,,,162,67,COUGH,SARCOIDOSIS,nasal polyps or COUGH.,147-154-157-141,56-73-78,SARCOIDOSIS skin lesions,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:37:24,1640463317,5/21/2015 17:37:09,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,56,SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533733,5/21/2015 17:41:32,1640466143,5/21/2015 17:41:04,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,157,56,,,162,67,COUGH,SARCOIDOSIS,COUGH.,157,51-56,mild SARCOIDOSIS,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough.,157,56,157,56,1,162,67,TWrex-cause,814620,B]  7.1 Consider topical steroids in patients with mild sarcoidosis with skin lesions or anterior uveitis and inhaled steroids in those with nasal polyps or cough,cough,sarcoidosis
724533734,5/21/2015 17:26:57,1640456838,5/21/2015 17:26:37,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 17:31:55,1640459939,5/21/2015 17:31:17,false,points4rewards,1,28703583,USA,,,97.73.83.199,110,52,,,118,60,HEADACHE,MIGRAINE,migraine HEADACHE,52-110,52-110,MIGRAINE headache,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 17:53:57,1640473902,5/21/2015 17:53:34,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:06:39,1640482521,5/21/2015 18:04:37,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:09:16,1640484113,5/21/2015 18:09:03,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,110,52,,,118,60,HEADACHE,MIGRAINE,migraine severely incapacitated by the HEADACHE and the indeterminate,52-89-103-106-110-119-123-127-80,35-38-47-52-61-65-73-110,of patients with MIGRAINE who usually become headache,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:10:01,1640484598,5/21/2015 18:09:29,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:15:56,1640489159,5/21/2015 18:15:38,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:15:57,1640489183,5/21/2015 18:14:15,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:38:15,1640499286,5/21/2015 18:37:50,false,clixsense,1,6574449,USA,,,216.216.68.85,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533734,5/21/2015 18:39:13,1640499967,5/21/2015 18:38:48,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,110,52,,,118,60,HEADACHE,MIGRAINE,HEADACHE,110,52,MIGRAINE,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2.",110,52,110,52,1,118,60,TWrex-cause,813474,"This study excluded the 25% to 35% of patients with migraine who usually become severely incapacitated by the headache and the indeterminate number of persons who develop rebound headache that is often attributed to the overenthusiastic use of nonprescription drugs that contain caffeine (1, 2",headache,migraine
724533735,5/21/2015 16:04:30,1640403729,5/21/2015 16:04:16,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63-75,CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:08:39,1640406145,5/21/2015 16:08:23,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63-75,CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:13:29,1640408863,5/21/2015 16:12:59,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63-75,CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:14:15,1640409549,5/21/2015 16:14:01,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63,CLOSTRIDIUM,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:14:46,1640409812,5/21/2015 16:14:24,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,24 CLOSTRIDIUM INFECTIONS,0-4-16,59-63-75,by CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:17:51,1640411758,5/21/2015 16:17:41,false,instagc,1,23287154,USA,CA,San Jose,130.65.251.20,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63-75,CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:18:47,1640412387,5/21/2015 16:18:38,false,instagc,1,31184650,USA,IA,West Des Moines,63.153.203.116,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63-75,CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:21:30,1640414210,5/21/2015 16:20:39,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63,CLOSTRIDIUM,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:24:52,1640416451,5/21/2015 16:24:33,false,clixsense,1,22947672,GBR,,,88.144.127.68,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,28-38-41-52-59-63-75,Treatment of infections caused by CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533735,5/21/2015 16:25:40,1640417001,5/21/2015 16:25:15,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,4,63,,,26,74,CLOSTRIDIUM INFECTION,CLOSTRIDIUM,CLOSTRIDIUM INFECTIONS,4-16,63-75,CLOSTRIDIUM perfringens,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections.,4 16,63,4,63,1,26,74,TWrex-cause,811236,24  Clostridium Infections  Treatment of infections caused by  Clostridium perfringens    +   ; alternative to penicillin G for those with penicillin hypersensitivity or for polymicrobial infections,clostridium infection,clostridium
724533736,5/21/2015 17:58:18,1640477053,5/21/2015 17:57:53,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,ST elevation MYOCARDIAL INFARCTION,88-91-101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:30:32,1640492228,5/21/2015 18:30:08,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,ST elevation MYOCARDIAL INFARCTION,88-91-101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:44:52,1640504376,5/21/2015 18:44:21,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST elevation MYOCARDIAL INFARCTION (TRITON TIMI 38): double blind, randomised controlled trial.",0-9-14-26-29-38-49-62-71-84-88-91-101-112-123-131-136-141-148-155-166-177,0-9-14-26-29-38-49-62-71-84-88-91-101-112-123-131-136-141-148-155-166-177,"compared with CLOPIDOGREL in patients undergoing percutaneous coronary intervention for ST elevation myocardial infarction (TRITON TIMI 38): double blind, randomised controlled trial.","compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:48:59,1640507815,5/21/2015 18:46:25,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,ST elevation MYOCARDIAL INFARCTION,88-91-101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:51:43,1640510046,5/21/2015 18:51:24,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,MYOCARDIAL INFARCTION,101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:51:59,1640510227,5/21/2015 18:51:44,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,ST elevation MYOCARDIAL INFARCTION,88-91-101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:52:04,1640510259,5/21/2015 18:51:49,false,elite,1,26544151,GBR,,,213.205.252.83,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,MYOCARDIAL INFARCTION,101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:52:26,1640510488,5/21/2015 18:52:07,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,for ST elevation MYOCARDIAL INFARCTION TIMI 38): randomised controlled trial.,84-88-91-101-112-131-136-155-166-177,0-9-14-26-29-38-141-148-155-166-177,"compared with CLOPIDOGREL in patients undergoing double blind, randomised controlled trial.","compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:53:17,1640511081,5/21/2015 18:52:35,false,cointasker,1,21783324,NLD,,,31.151.239.133,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,ST elevation MYOCARDIAL INFARCTION,88-91-101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533736,5/21/2015 18:53:30,1640511395,5/21/2015 18:53:02,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,101,14,,,122,25,MYOCARDIAL INFARCTION,CLOPIDOGREL,ST elevation MYOCARDIAL INFARCTION,88-91-101-112,14,CLOPIDOGREL,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial.",101 112,14,101,14,-1,122,25,TWrex-cause,803645,"compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial",myocardial infarction,clopidogrel
724533737,5/21/2015 18:48:55,1640507769,5/21/2015 18:48:13,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the EYE through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",0-5-12-18-21-26-30-33-37-41-49-54-63-73-76-84-96-105-109-113-123-126-128-133-136-142-149-152-156-164-167-171,0-5-12-18-21-26-30-33-37-41-49-54-63-73-76-84-96-105-109-113-123-126-128-133-136-142-149-152-156-164-167-171,"This allows fluid to flow out of the eye through this opening, resulting in LOWERED INTRAOCULAR PRESSURE and the formation of a bleb or fluid bubble on the surface of the eye.","This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 18:54:02,1640511889,5/21/2015 18:53:44,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,EYE,37,76-84-96,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 18:54:31,1640512333,5/21/2015 18:54:09,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,out of the EYE,26-30-33-37,63-73-76-84-96,resulting in LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 18:54:44,1640512613,5/21/2015 18:54:30,false,elite,1,26544151,GBR,,,213.205.252.83,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,EYE,37,76-84-96,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 18:55:21,1640513321,5/21/2015 18:54:53,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,"fluid to flow out of the EYE through this opening, resulting in lowered intraocular pressure",12-18-21-26-30-33-37-41-49-54-63-73-76-84-96,5-12-18-21-26-30-33-37-54-63-73-76-84-96-105-109-113-41,"allows fluid to flow out of the eye through opening, resulting in LOWERED INTRAOCULAR PRESSURE and the formation","This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 18:55:39,1640513617,5/21/2015 18:55:24,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,EYE,37,76-84-96,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 18:57:38,1640515172,5/21/2015 18:57:09,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,EYE,37,76-84-96,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 19:05:45,1640520997,5/21/2015 19:04:11,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,EYE lowered intraocular pressure,37-76-84-96,76-84-96-105-109-113,LOWERED INTRAOCULAR PRESSURE and the formation,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 19:10:45,1640524575,5/21/2015 19:10:11,false,cointasker,1,21783324,NLD,,,31.151.239.133,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,EYE,37,76-84-96,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533737,5/21/2015 19:27:06,1640546175,5/21/2015 19:26:16,false,clixsense,1,22947672,GBR,,,88.144.127.68,37,76,,,40,104,EYE,LOWERED INTRAOCULAR PRESSURE,fluid flow out of the EYE,12-21-26-30-33-37,76-84-96,LOWERED INTRAOCULAR PRESSURE,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye.",37,76 84 96,37,76,-1,40,104,TWrex-cause,802161,"This allows fluid to flow out of the eye through this opening, resulting in lowered intraocular pressure and the formation of a bleb or fluid bubble on the surface of the eye",eye,lowered intraocular pressure
724533738,5/21/2015 19:01:31,1640518099,5/21/2015 19:01:18,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY,66-70-81,66-70-81,HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:19:46,1640533454,5/21/2015 19:19:25,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY (HIVAN.,66-70-81-93,66-70-81-93,HIV associated nephropathy (HIVAN.,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:46:49,1640566136,5/21/2015 19:46:24,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY,66-70-81,50-55-63-66-70-81,this setting is HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:48:05,1640566922,5/21/2015 19:47:03,false,clixsense,1,22947672,GBR,,,88.144.127.68,81,66,,,92,69,NEPHROPATHY,HIV,NEPHROPATHY,81,66-70-81,HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:50:35,1640568620,5/21/2015 19:50:25,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY,66-70-81,66-70-81,HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:53:13,1640570125,5/21/2015 19:52:53,false,clixsense,1,31482589,NLD,,,31.201.11.16,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY,66-70-81,66-70-81,HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:54:28,1640570881,5/21/2015 19:54:00,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,81,66,,,92,69,NEPHROPATHY,HIV,NEPHROPATHY,81,66,HIV,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:54:49,1640571104,5/21/2015 19:54:33,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY,66-81-70,66-70-81,HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 19:58:25,1640573065,5/21/2015 19:58:09,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY,66-70-81,66-70-81,HIV associated nephropathy,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533738,5/21/2015 20:28:31,1640589774,5/21/2015 20:26:55,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,81,66,,,92,69,NEPHROPATHY,HIV,HIV associated NEPHROPATHY (HIVAN.,70-81-93-66,66-70-81-93,HIV associated nephropathy (HIVAN.,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN.,81,66,81,66,1,92,69,TWrex-cause,811930,176   The renal disease that occurs most often in this setting is HIV-associated nephropathy (HIVAN,nephropathy,HIV
724533739,5/21/2015 19:54:34,1640570945,5/21/2015 19:53:56,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS,15,29-32-42-48-59,is infection with TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 19:57:48,1640572752,5/21/2015 19:57:35,false,clixsense,1,31482589,NLD,,,31.201.11.16,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS,15,48-59,TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:01:47,1640575061,5/21/2015 20:01:34,false,clixsense,1,30313955,GBR,K5,Poole,2.30.145.202,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS,0-15,48-59,TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:01:48,1640575084,5/21/2015 20:01:13,false,neodev,1,11001780,AUS,7,Elwood,14.201.215.31,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS,15,48-59,TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:34:51,1640593769,5/21/2015 20:34:30,false,clixsense,1,7726579,USA,OH,Wauseon,98.30.211.36,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS,0-15,48-59,TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:38:16,1640595916,5/21/2015 20:37:44,false,clixsense,1,6335052,GBR,V2,Glasgow,90.217.206.84,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS is infection with Toxoplasma gondii.,0-15-29-32-42-48-59,48,TOXOPLASMA,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:39:46,1640597082,5/21/2015 20:39:12,false,elite,1,32173500,GBR,E4,Rayleigh,176.24.16.182,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS is infection with Toxoplasma gondii.,15-29-32-42-48-59-0,32-42-48-59,infection with TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:56:15,1640608972,5/21/2015 20:55:58,false,prodege,1,26499212,CAN,ON,Cambridge,70.27.23.230,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS,0-15,32-42-48-59,infection with TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:56:16,1640608982,5/21/2015 20:56:00,false,clixsense,1,25038425,AUS,2,Sydney,49.182.141.110,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS is infection with Toxoplasma gondii.,0-15-29-32-42-48-59,15-29-32-42-48-59-0,TOXOPLASMOSIS Toxoplasmosis is infection with TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533739,5/21/2015 20:58:11,1640610053,5/21/2015 20:57:20,false,prodege,1,21873876,CAN,NB,Fredericton,156.57.211.152,15,48,,,28,58,TOXOPLASMOSIS,TOXOPLASMA,TOXOPLASMOSIS TOXOPLASMOSIS is infection with Toxoplasma gondii.,0-15-29-32-42-48-59,0-29-32-42-48-59-15,TOXOPLASMOSIS Toxoplasmosis is infection with TOXOPLASMA gondii.,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii.,15,48,15,48,1,28,58,TWrex-cause,812422,TOXOPLASMOSIS  Toxoplasmosis is infection with  Toxoplasma gondii,toxoplasmosis,toxoplasma
724533740,5/21/2015 16:06:50,1640405077,5/21/2015 16:06:27,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,Severe SEPSIS,292-299,229-242-248-258-266,(RECOMBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:10:28,1640407254,5/21/2015 16:10:09,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,Evaluation in Severe SEPSIS [PROWESS]),278-289-292-299-306,229-242-248-258-266,(RECOMBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:15:53,1640410641,5/21/2015 16:15:37,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,SEPSIS,299,242-248-258-266,HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:16:23,1640410967,5/21/2015 16:15:56,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,SEPSIS,299,242-248-258-266,HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:18:05,1640411898,5/21/2015 16:17:32,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,Severe SEPSIS,292-299,229-242-248-258-266,(RECOMBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:24:37,1640416308,5/21/2015 16:24:16,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,SEPSIS,299,229-242-248-258-266,(RECOMBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:27:31,1640418484,5/21/2015 16:27:10,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,SEPSIS,299,229-242-248-258-266,(RECOMBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:29:25,1640419649,5/21/2015 16:29:02,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,SEPSIS,299,242-248-258-266,HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:49:20,1640432642,5/21/2015 16:48:35,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,SEPSIS,299,229-242-248-258-266,(RECOMBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533740,5/21/2015 16:54:04,1640435437,5/21/2015 16:53:24,false,clixsense,1,22947672,GBR,,,88.144.127.68,299,230,,,305,267,SEPSIS,RECOMBINANT HUMAN ACTIVATED PROTEIN C,Severe SEPSIS [PRO<span id=transmark></span>WESS]),292-299-306,242-248-258-266-229,(RECO<span id=transmark></span>MBINANT HUMAN ACTIVATED PROTEIN C,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +.",299,242 248 258 266,299,230,-1,305,267,TWrex-cause,800557,"DESIGN  Cost-effectiveness analysis from a patient perspective using a Markov model with benefit data from a {randomized (allocation concealed*), blinded (clinicians and patients),* placebo-controlled trial with 28-day follow-up (Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis [PROWESS]) +",sepsis,recombinant human activated protein c
724533741,5/21/2015 18:48:12,1640507105,5/21/2015 18:47:37,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,76,45,,,90,55,PANIC DISORDER,PAROXETINE,Paroxetine in the treatment of PANIC DISORDER:,45-56-59-63-73-76-82,45-56-59-63-73-76-82,PAROXETINE in the treatment of panic disorder:,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 18:53:43,1640511612,5/21/2015 18:53:26,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 18:54:08,1640511969,5/21/2015 18:53:51,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 18:54:27,1640512285,5/21/2015 18:54:08,false,elite,1,26544151,GBR,,,213.205.252.83,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 18:54:52,1640512758,5/21/2015 18:54:40,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,76,45,,,90,55,PANIC DISORDER,PAROXETINE,"Paroxetine in the treatment of PANIC DISORDER: a randomised, double blind, placebo controlled study.",45-56-59-63-73-76-82-92-94-106-113-120-128-139,36-38-41-45-56-59-63-73-76-82,K et al. PAROXETINE in the treatment of panic disorder:,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 18:55:23,1640513348,5/21/2015 18:55:03,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 18:57:08,1640514810,5/21/2015 18:56:55,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 19:02:31,1640518851,5/21/2015 19:01:29,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 19:04:11,1640519868,5/21/2015 19:02:04,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533741,5/21/2015 19:04:53,1640520429,5/21/2015 19:03:07,false,cointasker,1,21783324,NLD,,,31.151.239.133,76,45,,,90,55,PANIC DISORDER,PAROXETINE,PANIC DISORDER:,76-82,45,PAROXETINE,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study.",76 82,45,76,45,-1,90,55,TWrex-cause,800191,"Oehrberg S, Christiansen PE, Behnke K et al. Paroxetine in the treatment of panic disorder: a randomised, double-blind, placebo-controlled study",panic disorder,paroxetine
724533742,5/21/2015 16:10:02,1640407068,5/21/2015 16:09:49,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67-91,CHLORAMBUCIL therapy,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:13:54,1640409319,5/21/2015 16:13:34,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:20:02,1640413157,5/21/2015 16:19:43,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:22:20,1640414764,5/21/2015 16:22:02,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:31:33,1640421073,5/21/2015 16:31:14,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:33:14,1640422172,5/21/2015 16:33:00,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:34:07,1640422737,5/21/2015 16:33:54,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,LEUKEMIA.,123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 16:58:58,1640439021,5/21/2015 16:58:45,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,chronic lymphocytic LEUKEMIA.,103-111-123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 17:00:07,1640439646,5/21/2015 16:59:56,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,LEUKEMIA.,123,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533742,5/21/2015 17:02:04,1640440958,5/21/2015 17:01:56,false,clixsense,1,28457001,CAN,ON,North Bay,24.204.202.220,123,67,,,131,79,LEUKEMIA,CHLORAMBUCIL,lymphocytic LEUKEMIA.,123-111,67,CHLORAMBUCIL,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia.",123,67,123,67,-1,131,79,TWrex-cause,803413,"Rai KR, Peterson BL, Appelbaum FR et al. Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia",leukemia,chlorambucil
724533743,5/21/2015 16:13:49,1640409224,5/21/2015 16:13:37,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 16:17:34,1640411555,5/21/2015 16:17:21,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 16:24:32,1640416284,5/21/2015 16:24:13,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,39,0,,,47,7,DEMENTIA,TACRINE,DEMENTIA:,39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 16:27:02,1640417981,5/21/2015 16:26:40,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0-11,TACRINE a,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 16:36:22,1640424084,5/21/2015 16:35:57,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 16:36:29,1640424187,5/21/2015 16:36:13,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 16:54:44,1640436017,5/21/2015 16:54:02,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0-27-39,TACRINE Alzheimer's dementia:,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 17:02:53,1640441461,5/21/2015 17:02:29,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,39,0,,,47,7,DEMENTIA,TACRINE,Alzheimer's DEMENTIA:,27-39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 17:04:13,1640442052,5/21/2015 17:03:54,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,39,0,,,47,7,DEMENTIA,TACRINE,DEMENTIA:,39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533743,5/21/2015 17:12:55,1640447462,5/21/2015 17:12:18,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,39,0,,,47,7,DEMENTIA,TACRINE,DEMENTIA:,39,0,TACRINE,Tacrine as a treatment for Alzheimer's dementia: editor's note.,39,0,39,0,-1,47,7,TWrex-cause,800312,Tacrine as a treatment for Alzheimer's dementia: editor's note,dementia,tacrine
724533744,5/21/2015 18:51:53,1640510146,5/21/2015 18:49:37,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,182,166,,,188,170,ANEMIA,IRON,"Sidebars Sidebar Iron Replacement Therapy Introduction ORAL IRON THERAPY Indication Treatment of choice for iron deficiency anemia Initial therapy to correct iron deficiency ANEMIA Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal Continued therapy to replace iron stores Ferrous iron salt given one to three times daily until the plasma ferritin concentration is &gt;.",0-10-20-25-37-46-60-65-70-79-91-101-104-111-115-120-131-139-147-155-158-166-171-182-190-198-203-208-215-223-232-238-249-254-260-263-269-277-284-288-297-305-313-322-326-329-335-341-343-348-351-359-369-378-382-385-391-397-399-404-410-421-425-430-442-449-453-461-471-479-482-490-495-503-511-516-521-527-531-534-540-546-552-558-562-569-578-592-595,0-10-20-25-37-46-60-65-70-79-91-101-104-111-115-120-131-139-147-155-158-166-171-182-190-198-203-208-215-223-232-238-249-254-260-263-269-277-284-288-297-305-313-322-326-329-335-341-343-348-351-359-369-378-382-385-391-397-399-404-410-421-425-430-442-449-453-461-471-479-482-490-495-503-511-516-521-527-531-534-540-546-552-558-562-569-578-592-595,"Sidebars Sidebar Iron Replacement Therapy Introduction ORAL IRON THERAPY Indication Treatment of choice for iron deficiency anemia Initial therapy to correct IRON deficiency anemia Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal Continued therapy to replace iron stores Ferrous iron salt given one to three times daily until the plasma ferritin concentration is &gt;.","Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 18:54:40,1640512543,5/21/2015 18:54:21,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,182,166,,,188,170,ANEMIA,IRON,iron deficiency ANEMIA,166-171-182,166-171-182,IRON deficiency anemia,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 18:55:14,1640513245,5/21/2015 18:54:58,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,182,166,,,188,170,ANEMIA,IRON,iron deficiency ANEMIA,166-171-182,166-171-182,IRON deficiency anemia,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 18:55:31,1640513472,5/21/2015 18:55:07,false,elite,1,26544151,GBR,,,213.205.252.83,182,166,,,188,170,ANEMIA,IRON,ANEMIA,182,166,IRON,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 18:56:18,1640514142,5/21/2015 18:56:01,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,182,166,,,188,170,ANEMIA,IRON,iron deficiency ANEMIA,166-171-182,166-171-182,IRON deficiency anemia,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 18:56:21,1640514172,5/21/2015 18:55:58,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,182,166,,,188,170,ANEMIA,IRON,Iron Replacement Therapy correct iron deficiency ANEMIA Ferrous iron salt,20-25-158-166-171-182-190-198-203-37,91-101-104-111-115-147-155-158-166-171-182-190-120,Treatment of choice for iron deficiency therapy to correct IRON deficiency anemia Ferrous,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 18:58:45,1640515891,5/21/2015 18:58:17,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,182,166,,,188,170,ANEMIA,IRON,iron deficiency ANEMIA,166-171-182,166-171-182,IRON deficiency anemia,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 19:07:37,1640522514,5/21/2015 19:06:40,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,182,166,,,188,170,ANEMIA,IRON,iron deficiency ANEMIA,166-171-182,166-171-182,IRON deficiency anemia,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 19:11:21,1640525011,5/21/2015 19:11:05,false,cointasker,1,21783324,NLD,,,31.151.239.133,182,166,,,188,170,ANEMIA,IRON,iron deficiency ANEMIA Ferrous,166-171-182-190,166-171-182-190,IRON deficiency anemia Ferrous,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533744,5/21/2015 19:31:42,1640553248,5/21/2015 19:30:57,false,instagc,1,23657877,USA,DE,Dover,98.252.20.214,182,166,,,188,170,ANEMIA,IRON,correct iron deficiency ANEMIA Ferrous iron salt,158-166-171-182-190-198-203,147-155-158-166-171-182-190,therapy to correct IRON deficiency anemia Ferrous,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >.",182,166,182,166,-1,188,170,TWrex-cause,800056,"Sidebars  Sidebar - Iron Replacement Therapy  Introduction  ORAL IRON THERAPY  Indication  Treatment of choice for iron deficiency anemia  Initial therapy to correct iron deficiency anemia  Ferrous iron salt (e.g., ferrous sulfate) given separately from meals in three divided doses, for example, ferrous sulfate tablets, 325 mg three times a day, or ferrous gluconate tablets, 300 mg three times a day, until hematocrit and mean corpuscular volume are normal  Continued therapy to replace iron stores  Ferrous iron salt given one to three times daily until the plasma ferritin concentration is >",anemia,iron
724533745,5/21/2015 16:08:47,1640406218,5/21/2015 16:08:23,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76-86,ACYCLOVIR suppression,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:12:32,1640408313,5/21/2015 16:12:02,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76-86,ACYCLOVIR suppression,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:18:34,1640412245,5/21/2015 16:18:08,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76,ACYCLOVIR,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:20:37,1640413596,5/21/2015 16:19:59,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES in pregnancy:,162-170-177-180,76-86,ACYCLOVIR suppression,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:29:50,1640419899,5/21/2015 16:29:27,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76,ACYCLOVIR,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:31:28,1640420971,5/21/2015 16:30:46,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76-162-170,ACYCLOVIR genital herpes,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:32:02,1640421529,5/21/2015 16:31:43,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76,ACYCLOVIR,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:51:49,1640433942,5/21/2015 16:51:38,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76,ACYCLOVIR,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:57:45,1640438003,5/21/2015 16:57:32,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76,ACYCLOVIR,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533745,5/21/2015 16:58:08,1640438300,5/21/2015 16:57:56,false,clixsense,1,21933552,CAN,ON,Ottawa,70.49.14.161,162,76,,,176,85,GENITAL HERPES,ACYCLOVIR,GENITAL HERPES,162-170,76-86,ACYCLOVIR suppression,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.",162 170,76,162,76,-1,176,85,TWrex-cause,804390,"2]  Scott LL, Hollier LM, McIntire D, Sanchez PJ, Jackson GL, Wendel GD Jr. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial",genital herpes,acyclovir
724533746,5/21/2015 16:08:20,1640406015,5/21/2015 16:08:05,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:12:01,1640408015,5/21/2015 16:11:44,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,"SEIZURES (including status epilepticus),",62-82-89-71,59-62-71-82-89,"in seizures (including STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:18:07,1640411901,5/21/2015 16:17:47,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:19:58,1640413132,5/21/2015 16:19:32,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:29:26,1640419651,5/21/2015 16:29:01,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:30:24,1640420361,5/21/2015 16:29:51,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:31:42,1640421250,5/21/2015 16:30:59,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:51:36,1640433806,5/21/2015 16:51:23,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:57:31,1640437879,5/21/2015 16:57:18,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,SEIZURES,62,82-89,"STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533746,5/21/2015 16:58:15,1640438394,5/21/2015 16:57:55,false,clixsense,1,22947672,GBR,,,88.144.127.68,62,82,,,70,100,SEIZURE,STATUS EPILEPTICUS,"SEIZURES (inclu<span id=transmark></span>ding status epilepticus),",62-82-89-71,62-71-82-89,"seizures (including STATUS EPILEPTICUS),","Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms.",62,82 89,62,82,1,70,100,TWrex-cause,813855,"Rapid dosage reduction or abrupt discontinuance may result in seizures (including status epilepticus),  102 ,   103   delirium,  102 ,   104   or withdrawal symptoms",seizure,status epilepticus
724533747,5/21/2015 18:59:11,1640516240,5/21/2015 18:58:52,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,407,46,,,417,54,INFARCTION,WARFARIN,Myocardial INFARCTION,396-407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 18:59:18,1640516337,5/21/2015 18:58:57,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,407,46,,,417,54,INFARCTION,WARFARIN,Myocardial INFARCTION,396-407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 18:59:58,1640516877,5/21/2015 18:59:45,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,407,46,,,417,54,INFARCTION,WARFARIN,systemic embolism Myocardial INFARCTION,378-387-396-407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:01:16,1640517879,5/21/2015 19:00:55,false,elite,1,26544151,GBR,,,213.205.252.83,407,46,,,417,54,INFARCTION,WARFARIN,INFARCTION,407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:01:54,1640518397,5/21/2015 19:01:42,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,407,46,,,417,54,INFARCTION,WARFARIN,systemic embolism Myocardial INFARCTION,378-387-396-407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:17:31,1640529968,5/21/2015 19:17:04,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,407,46,,,417,54,INFARCTION,WARFARIN,systemic embolism Myocardial INFARCTION,378-387-396-407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:42:19,1640562199,5/21/2015 19:41:16,false,clixsense,1,22947672,GBR,,,88.144.127.68,407,46,,,417,54,INFARCTION,WARFARIN,Myocardial INFARCTION,396-407,32-41-46,adjusted dose WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:43:12,1640563177,5/21/2015 19:42:37,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,407,46,,,417,54,INFARCTION,WARFARIN,systemic embolism Myocardial INFARCTION,378-387-396-407,32-41-46-55-58-70,adjusted dose WARFARIN in nonvalvular atrial,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:49:14,1640567812,5/21/2015 19:48:55,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,407,46,,,417,54,INFARCTION,WARFARIN,systemic embolism Myocardial INFARCTION,378-387-396-407,46-55-58-70,WARFARIN in nonvalvular atrial,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533747,5/21/2015 19:49:56,1640568150,5/21/2015 19:49:35,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,407,46,,,417,54,INFARCTION,WARFARIN,systemic embolism Myocardial INFARCTION,378-387-396-407,46,WARFARIN,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++.,407,46,407,46,-1,417,54,TWrex-cause,803724,Fixed-dose oral ximelagatran vs adjusted-dose warfarin in nonvalvular atrial fibrillation requiring long-term anticoagulation therapy at mean 20 months +  Outcomes                                 Event rate per     Difference patient-y          (95% CI) Ximelagatran       Warfarin Any stroke (ischemic or hemorrhagic)   1.6%             1.2%         0.45% (-0.13 to 1.0) ++ or systemic embolism Myocardial infarction                  1.0%             1.4%         -0.4% {-0.9 to 0.2 +++,infarction,warfarin
724533748,5/21/2015 18:56:22,1640514207,5/21/2015 18:55:07,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous THROMBOEMBOLISM, major psychiatric disorders, life expectancy INTERVENTION After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3 mo treatment group) and 133 patients to continue (1 y treatment group) oral anticoagulant therapy for 9 additional months.",0-10-19-28-42-50-54-62-68-73-80-97-103-115-126-131-144-158-164-166-173-176-184-189-198-203-206-216-219-234-238-247-252-262-265-277-280-283-293-300-304-308-317-320-329-332-334-344-351-356-370-378-382-384-395,0-10-19-28-42-50-54-62-68-73-80-97-103-115-126-131-144-158-164-166-173-176-184-189-198-203-206-216-219-234-238-247-252-262-265-277-280-283-293-300-304-308-317-320-329-332-334-344-351-356-370-378-382-384-395,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy INTERVENTION After 3 months of therapy with WARFARIN (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3 mo treatment group) and 133 patients to continue (1 y treatment group) oral anticoagulant therapy for 9 additional months.","Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 18:57:21,1640514966,5/21/2015 18:57:01,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM,",73-80,189,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 18:57:27,1640515001,5/21/2015 18:57:10,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM,",73-80,176-184-189,therapy with WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 18:58:24,1640515643,5/21/2015 18:58:09,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM,",73-80,189,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 18:59:13,1640516276,5/21/2015 18:58:51,false,elite,1,26544151,GBR,,,213.205.252.83,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"THROMBOEMBOLISM,",80,189,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 19:00:52,1640517608,5/21/2015 19:00:38,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM,",73-80,189,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 19:14:01,1640526751,5/21/2015 19:13:17,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM, major psychiatric disorders,",73-80-97-103-115,189,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 19:38:42,1640559108,5/21/2015 19:38:19,false,clixsense,1,22947672,GBR,,,88.144.127.68,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM,",73-80,176-184-189,therapy with WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 19:39:38,1640559830,5/21/2015 19:37:15,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM,",73-80,189,WARFARIN,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533748,5/21/2015 19:39:58,1640560202,5/21/2015 19:39:17,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,80,189,,,95,197,THROMBOEMBOLISM,WARFARIN,"venous THROMBOEMBOLISM, major psychiatric disorders,",73-80-97-103-115,176-184-189-203-206,therapy with WARFARIN of patients),"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months.",80,189,80,189,-1,95,197,TWrex-cause,800158,"Exclusion criteria included anticoagulant therapy for reasons other than venous thromboembolism, major psychiatric disorders, life expectancy   INTERVENTION  After 3 months of therapy with warfarin (97% of patients) or acenocoumarol, 133 patients were allocated to discontinue (3-mo treatment group) and 133 patients to continue (1-y treatment group) oral anticoagulant therapy for 9 additional months",thromboembolism,warfarin
724533749,5/21/2015 16:07:10,1640405244,5/21/2015 16:06:51,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:10:55,1640407453,5/21/2015 16:10:35,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,65-76-81-93-106-108-112,meningitis with combination AMPHOTERICIN B and flucytosine,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:16:46,1640411165,5/21/2015 16:16:24,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:17:30,1640411515,5/21/2015 16:15:54,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-65,meningitis AMPHOTERICIN,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:18:34,1640412257,5/21/2015 16:18:06,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,81-93-106-108-112,combination AMPHOTERICIN B and flucytosine,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:25:02,1640416581,5/21/2015 16:24:38,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:27:54,1640418676,5/21/2015 16:27:32,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:29:48,1640419883,5/21/2015 16:29:26,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:49:51,1640432921,5/21/2015 16:49:31,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,CRYPTOCOCCAL MENINGITIS,52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533749,5/21/2015 16:54:26,1640435638,5/21/2015 16:54:07,false,clixsense,1,22947672,GBR,,,88.144.127.68,52,93,,,75,105,CRYPTOCOCCAL MENINGITIS,AMPHOTERICIN,Treatment of CRYPTOCOCCAL MENINGITIS,39-49-52-65,93-106,AMPHOTERICIN B,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks.",52 65,93,52,93,-1,75,105,TWrex-cause,800370,"Dismukes WE, Cloud G, Gallis HA et al. Treatment of cryptococcal meningitis with combination amphotericin B and flucytosine for four as compared with six weeks",cryptococcal meningitis,amphotericin
724533750,5/21/2015 16:07:29,1640405436,5/21/2015 16:07:17,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:11:16,1640407676,5/21/2015 16:10:56,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:17:08,1640411350,5/21/2015 16:16:47,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:17:41,1640411626,5/21/2015 16:17:31,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:18:52,1640412411,5/21/2015 16:18:36,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:25:13,1640416630,5/21/2015 16:25:04,false,onestopgpt,1,21275875,CAN,ON,Hamilton,24.36.121.10,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:28:17,1640418894,5/21/2015 16:27:55,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:30:12,1640420159,5/21/2015 16:29:50,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:50:22,1640433012,5/21/2015 16:49:58,false,elite,1,32303982,GBR,A8,Blackburn,88.106.0.215,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533750,5/21/2015 16:55:02,1640436256,5/21/2015 16:54:27,false,clixsense,1,22947672,GBR,,,88.144.127.68,45,0,,,59,23,NUCLEAR ATYPIA,ANAPLASTIC ASTROCYTOMA,NUCLEAR ATYPIA,45-53,0-11,ANAPLASTIC ASTROCYTOMAS,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity.,45 53,0 11,45,0,1,59,23,TWrex-cause,812912,Anaplastic astrocytomas are characterized by nuclear atypia and mitotic activity,nuclear atypia,anaplastic astrocytoma
724533751,5/21/2015 17:25:18,1640455764,5/21/2015 17:24:58,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,290,2,,,300,11,DEPRESSION,BUPROPION,DEPRESSion.,293,3,BUPROPIOn,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 17:27:05,1640456910,5/21/2015 17:25:51,false,points4rewards,1,28703583,USA,,,97.73.83.199,290,2,,,300,11,DEPRESSION,BUPROPION,depression,137,0-3-13-18-137,— BUPROPIOn plus SSRI depression,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 17:51:52,1640472451,5/21/2015 17:51:28,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,290,2,,,300,11,DEPRESSION,BUPROPION,Drug Treatment fOR DEPRESSion.,274-279-289-293,0-3-13-18,— BUPROPIOn plus SSRI,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 17:58:15,1640476994,5/21/2015 17:57:42,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,290,2,,,300,11,DEPRESSION,BUPROPION,DEPRESSion.,293,3-13-18,BUPROPIOn plus SSRI,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 18:04:32,1640480926,5/21/2015 18:02:41,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,290,2,,,300,11,DEPRESSION,BUPROPION,DEPRESSion.,293,3,BUPROPIOn,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 18:07:46,1640483106,5/21/2015 18:07:27,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,290,2,,,300,11,DEPRESSION,BUPROPION,Drug Treatment fOR DEPRESSion.,274-279-289-293,0-3-13-18-40-50-65-61,— BUPROPIOn plus SSRI carefully monitoring TCA levels,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 18:08:43,1640483786,5/21/2015 18:08:25,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,290,2,,,300,11,DEPRESSION,BUPROPION,DEPRESSion.,293,3,BUPROPIOn,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 18:13:59,1640487579,5/21/2015 18:13:32,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,290,2,,,300,11,DEPRESSION,BUPROPION,DEPRESSion.,293,3,BUPROPIOn,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 18:36:05,1640497428,5/21/2015 18:35:51,false,clixsense,1,6574449,USA,,,216.216.68.85,290,2,,,300,11,DEPRESSION,BUPROPION,DEPRESSion.,293,3,BUPROPIOn,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533751,5/21/2015 18:36:35,1640497883,5/21/2015 18:36:11,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,290,2,,,300,11,DEPRESSION,BUPROPION,See table Drug Treatment fOR DEPRESSion.,263-274-279-289-293-267,0-3-13-18-25-29-34-40-50-61-65,"— BUPROPIOn plus SSRI TCA plus SSRI, carefully monitoring TCA levels","— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",,,290,2,-1,300,11,TWrex-cause,800805,"— Bupropion plus SSRI — TCA plus SSRI, carefully monitoring TCA levels — Mirtazapine plus SSRI ◊ Adding an agent not typically used for depression ('augmentation' therapy): — Lithium — Liothyronine — Risperidone — Pindolol — Buspirone ◊ Adding psychotherapy • See table  Drug Treatment for Depression....",depression,bupropion
724533752,5/21/2015 17:09:49,1640445479,5/21/2015 17:09:30,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE,12,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 17:24:02,1640454945,5/21/2015 17:23:36,false,points4rewards,1,28703583,USA,,,97.73.83.199,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE Paget's disease,12-29-37,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 17:24:18,1640455163,5/21/2015 17:24:00,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE,12,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 17:50:38,1640471586,5/21/2015 17:50:10,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE,12,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 17:56:05,1640475393,5/21/2015 17:55:33,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE affected by Paget's disease,12-17-26-29-37,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 17:59:51,1640477920,5/21/2015 17:57:51,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE,12,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 18:06:49,1640482558,5/21/2015 18:06:32,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,12,29,,,16,44,BONE,PAGET'S DISEASE,"Evidence: • BONE affected by Paget's disease can enlarge,",0-10-12-17-26-29-37-45-49,12-17-26-29-37-45-49-58-108-116-119-123-126,"Bone affected by PAGET'S DISEASE can enlarge, and symptom in 20% of patients.","Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 18:07:34,1640483027,5/21/2015 18:07:15,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE,12,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 18:12:33,1640486592,5/21/2015 18:12:13,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,12,29,,,16,44,BONE,PAGET'S DISEASE,BONE,12,29-37,PAGET'S DISEASE,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533752,5/21/2015 18:35:13,1640496404,5/21/2015 18:34:42,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,12,29,,,16,44,BONE,PAGET'S DISEASE,"Evidence: • BONE affected by Paget's disease can enlarge,",0-10-12-17-26-29-37-45-49,12-17-26-29-37-45-49-58-92-95-97-108-116-119-123-126,"Bone affected by PAGET'S DISEASE can enlarge, and is a presenting symptom in 20% of patients.","Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients.",12,29 37,12,29,-1,16,44,TWrex-cause,802286,"Evidence: • Bone affected by Paget's disease can enlarge, and this enlargement of deformity is a presenting symptom in 20% of patients",bone,paget's disease
724533753,5/21/2015 16:11:54,1640408005,5/21/2015 16:11:44,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81-93,GLUCOSAMINE therapy,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 16:16:07,1640410816,5/21/2015 16:15:54,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81,GLUCOSAMINE,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 16:22:20,1640414763,5/21/2015 16:22:03,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,for OSTEOARTHRITIS.,101-114,81,GLUCOSAMINE,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 16:24:54,1640416462,5/21/2015 16:24:40,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81-93,GLUCOSAMINE therapy,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 16:34:00,1640422685,5/21/2015 16:33:42,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81,GLUCOSAMINE,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 16:34:47,1640423063,5/21/2015 16:34:35,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,for OSTEOARTHRITIS.,101-114,81,GLUCOSAMINE,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 16:43:56,1640429427,5/21/2015 16:42:55,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81-114,GLUCOSAMINE osteoarthritis.,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 17:00:42,1640439966,5/21/2015 17:00:32,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81,GLUCOSAMINE,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 17:02:31,1640441248,5/21/2015 17:02:08,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81,GLUCOSAMINE,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533753,5/21/2015 17:10:46,1640446230,5/21/2015 17:10:37,false,clixsense,1,32549163,CAN,MB,Winnipeg,206.45.167.246,114,81,,,128,92,OSTEOARTHRITIS,GLUCOSAMINE,OSTEOARTHRITIS.,114,81-93,GLUCOSAMINE therapy,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis.",114,81,114,81,-1,128,92,TWrex-cause,803494,"1]  Towheed TE, Maxwell L, Anastassiades TP, Shea B, Houpt J, Robinson V, et al. Glucosamine therapy for treating osteoarthritis",osteoarthritis,glucosamine
724533754,5/21/2015 17:06:21,1640443538,5/21/2015 17:05:53,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,COCCIDIOIDOMYCOSIS:,114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:06:58,1640443946,5/21/2015 17:06:42,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,COCCIDIOIDOMYCOSIS:,114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:14:46,1640448580,5/21/2015 17:14:27,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,COCCIDIOIDOMYCOSIS:,114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:19:39,1640452029,5/21/2015 17:18:23,false,points4rewards,1,28703583,USA,,,97.73.83.199,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,diffuse pulmonary extrathoracic disseminated COCCIDIOIDOMYCOSIS:,66-74-87-101-114,18-31-36-40-66-74-87-101-114,AMPHOTERICIN B HIV infected diffuse pulmonary extrathoracic disseminated coccidioidomycosis:,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:22:17,1640453774,5/21/2015 17:21:38,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,COCCIDIOIDOMYCOSIS:,114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:29:49,1640458688,5/21/2015 17:29:19,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,extrathoracic disseminated COCCIDIOIDOMYCOSIS:,87-101-114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:38:53,1640464303,5/21/2015 17:38:42,false,instagc,1,13581319,USA,IL,Mount Vernon,66.232.166.86,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,COCCIDIOIDOMYCOSIS:,114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:39:05,1640464398,5/21/2015 17:38:48,false,neodev,1,20961587,NLD,5,Maastricht,84.26.48.136,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,COCCIDIOIDOMYCOSIS:,114,18-31,AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:46:13,1640469233,5/21/2015 17:44:58,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,extrathoracic disseminated COCCIDIOIDOMYCOSIS:,87-101-114,5-18-31,Conventional AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533754,5/21/2015 17:47:21,1640469910,5/21/2015 17:46:48,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,114,18,,,132,32,COCCIDIOIDOMYCOSIS,AMPHOTERICIN B,extrathoracic disseminated COCCIDIOIDOMYCOSIS: 1,87-101-114-138,5-18-31,Conventional AMPHOTERICIN B,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily.,114,18 31,114,18,-1,132,32,TWrex-cause,803451,441  Conventional amphotericin B in HIV-infected adolescents with diffuse pulmonary or extrathoracic disseminated coccidioidomycosis: 0.7-1 mg/kg daily,coccidioidomycosis,amphotericin b
724533755,5/21/2015 18:49:35,1640508209,5/21/2015 18:48:55,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,99,137,,,105,145,STROKE,WARFARIN,"CONCLUSION In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for STROKE or systemic embolism more than warfarin and had similar rates of major hemorrhage.",0-12-15-24-29-36-50-62-66-69-75-82-90-95-99-106-109-118-127-132-137-146-150-154-162-168-171-177,0-12-15-24-29-36-50-62-66-69-75-82-90-95-99-106-109-118-127-132-137-146-150-154-162-168-171-177,"CONCLUSION In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than WARFARIN and had similar rates of major hemorrhage.","CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 18:54:19,1640512157,5/21/2015 18:54:03,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,99,137,,,105,145,STROKE,WARFARIN,STROKE,99,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 18:54:58,1640512840,5/21/2015 18:54:32,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,99,137,,,105,145,STROKE,WARFARIN,STROKE,99,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 18:55:05,1640512973,5/21/2015 18:54:47,false,elite,1,26544151,GBR,,,213.205.252.83,99,137,,,105,145,STROKE,WARFARIN,STROKE,99,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 18:55:57,1640513846,5/21/2015 18:55:23,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,99,137,,,105,145,STROKE,WARFARIN,"patients with atrial fibrillation, dabigatran, 150 twice daily, reduced risk for STROKE or systemic embolism",15-24-29-36-50-62-69-82-90-95-99-106-109-118-75,29-36-50-69-75-82-90-95-99-106-118-127-132-137-146-150-154-162,"atrial fibrillation, dabigatran, twice daily, reduced risk for stroke or embolism more than WARFARIN and had similar rates","CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 18:56:00,1640513905,5/21/2015 18:55:40,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,99,137,,,105,145,STROKE,WARFARIN,STROKE systemic embolism,99-118-109,137-154,WARFARIN similar,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 18:58:16,1640515581,5/21/2015 18:57:38,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,99,137,,,105,145,STROKE,WARFARIN,STROKE embolism,99-118,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 19:06:39,1640521818,5/21/2015 19:05:46,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,99,137,,,105,145,STROKE,WARFARIN,STROKE or systemic embolism,99-106-109-118,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 19:11:03,1640524828,5/21/2015 19:10:51,false,cointasker,1,21783324,NLD,,,31.151.239.133,99,137,,,105,145,STROKE,WARFARIN,STROKE,99,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533755,5/21/2015 19:29:40,1640551385,5/21/2015 19:27:08,false,clixsense,1,22947672,GBR,,,88.144.127.68,99,137,,,105,145,STROKE,WARFARIN,STROKE,99,137,WARFARIN,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage.",99,137,99,137,-1,105,145,TWrex-cause,804882,"CONCLUSION  In patients with atrial fibrillation, dabigatran, 150 mg twice daily, reduced risk for stroke or systemic embolism more than warfarin and had similar rates of major hemorrhage",stroke,warfarin
724533756,5/21/2015 18:57:57,1640515395,5/21/2015 18:57:25,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,82,128,,,90,134,DIABETES,LISPRO,Long term intensive treatment of type 1 DIABETES with the short acting insulin analog lispro in variable combination with NPH insulin at mealtime.,42-47-52-62-72-75-80-82-91-96-100-106-113-121-128-135-138-147-159-164-168-176-179,42-47-52-62-72-75-80-82-91-96-100-106-113-121-128-135-138-147-159-164-168-176-179,Long term intensive treatment of type 1 diabetes with the short acting insulin analog LISPRO in variable combination with NPH insulin at mealtime.,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 18:58:27,1640515673,5/21/2015 18:58:07,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,82,128,,,90,134,DIABETES,LISPRO,type 1 DIABETES,75-80-82,128,LISPRO,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 18:58:34,1640515754,5/21/2015 18:58:06,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,82,128,,,90,134,DIABETES,LISPRO,type 1 DIABETES,75-80-82,100-106-113-121-128,short acting insulin analog LISPRO,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 18:59:11,1640516256,5/21/2015 18:58:58,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,82,128,,,90,134,DIABETES,LISPRO,type 1 DIABETES,75-80-82,128,LISPRO,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 19:00:38,1640517444,5/21/2015 19:00:15,false,elite,1,26544151,GBR,,,213.205.252.83,82,128,,,90,134,DIABETES,LISPRO,DIABETES,82,128,LISPRO,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 19:01:31,1640518093,5/21/2015 19:01:21,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,82,128,,,90,134,DIABETES,LISPRO,type 1 DIABETES,75-80-82,113-121-128,insulin analog LISPRO,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 19:16:45,1640528937,5/21/2015 19:16:15,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,82,128,,,90,134,DIABETES,LISPRO,type 1 DIABETES,75-80-82,100-106-113-121-128,short acting insulin analog LISPRO,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 19:40:58,1640561089,5/21/2015 19:39:54,false,clixsense,1,22947672,GBR,,,88.144.127.68,82,128,,,90,134,DIABETES,LISPRO,of type 1 DIABETES,72-75-80-82,113-121-128-138-147-135,insulin analog LISPRO <span id=transmark></span>in variable combination,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 19:42:00,1640561880,5/21/2015 19:41:30,false,clixsense,1,17950689,GBR,Y9,Tonypandy,92.2.44.79,82,128,,,90,134,DIABETES,LISPRO,of type 1 DIABETES,72-75-80-82,113-121-128-135-138-147,insulin analog LISPRO in variable combination,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533756,5/21/2015 19:48:27,1640567256,5/21/2015 19:47:59,false,clixsense,1,30130805,USA,MI,Wyandotte,63.141.31.35,82,128,,,90,134,DIABETES,LISPRO,DIABETES with the short acting insulin,82-91-96-100-106-113,106-113-121-128-135-138-147,acting insulin analog LISPRO in variable combination,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime.",82,128,82,128,-1,90,134,TWrex-cause,800069,"Lalli C, Ciofetta M, Del Sindaco P et al. Long-term intensive treatment of type 1 diabetes with the short-acting insulin analog lispro in variable combination with NPH insulin at mealtime",diabetes,lispro
724533757,5/21/2015 17:06:58,1640443949,5/21/2015 17:06:34,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:08:01,1640444464,5/21/2015 17:07:40,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:15:31,1640449093,5/21/2015 17:14:59,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:20:57,1640452957,5/21/2015 17:20:23,false,points4rewards,1,28703583,USA,,,97.73.83.199,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,Crohn's disease DIARRHEA,0-8-49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:22:44,1640454048,5/21/2015 17:22:31,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:30:16,1640458916,5/21/2015 17:30:05,false,meprizescf,1,31395940,USA,NY,Victor,72.230.179.20,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:48:09,1640470340,5/21/2015 17:47:49,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:48:09,1640470345,5/21/2015 17:46:56,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 17:52:10,1640472652,5/21/2015 17:51:16,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,"DIARRHEA (with or without blood),",49-58-64-67-75,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533757,5/21/2015 18:04:05,1640480703,5/21/2015 18:02:58,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,49,0,,,57,15,DIARRHEA,CROHN'S DISEASE,DIARRHEA,49,0-8,CROHN'S DISEASE,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders.",49,0 8,49,0,1,57,15,TWrex-cause,812674,"Crohn's disease  Presenting symptoms can include diarrhea (with or without blood), fever, weight loss, fatigue and abdominal pain  History, chronicity of symptoms, and colonoscopic exam with biopsy may differentiate the disorders",diarrhea,crohn's disease
724533758,5/21/2015 18:52:07,1640510327,5/21/2015 18:51:54,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,Fluconazole therapy for HISTOPLASMOSIS.,44-56-64-68,44-56-64-68,FLUCONAZOLE therapy for histoplasmosis.,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 18:54:55,1640512815,5/21/2015 18:54:41,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44,FLUCONAZOLE,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 18:55:31,1640513475,5/21/2015 18:55:15,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44-56,FLUCONAZOLE therapy,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 18:55:55,1640513793,5/21/2015 18:55:33,false,elite,1,26544151,GBR,,,213.205.252.83,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44,FLUCONAZOLE,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 18:56:28,1640514328,5/21/2015 18:56:22,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,Fluconazole therapy for HISTOPLASMOSIS.,44-56-64-68,33-37-40-44-56-64-68,"PG, et al: FLUCONAZOLE therapy for histoplasmosis.","McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 18:56:32,1640514400,5/21/2015 18:56:19,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44,FLUCONAZOLE,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 18:58:57,1640516047,5/21/2015 18:58:46,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44-56,FLUCONAZOLE therapy,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 19:08:12,1640522840,5/21/2015 19:07:38,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44-56,FLUCONAZOLE therapy,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 19:11:32,1640525166,5/21/2015 19:11:22,false,cointasker,1,21783324,NLD,,,31.151.239.133,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,HISTOPLASMOSIS.,68,44,FLUCONAZOLE,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533758,5/21/2015 19:30:48,1640552296,5/21/2015 19:29:21,false,instagc,1,23657877,USA,DE,Dover,98.252.20.214,68,44,,,82,55,HISTOPLASMOSIS,FLUCONAZOLE,Fluconazole therapy for HISTOPLASMOSIS.,44-56-64-68,33-37-40-44-56-64-68,"PG, et al: FLUCONAZOLE therapy for histoplasmosis.","McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis.",68,44,68,44,-1,82,55,TWrex-cause,803595,"McKinsey DS, Kauffman CA, Pappas PG, et al: Fluconazole therapy for histoplasmosis",histoplasmosis,fluconazole
724533759,5/21/2015 16:12:50,1640408507,5/21/2015 16:12:29,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97-108,TAZAROTENE gel,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 16:16:54,1640411218,5/21/2015 16:16:31,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97-108-112-116,TAZAROTENE gel and cream,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 16:23:14,1640415397,5/21/2015 16:22:54,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97-108-112-116,TAZAROTENE gel and cream,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 16:25:46,1640417096,5/21/2015 16:25:20,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97-108-112-116-122,TAZAROTENE gel and cream formulations,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 16:34:47,1640423060,5/21/2015 16:34:21,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97,TAZAROTENE,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 16:35:14,1640423324,5/21/2015 16:35:04,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97,TAZAROTENE,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 16:45:16,1640430232,5/21/2015 16:44:56,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97,TAZAROTENE,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 17:01:17,1640440380,5/21/2015 17:01:01,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97,TAZAROTENE,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 17:03:05,1640441543,5/21/2015 17:02:53,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97,TAZAROTENE,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533759,5/21/2015 17:11:26,1640446612,5/21/2015 17:11:15,false,dailyrewardsca,1,32438879,CAN,NB,Fredericton,156.57.46.234,181,97,,,190,107,PSORIASIS,TAZAROTENE,PSORIASIS.,181,97,TAZAROTENE,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis.,181,97,181,97,-1,190,107,TWrex-cause,800769,Acne exacerbation may occur in the early weeks of treatment  Slow onset of clinical improvement; tazarotene gel and cream formulations are available in 0.05% concentration to treat psoriasis,psoriasis,tazarotene
724533760,5/21/2015 17:24:56,1640455577,5/21/2015 17:24:38,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 17:25:47,1640456046,5/21/2015 17:24:46,false,points4rewards,1,28703583,USA,,,97.73.83.199,214,187,,,221,191,ANXIETY,PTSD,"PTSD ANXIETY,",70-214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 17:51:26,1640472151,5/21/2015 17:51:01,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 17:57:39,1640476519,5/21/2015 17:57:15,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 18:02:34,1640479841,5/21/2015 18:00:48,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 18:07:26,1640482915,5/21/2015 18:07:08,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,214,187,,,221,191,ANXIETY,PTSD,"nightmares improve other symptoms; and their nightmares, ANXIETY, and other PTSD",112-127-145-192-196-202-214-223-227-233-151,173-178-182-187-192-196-202-214,"does not cure PTSD and their nightmares, anxiety,","101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 18:08:23,1640483420,5/21/2015 18:08:06,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 18:13:30,1640487205,5/21/2015 18:13:03,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 18:35:50,1640497139,5/21/2015 18:35:25,false,clixsense,1,6574449,USA,,,216.216.68.85,214,187,,,221,191,ANXIETY,PTSD,"ANXIETY,",214,187,PTSD,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533760,5/21/2015 18:36:09,1640497502,5/21/2015 18:35:14,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,214,187,,,221,191,ANXIETY,PTSD,"PTSD and their nightmares, ANXIETY, and other PTSD related symptoms may return if therapy is stopped.",187-192-196-202-214-223-227-233-238-246-255-259-266-269-277-280,70-77-82-87-91-127-135-145-151-161-170-173-178-182-187-192-196-202-141,"PTSD + that the drug improve sleep and other symptoms; however, it does not cure PTSD and their nightmares,","101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped.",214,187,214,187,1,221,191,TWrex-cause,810468,"101 ,   218 •  Importance of advising patients receiving prazosin for PTSD   +    that the drug may help reduce nightmares and improve sleep and other symptoms; however, it does not cure PTSD and their nightmares, anxiety, and other PTSD-related symptoms may return if therapy is stopped",anxiety,PTSD
724533761,5/21/2015 17:25:41,1640455987,5/21/2015 17:25:19,false,gifthunterclub,1,29582088,GBR,I2,Manchester,89.240.68.44,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,MEMBRANE,33,71-78,MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 17:28:23,1640457717,5/21/2015 17:27:27,false,points4rewards,1,28703583,USA,,,97.73.83.199,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,MEMBRANE hypertrophy,33-52,52-71-78,hypertrophy MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 17:52:16,1640472779,5/21/2015 17:51:54,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,nasal mucous MEMBRANE,20-26-33,52-64-67-71-78,hypertrophy of the MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 17:58:41,1640477294,5/21/2015 17:58:16,false,neodev,1,18881135,CAN,ON,Ajax,99.243.87.224,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,nasal mucous MEMBRANE,20-26-33,71-78,MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 18:06:09,1640482124,5/21/2015 18:04:36,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,mucous MEMBRANE,26-33,71-78,MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 18:08:02,1640483247,5/21/2015 18:07:47,false,neodev,1,31743852,GBR,G5,Margate,85.210.116.118,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,the nasal mucous MEMBRANE marked by hypertrophy turbinates and the septum.,16-20-26-33-42-49-52-94-105-109-113,52-64-67-71-78-87-90-94-109-113,hypertrophy of the MUCOUS MEMBRANE of the turbinates the septum.,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 18:09:08,1640484035,5/21/2015 18:08:46,false,instagc,1,20312760,GBR,I2,Manchester,90.244.152.57,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,nasal mucous MEMBRANE,20-26-33,71-78,MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 18:14:37,1640487950,5/21/2015 18:14:00,false,clixsense,1,6338946,CAN,ON,Ottawa,23.91.230.44,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,nasal mucous MEMBRANE,26-33-20,71-78,MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 18:36:30,1640497820,5/21/2015 18:36:06,false,clixsense,1,6574449,USA,,,216.216.68.85,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,nasal mucous MEMBRANE,20-26-33,71-78,MUCOUS MEMBRANE,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533761,5/21/2015 18:37:30,1640498684,5/21/2015 18:36:36,false,neodev,1,32216655,NLD,7,Amsterdam,145.100.72.168,33,71,,,41,86,MEMBRANE,MUCOUS MEMBRANE,Inflammation of the nasal mucous MEMBRANE marked by hypertrophy,0-16-20-26-33-42-49-52-13,52-64-67-71-78-87-90-94-105-109-113,hypertrophy of the MUCOUS MEMBRANE of the turbinates and the septum.,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum.,33,71 78,33,71,-1,41,86,TWrex-cause,802426,Inflammation of the nasal mucous membrane marked by hypertrophy of the mucous membrane of the turbinates and the septum,membrane,mucous membrane
724533762,5/21/2015 17:58:43,1640477287,5/21/2015 17:58:20,false,clixsense,1,29155723,GBR,H8,Liverpool,92.25.104.189,77,108,,,84,118,MALARIA,PLASMODIUM,uncomplicated MALARIA,63-77,108-119,"PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:31:38,1640493166,5/21/2015 18:30:35,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,77,108,,,84,118,MALARIA,PLASMODIUM,uncomplicated MALARIA,63-77,99-108-119,"parasite PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:45:29,1640505101,5/21/2015 18:44:53,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,77,108,,,84,118,MALARIA,PLASMODIUM,"Quinine is only FDA approved for the treatment of uncomplicated MALARIA caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria endemic areas.",13-21-24-29-33-42-46-50-60-63-77-85-92-95-99-108-119-131-141-144-154-164-169-177-185,13-21-24-29-33-42-46-50-60-63-77-85-92-95-99-108-119-131-141-144-154-164-169-177-185,"Quinine is only FDA approved for the treatment of uncomplicated malaria caused by the parasite PLASMODIUM falciparum, primarily in travelers returning from malaria endemic areas.","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:50:57,1640509412,5/21/2015 18:49:01,false,gifthunterclub,1,24043308,GBR,,,94.102.147.250,77,108,,,84,118,MALARIA,PLASMODIUM,uncomplicated MALARIA,63-77,108-119,"PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:52:00,1640510235,5/21/2015 18:51:44,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,77,108,,,84,118,MALARIA,PLASMODIUM,MALARIA,77,108-119,"PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:52:21,1640510451,5/21/2015 18:52:00,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,77,108,,,84,118,MALARIA,PLASMODIUM,MALARIA,77,99-108-119,"parasite PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:52:21,1640510456,5/21/2015 18:52:06,false,elite,1,26544151,GBR,,,213.205.252.83,77,108,,,84,118,MALARIA,PLASMODIUM,MALARIA,77,108,PLASMODIUM,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:53:04,1640510970,5/21/2015 18:52:27,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,77,108,,,84,118,MALARIA,PLASMODIUM,"Quinine is approved treatment of uncomplicated MALARIA caused by the parasite Plasmodium falciparum,",13-21-33-50-60-63-77-85-92-95-99-108-119,13-21-92-95-99-108-119-131-141-33,"Quinine is approved by the parasite PLASMODIUM falciparum, primarily in","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:53:46,1640511615,5/21/2015 18:53:31,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,77,108,,,84,118,MALARIA,PLASMODIUM,uncomplicated MALARIA,63-77,108-119,"PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533762,5/21/2015 18:54:09,1640512014,5/21/2015 18:53:18,false,cointasker,1,21783324,NLD,,,31.151.239.133,77,108,,,84,118,MALARIA,PLASMODIUM,uncomplicated MALARIA,63-77,108-119,"PLASMODIUM falciparum,","BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas.",77,108,77,108,1,84,118,TWrex-cause,812377,"BACKGROUND : Quinine is only FDA-approved for the treatment of uncomplicated malaria caused by the parasite Plasmodium falciparum, primarily in travelers returning from malaria-endemic areas",malaria,plasmodium
724533763,5/21/2015 16:10:20,1640407147,5/21/2015 16:10:04,false,clixsense,1,30681826,GBR,I3,Rochester,86.163.150.232,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232-240-243,Paget's DISEASE of bone.,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:14:09,1640409497,5/21/2015 16:13:55,false,instagc,1,32352104,USA,ME,Bangor,74.75.63.81,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN given,186-191-201,210-219-224-232-240-243,patients with Paget's DISEASE of bone.,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:20:24,1640413455,5/21/2015 16:20:03,false,points4rewards,1,28755767,USA,VA,Chester,68.57.118.32,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232,Paget's DISEASE,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:22:39,1640414991,5/21/2015 16:22:21,false,prodege,1,14848125,GBR,U8,Edinburgh,86.149.215.103,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232,Paget's DISEASE,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:32:11,1640421638,5/21/2015 16:31:35,false,prodege,1,27934334,GBR,D2,Derby,86.162.35.12,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232,Paget's DISEASE,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:33:29,1640422406,5/21/2015 16:33:16,false,sharecashgpt,1,28627999,CAN,ON,Sudbury,66.103.55.12,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232,Paget's DISEASE,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:39:12,1640425892,5/21/2015 16:38:31,false,points4rewards,1,20306700,USA,WA,Bothell,50.125.145.37,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232-240-243,Paget's DISEASE of bone.,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 16:59:15,1640439170,5/21/2015 16:58:59,false,instagc,1,25990856,USA,NV,Las Vegas,98.160.220.169,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,224-232,Paget's DISEASE,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 17:00:23,1640439831,5/21/2015 17:00:09,false,clixsense,1,21776599,NLD,6,Tilburg,82.157.8.252,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN,186-191,232,DISEASE,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533763,5/21/2015 17:08:26,1640444745,5/21/2015 17:07:31,false,points4rewards,1,28703583,USA,,,97.73.83.199,186,232,,,195,239,BONE PAIN,DISEASE,BONE PAIN Paget's disease,186-191-224-232,232-240-243-224,Paget's DISEASE of bone.,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone.",186 191,232,186,232,1,195,239,TWrex-cause,813047,"Evidence: • Two clinical randomized, double-blind trials have shown that alendronate (40 mg, orally, daily, for 6 months) results in reduction in bone turnover markers, radiographs, and bone pain when given to patients with Paget's disease of bone",bone pain,disease
724533764,5/21/2015 18:34:52,1640496144,5/21/2015 18:34:03,false,points4rewards,1,20113482,USA,OR,Portland,67.213.218.72,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING,12-27,79-91,ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:47:20,1640506528,5/21/2015 18:46:50,false,clixsense,1,10798016,GBR,C7,Coventry,86.24.245.191,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING is the most frequent presenting symptom of endometrial carcinoma ( 35.,12-27-36-39-43-48-57-68-76-79-91-103-101,12-27-36-39-43-48-57-68-76-79-91-103-101,Postmenopausal bleeding is the most frequent presenting symptom of ENDOMETRIAL CARCINOMA ( 35.,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:53:02,1640510896,5/21/2015 18:52:47,false,clixsense,1,10032240,USA,FL,Naples,76.101.211.223,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING,12-27,79-91,ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:53:22,1640511236,5/21/2015 18:53:10,false,elite,1,26544151,GBR,,,213.205.252.83,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING,12-27,79-91,ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:53:35,1640511450,5/21/2015 18:53:19,false,instagc,1,30326470,USA,CA,Santee,99.44.37.73,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING,12-27,79-91,ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:54:23,1640512265,5/21/2015 18:53:59,false,prodege,1,3587109,CAN,NS,Sydney,142.177.43.88,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,Evidence: • POSTMENOPAUSAL BLEEDING is the most presenting symptom of endometrial carcinoma,0-10-12-27-36-39-43-68-76-79-91-57,12-57-68-76-79-91-103-27,Postmenopausal bleeding presenting symptom of ENDOMETRIAL CARCINOMA 35.,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:54:45,1640512614,5/21/2015 18:54:29,false,instagc,1,15864091,USA,OK,Oklahoma City,104.0.113.133,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING,12-27,79-91,ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 18:56:43,1640514513,5/21/2015 18:56:33,false,instagc,1,30398579,USA,MA,Winchendon,73.38.174.116,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,POSTMENOPAUSAL BLEEDING,12-27,79-91,ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 19:00:28,1640517296,5/21/2015 18:59:38,false,neodev,1,32103286,USA,CA,San Jose,23.27.248.112,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,Evidence: • POSTMENOPAUSAL BLEEDING is the most,0-10-12-27-36-39-43,57-68-76-79-91-103,presenting symptom of ENDOMETRIAL CARCINOMA 35.,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
724533764,5/21/2015 19:00:53,1640517639,5/21/2015 18:59:58,false,cotter,1,577723,USA,FL,Kissimmee,71.52.102.94,12,79,,,35,100,POSTMENOPAUSAL BLEEDING,ENDOMETRIAL CARCINOMA,Evidence: • POSTMENOPAUSAL BLEEDING endometrial carcinoma,0-10-12-27-79-91,12-79-91-27,Postmenopausal bleeding ENDOMETRIAL CARCINOMA,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35.,12 27,79 91,12,79,1,35,100,TWrex-cause,812838,Evidence: • Postmenopausal bleeding is the most frequent presenting symptom of endometrial carcinoma ( 35,postmenopausal bleeding,endometrial carcinoma
